<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="result">
            <roleset id="result.01" name="" wordnet="2">
                <roles>
                    <role n="0" descr="Theme, prior condition &#x0A;" />
                    <role n="1" descr="Goal, end condition&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype is conferred by an activated mutation of egl-15 or a lf clr-1.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>Change can cause heat instability and affect the net charge of the varying subunit resulting in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Change can cause heat instability and affect the net charge of the varying subunit results in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>DNA II expression of Isoform II DNA in COS7 has the ability to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Exon 13 jumping in s1031 animals can eventually result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Exon 13 jumping in s1031 animals can result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Exon 13 jumping in s1031 animals is able to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Exon 13 jumping in s1031 animals is likely to resulting in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Exon 13 jumping in s1031 animals may have resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Expression of cDNA isoform II DNA in COS7 cells is eventually able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Expression of cDNA isoform II DNA in COS7 cells may ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells will finally result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells will result in a marked increase in the activity of acetylhydralase of PAF .</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Expression of isoform II cDNA in COS7 cells may result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Induction of a mutation in the lacI gene may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, has the ability to result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Induction of a mutation in the lacI gene, as our study revealed, may have resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>It has also been reported that the existence of NF-YA isoforms has been result as a result of differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>It is result that growth in ras-dependent signaling results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Lets show that the negative effect of the mutation cpxA in biofilm formation has the ability to result from a decrease in the transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Lets show that the negative effect of the mutation cpxA in biofilm formation may have resulted from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Mutations that can result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Mutations that can result in symultaneous derepression of both genes can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Mutations that can resulted in symultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Mutations that result repressor binding to any site or alter the binding phase of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Mutations that result the binding of repressors to the site or alter the phase of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Mutations that resulted in symultaneous derepression of both genes can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Mutations that resulting in symultaneous derepression of both genes can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Research shows the existence of isoforms of NF-YA resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>Research shows the existence of isoforms of NF-YA results from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Sequence analysis of the HDIbeta gene resulted that difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) is the result of alternative of a single transcription cut.</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>Sequence analysis of the HDIbeta gene resulted that difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut) (difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of alternative of a single transcription cut.</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) may resulted from alternative splicing of a single transcription.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>Sequence analysis of the IDHbeta gene result that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) has been shown to be the result of alternative splicing of a single transcription.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>Sequence analysis of the IDHbeta gene resulted that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) may have been the result of alternative splicing of a single transcription.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>The Diminutive EGL-15 signal that resulted in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>The Diminutive EGL-15 signal, conferred by a partial mutation lf egl-15, has resulted in a phenotype of scrawny morphology(Kokel et al., 1998).</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits that may have resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>The alteration can cause thermal instability and affect liquid load of the variant subunit, which ended up resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>The alteration can result thermal instability and affect liquid charge of varying subunits which is capable of giving rise to a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which ultimately results in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>The alteration can results thermal instability and affect liquid load of variant subunit which results in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The alteration may cause thermal instability and affect liquid load of variant subunit which finally resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>The alteration may cause thermal instability and affect liquid load of variant subunit which has been demonstrated to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>The alteration may cause thermal instability and affect liquid load of variant subunit, which may ultimately resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to ultimately result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>The decreases the EGL-15 signaling that is capable of result rise to a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 and was able to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that was observed to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 resulting in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 that may result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>The grid-dependent fluctuation in signaling has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains that are result as entirely super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains that results in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes mixed alternative subdomains that are observed to result entirely in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes mixed alternative subdomains that can result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains result able to give the complete result a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>The human mucin gene MUC5B, the 10.7kb large central exon encodes multiple alternative subdomains resulting in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that can result entirely in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternate subdomains that resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes mixed alternative subdomains that result entirely in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternative subdomains which may have resulted entirely in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes multiple alternative subdomains that have resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes multiple alternative subdomains that may have resulted entirely in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes multiple alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>The induction of a mutation in the lacI gene, as revealed by our study, has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>The induction of a mutation in the lacI gene, as revealed in our study, is seen to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>The reduced EGL-15 signaling that can result in a phenotype of dirty body morphology (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>The research results existence of NF-YA isoforms that results from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>The sequence analysis of the HDIbeta gene indicates that difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) (difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>The sequence analysis of the HDIbeta gene result that difference in the 28 C-terminal amino acids between beta(1) and beta(2) has been the result of alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame mutation, and a splicing mutation) can result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>These observations show that repression can be the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>These observations show that repression is thought to be the result of cooperative binding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>These observations show that repression was the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>Two are the meaningless mutations in exon 2 (G339D and R340C), and the other three changes (one meaningless mutation, a change in table and a splicing mutation) are result as a result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) are result as a result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) has been shown to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>Two result the meaningless mutations in exon 2 (G339D and R340C), and the other three changes (one meaningless mutation, a change in table and a splicing mutation) result able to give rise to non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>We also report existence of NF-YA isoforms that is able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>We also report existence of NF-YA isoforms that may have resulted from differential slicing.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>We also reported existence of NF-YA isoforms that may result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>We also reported that existence of NF-YA isoforms is able to result from differential spacing.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>We also result the the existence of NF-YA isoforms that will be derived from the differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>We show that the negative effect of cpxA mutation on biofilm formation may have resulted from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>We show that the negative effect of cpxA mutation on biofilm formation may result from a decrease in the transcription of csgA coding gene csgA csgA.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, conferred by an activated egl-15 or a lf clr-1 mutation, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, conferred by an activated egl-15 or a mutation lf clr-1, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive, conferred by an activated egl-15 or a lf clr-1 mutation, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that has resulted in a Clr phenotype is conferred by an activated egl-15 or lf clr-1 mutation.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, conferred by an activated egl-15 or a mutation lf clr-1, is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF, conferred by an activated egl-15 or a mutation lf clr-1, has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that can result in a Clr phenotype is conferred by an activated egl-15 mutation or lf clr-1.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, conferred by an activated egl-15 or a mutation lf clr-1, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which may have resulted in a Clr phenotype is conferred by an activated mutation of egl-15 or a lf clr-1.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="99">
                    <text>a variant resulted the result of the normal splice donor site of the 12th intron could not be used.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="EGRAM" no="100">
                    <text>a variant was probably able to result from the normal site of the intron 12 splice donor could not be used.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="EGRAM" no="101">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, will result in the mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="EGRAM" no="102">
                    <text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, may result in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="EGRAM" no="103">
                    <text>both the mutations at the site of 5 and 3 splices (1060 + 2t--c and 678-7g--a, respectively) will result in of high proportion of mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="EGRAM" no="104">
                    <text>both the mutations of 5 and 3 splices (1060 + 2t--c and 678-7g--a respectively), in contrast, resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="105">
                    <text>both the mutations of 5 and 3 splices (1060 + 2t--c and 678-7g--a, respectively) resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="106">
                    <text>exon 13 jump in s1031 animals can eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="107">
                    <text>exon 13 jump in s1031 animals will result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="108">
                    <text>exon 13 jump in s1031 animals will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="109">
                    <text>exon 13 jumping in animals s1031 is likely to resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="EGRAM" no="110">
                    <text>expression of cDNA ISOform II DNA in COS7 cells eventually resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="EGRAM" no="111">
                    <text>expression of cDNA ISOform II DNA in COS7 cells has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="EGRAM" no="112">
                    <text>fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="EGRAM" no="113">
                    <text>fluctuation in ras-dependent signaling, as result, results in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="EGRAM" no="114">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="EGRAM" no="115">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, may result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="EGRAM" no="116">
                    <text>fluctuation in ras-dependent signaling, as we have result, results in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="EGRAM" no="117">
                    <text>negative effect of cpxA mutation in biofilm formation has been result to be the result of reduction of csgA gene transcription csgA coding.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="EGRAM" no="118">
                    <text>reduction of EGL-15 signaling that is able to result in a dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="119">
                    <text>reduction of EGL-15 signaling that resulted in dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="120">
                    <text>reduction of EGL-15 signaling which may result in dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="121">
                    <text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, is able to result in scratched body morphology phenotype (Kokel et al., 1998).</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="122">
                    <text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, may result in scratched body morphology phenotype (Kokel et al., 1998).</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>CdNA II DNA expression of isoform II in COS7 cells can result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>CdNA II DNA expression of isoform II in COS7 cells cells can result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>CdNA II DNA expression of isoform II in COS7 cells cells is eventually able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>CdNA II DNA expression of isoform II in COS7 cells eventually resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>CdNA II DNA expression of isoform II in COS7 cells has finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>CdNA II DNA expression of isoform II in COS7 cells has the ability to eventually result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>CdNA II DNA expression of isoform II in COS7 cells is capable of result rise to a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>CdNA II DNA expression of isoform II in COS7 cells is shown to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>CdNA II DNA expression of isoform II in COS7 cells is shown to ultimately result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>CdNA II DNA expression of isoform II in COS7 cells may ultimately resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>CdNA II DNA expression of isoform II in COS7 cells will result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>CdNA II DNA expression of isoform II in COS7 cells, as we have predicted, has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>CdNA II DNA expression of isoform II in COS7 cells, as we have predicted, is likely to resulting in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 resulting in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Change can cause heat instability and affect a new mutation in codon 210 results in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Change can cause heat instability and affect a new mutation in codon 210 results in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulting in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Change can cause heat instability and affect alternative exon coupling 139 nt resulting in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Change can cause heat instability and affect alternative mixed subdomains resulting in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Change can cause heat instability and affect alternative mixed subdomains results in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Change can cause heat instability and affect differential slicing resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells results in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 results in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Change can cause heat instability and affect failure to use the normal donor site of the intron 12 ear results in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>Change can cause heat instability and affect fluctuation in ras-dependent signaling resulting in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Change can cause heat instability and affect fluctuation in signaling depending on the ras results in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Change can cause heat instability and affect glow in signaling depending on the ras results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Change can cause heat instability and affect liquid load of the variable subunit resulting in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>Change can cause heat instability and affect liquid load of variant subunit resulting in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Change can cause heat instability and affect missing to use the normal donor site of the ear 12 intron results in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Change can cause heat instability and affect multiple alternative subdomains results in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Change can cause heat instability and affect some alternative subdomains results in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Change can cause heat instability and affect the net charge of the variant subunit results in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Change can cause heat instability and affect the net load of the variant subunit results in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>DNA II expression of Isoform II DNA in COS7 cells can result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>DNA II expression of Isoform II DNA in COS7 has the ability to eventually result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>DNA II expression of Isoform II DNA in COS7 is shown to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>DNA II expression of Isoform II DNA in COS7 may result in a marked increase in the activity of PAF acetylhydase .</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>DNA II expression of Isoform II DNA in COS7 may result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>DNA II expression of Isoform II DNA in COS7, as we have predicted, has the ability to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>DNA II expression of Isoform II DNA in COS7, as we have predicted, resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>DNA II expression of Isoform II DNA in COS7, as we have result, is able to give rise to a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Exon 13 jumping in s1031 animals cells can result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>Exon 13 jumping in s1031 animals cells has the ability to ultimately result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>Exon 13 jumping in s1031 animals may eventually result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>Exon 13 jumping in s1031 animals may result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>Exon 13 jumping in s1031 animals may ultimately resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>Exon 13 jumping in s1031 animals will result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Exon 13 jumping in s1031 animals, as predicted, resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Exon 13 jumping in s1031 animals, as we have predicted, is able to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Exon 13 jumping in s1031 animals, as we have result, is able to give rise to a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Expression of cDNA isoform II DNA in COS7 can ultimately resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Expression of cDNA isoform II DNA in COS7 cells can result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Expression of cDNA isoform II DNA in COS7 cells cells has resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Expression of cDNA isoform II DNA in COS7 cells eventually resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Expression of cDNA isoform II DNA in COS7 cells eventually resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Expression of cDNA isoform II DNA in COS7 cells has finally resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Expression of cDNA isoform II DNA in COS7 cells is capable of result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Expression of cDNA isoform II DNA in COS7 cells is eventually able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Expression of cDNA isoform II DNA in COS7 cells is shown to ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Expression of cDNA isoform II DNA in COS7 cells may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Expression of cDNA isoform II DNA in COS7 cells will result in a marked increase in the activity of PAF acetylhydrolase .</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Expression of cDNA isoform II DNA in COS7 cells, as predicted, may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Expression of cDNA isoform II DNA in COS7 cells, as we have predicted, has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Expression of cDNA isoform II DNA in COS7 cells, as we have predicted, will result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Expression of cDNA isoform II DNA in COS7 is able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Expression of cDNA isoform II DNA in COS7 is able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Expression of cDNA isoform II DNA in COS7 is shown to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Expression of cDNA isoform II DNA in COS7 is shown to ultimately result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Expression of cDNA isoform II DNA in COS7 may eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Expression of cDNA isoform II DNA in COS7 may eventually result in a marked increase in the activity of PAF acetylhydrolase</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Expression of cDNA isoform II DNA in COS7 may have finally resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Expression of cDNA isoform II DNA in COS7 will finally result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>Expression of cDNA isoform II DNA in COS7, as predicted, can result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>Expression of cDNA isoform II DNA in COS7, as predicted, may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, may result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, may result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, will result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have result, is able to give rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells can ultimately resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells cells can result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has finally resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is capable of result rise to a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is capable of result rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is shown to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is shown to ultimately result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is shown to ultimately result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells may eventually result in a marked increase in the activity of acetylhydralase of PAF</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells may have finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells may result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells resulted in a marked increase in the activity of acetylhydralase of PAF .</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells will finally result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells will result in a marked increase in the acetylhydrase activity of PAF .</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as predicted, resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, is likely to resulting in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, may result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, may resulting in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, will result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have result, is able to give rise to a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have result, is able to give rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>Expression of isoform II cDNA in COS7 cells cells can result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>Expression of isoform II cDNA in COS7 cells cells eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>Expression of isoform II cDNA in COS7 cells cells has resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>Expression of isoform II cDNA in COS7 cells finally resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>Expression of isoform II cDNA in COS7 cells is likely to resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>Expression of isoform II cDNA in COS7 cells may eventually result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>Expression of isoform II cDNA in COS7 cells may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>Expression of isoform II cDNA in COS7 cells will result in a marked increase in the activity of acetylhydralase of PAF .</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>Expression of isoform II cDNA in COS7 cells, as we have predicted, has the ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>Expression of isoform II cDNA in COS7 cells, as we have predicted, is likely to resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Expression of isoform II cDNA in COS7 cells, as we have predicted, resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Expression of the cD DNA of isoform II in COS7 cells can ultimately resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Expression of the cD DNA of isoform II in COS7 cells cells has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Expression of the cD DNA of isoform II in COS7 cells cells has the ability to ultimately result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Expression of the cD DNA of isoform II in COS7 cells finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Expression of the cD DNA of isoform II in COS7 cells has finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Expression of the cD DNA of isoform II in COS7 cells is capable of result rise to a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Expression of the cD DNA of isoform II in COS7 cells may eventually result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Expression of the cD DNA of isoform II in COS7 cells may have finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Expression of the cD DNA of isoform II in COS7 cells resulted in a marked increase in the activity of acetylhydrolase PAF .</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Expression of the cD DNA of isoform II in COS7 cells will eventually result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as we have predicted, is able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 can ultimately resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 cells has resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 has resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 will finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>Expression of the cdNA II DNA from isoform II in COS7, as predicted, resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that DNA II expression of Isoform II DNA in COS7 had the ability to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that Expression of cDNA isoform II DNA in COS7 cells had the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that Expression of the cD DNA of isoform II in COS7 cells had the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a new mutation to codon 210 had the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that expression of cADNA DNA isoform II in COS7 cells had the ability to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that expression of cDNA ISOform II DNA in COS7 had the ability to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that expression of cDNA ISOform II DNA in COS7 had the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that fluctuation in ras-dependent signaling had the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that fluctuation in ras-dependent signaling had the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that fluctuation in signaling depending on ras had the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that fluctuation in signaling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that glow in signaling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that glow in signalling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that grid-dependent fluctuation in signaling had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the net charge of the variant subunit had the ability to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the net charge of the variant subunit had the ability to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the net charge of the varying subunit had the ability to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the net load of the variant subunit had the ability to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>It has also been reported that a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity resulted from fluctuation in signaling depending on ras.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>It has also been reported that a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 resulted from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>It has also been reported that a fast-type LDH-B electrophoretic subunit resulted from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>It has also been reported that a marked increase in acetylhydratelase PAF activity resulted from expression of cADNA DNA isoform II in COS7 cells.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>It has also been reported that a marked increase in acetylhydrolase PAF activity resulted from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>It has also been reported that a marked increase in the acetylhydrase activity of PAF resulted from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>It has also been reported that a marked increase in the activity of PAF acetylhydrolase resulted from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>It has also been reported that a marked increase in the activity of PAF acetylhydrolase resulted from Expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>It has also been reported that a product of 543 bp resulted from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>It has also been reported that a variant resulted from missing to use the normal donor site of the ear 12 intron.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>It has also been reported that a variant resulted from not to use the normal donor site of the coupling of intron 12.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>It has also been reported that an electrophoretic subunit LDH-B resulted from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>It has also been reported that mRNA species with 5 different UTRs resulted from alternative exon 2 cutting (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>It has also been reported that mRNA species with 5 different UTRs resulted from alternative exon 2 cutting (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>It has also been reported that replacement of isoleucine to valine resulted from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>It has also been reported that replacing isoleukin with valine resulted from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>It has also been reported that superrepetition resulted from multiple alternate subdomains.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Mutations that can result in simultaneous derepression of both genes can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Mutations that may result in symultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Mutations that resulting in simultaneous derepression of both genes can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>The CdNA II DNA expression of isoform II in COS7 cells may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>The CdNA II DNA expression of isoform II in COS7 cells resulted in the a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>The CdNA II DNA expression of isoform II in COS7 cells, as predicted, has resulted in the a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>The DNA II expression of Isoform II DNA in COS7 has resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>The DNA II expression of Isoform II DNA in COS7 resulted in the a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>The DNA II expression of Isoform II DNA in COS7 will result in the a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>The Exon 13 jumping in s1031 animals, as predicted, has resulted in the a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>The Expression of cDNA isoform II DNA in COS7 cells and alternative transcriptional initiation, as result in our study, are capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>The Expression of cDNA isoform II DNA in COS7 cells has resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>The Expression of cDNA isoform II DNA in COS7 cells has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>The Expression of cDNA isoform II DNA in COS7 is capable of result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>The Expression of cDNA isoform II DNA in COS7 may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>The Expression of cDNA isoform II DNA in COS7, as predicted, has resulted in the a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>The Expression of cdNA II DNA of isoform II in COS7 cells and alternative transcriptional initiation, as result in our study, are capable of giving rise to a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>The Expression of cdNA II DNA of isoform II in COS7 cells has resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>The Expression of cdNA II DNA of isoform II in COS7 cells will result in the a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>The Expression of cdNA II DNA of isoform II in COS7 cells, as predicted, has resulted in the a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>The Expression of isoform II cDNA in COS7 cells, as predicted, has resulted in the a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>The Expression of the cD DNA of isoform II in COS7 cells has the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>The Expression of the cD DNA of isoform II in COS7 cells may have resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>The Expression of the cD DNA of isoform II in COS7 cells, as predicted, has the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>The Expression of the cdNA II DNA from isoform II in COS7 and alternative transcriptional initiation, as result in our study, are capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>The Expression of the cdNA II DNA from isoform II in COS7 is capable of result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>The Expression of the cdNA II DNA from isoform II in COS7 resulted in the a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>The a new mutation in codon 210 and alternative transcriptional initiation, as result in our study, are capable of giving rise to replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>The a new mutation in codon 210 has resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>The a new mutation in codon 210 has the ability to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>The a new mutation in codon 210 resulted in the replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>The a new mutation in codon 210 resulted in the replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>The a new mutation in codon 210 resulted in the replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>The a new mutation in codon 210 will result in the replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>The a new mutation in codon 210, as predicted, has resulted in the replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>The a new mutation in codon 210, as predicted, has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>The a new mutation in codon 210, as predicted, has the ability to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>The a new mutation in codon 210, as predicted, has the ability to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>The a new mutation to codon 210 is capable of result rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>The a new mutation to codon 210 may have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>The a new mutation to codon 210 resulted in the replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>The a new mutation to codon 210 resulted in the replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>The alteration can cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells because it is able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>The alteration can cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells being observed to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>The alteration can cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells that may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>The alteration can cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells, which can result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>The alteration can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 after having resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>The alteration can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 which is able to finally result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>The alteration can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7, which can result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>The alteration can cause thermal instability and affect Exon 13 jumping in s1031 animals which is shown to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 because it is able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells being observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells which is observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells, which ended up resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7, which can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells after having resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells being observed to finally result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells being observed to finally result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells being observed to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells, which ended up resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>The alteration can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells that may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>The alteration can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells, which can result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>The alteration can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells because it is able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>The alteration can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which is observed to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 after having resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7, which can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7, which ended up resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 after having resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 after having resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 because it is able to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 being observed to finally result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 being observed to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 that may have resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 that may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which has proven to result finally in replace isoleucine with valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which has proven to result finally in replacement of isoleucine with valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is able to finally result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is observed to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is observed to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210, which can result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210, which can result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210, which ended up resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 after having resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 being observed to finally result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 being observed to finally result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 being observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 that may have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210, which ended up resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which is able to finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, which ended up resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which is able to finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start being observed to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is observed to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is shown to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, which ended up resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>The alteration can cause thermal instability and affect alternative exon coupling 139 nt, which can result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains which has proven to result finally in super-repetitor .</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains which is able to finally result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains, which ended up resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>The alteration can cause thermal instability and affect alternative spacer of a single transcription being observed to finally result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>The alteration can cause thermal instability and affect alternative spacer of a single transcription being observed to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>The alteration can cause thermal instability and affect differential slicing after having resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>The alteration can cause thermal instability and affect differential slicing being observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>The alteration can cause thermal instability and affect differential slicing which has proven to result finally in existence of NF-YA isoforms .</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>The alteration can cause thermal instability and affect differential slicing, which can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>The alteration can cause thermal instability and affect differential spacing, which ended up resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>The alteration can cause thermal instability and affect differential spasms being observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>The alteration can cause thermal instability and affect differential spasms which is able to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>The alteration can cause thermal instability and affect differentiated xis after having resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>The alteration can cause thermal instability and affect exon 13 juar in s1031 animals being observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>The alteration can cause thermal instability and affect exon 13 juar in s1031 animals, which ended up resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals because it is able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals being observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals which has proven to result finally in a product of 543 bp .</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals which is observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>The alteration can cause thermal instability and affect exon 13 jumping in animals s1031 being observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>The alteration can cause thermal instability and affect exon 13 jumping in animals s1031 which has proven to result finally in a product of 543 bp .</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>The alteration can cause thermal instability and affect exon 13 jumping in animals s1031, which can result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>The alteration can cause thermal instability and affect expression of cADNA DNA isoform II in COS7 cells, which ended up resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 after having resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being observed to finally result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being observed to finally result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being observed to finally result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being observed to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which is observed to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which is shown to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which can result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which can result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which ended up resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells being observed to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells which has proven to result finally in a marked increase in the activity of acetylhydroxylase PAF .</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells after having resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells which has proven to result finally in a marked increase in the activity of acetylhydroxylase PAF .</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells, which ended up resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>The alteration can cause thermal instability and affect failure to use the normal donor site of the intron 12 ear being observed to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>The alteration can cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which is able to finally result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>The alteration can cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which is shown to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>The alteration can cause thermal instability and affect float in ras-dependent signaling being observed to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>The alteration can cause thermal instability and affect float in ras-dependent signaling which has proven to result finally in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>The alteration can cause thermal instability and affect float in ras-dependent signaling which is able to finally result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling because it is able to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling being observed to finally result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling being observed to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling being observed to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which has proven to result finally in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1 .</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is able to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is observed to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is shown to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is shown to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling, which can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling, which can result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on ras being observed to finally result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on ras which has proven to result finally in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on ras, which can result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras being observed to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras which has proven to result finally in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras which is able to finally result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras after having resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras which has proven to result finally in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras which is able to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras which is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>The alteration can cause thermal instability and affect glow in signalling depending on the ras which is able to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>The alteration can cause thermal instability and affect glow in signalling depending on the ras which is shown to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>The alteration can cause thermal instability and affect glow in signalling depending on the ras, which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>The alteration can cause thermal instability and affect glow-dependent signaling fluctuation being observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>The alteration can cause thermal instability and affect grid-dependent fluctuation in signaling that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits because it is able to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits being observed to finally result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which has proven to result finally in an electrophoretic subunit of fast-type LDH-B subunits .</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is able to finally result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is shown to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>The alteration can cause thermal instability and affect liquid load of the variable subunit that may have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>The alteration can cause thermal instability and affect liquid load of the variable subunit which is shown to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>The alteration can cause thermal instability and affect liquid load of the variant subunit, which can result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>The alteration can cause thermal instability and affect liquid load of variant subunit which has proven to result finally in a variant electrophoretic subunit LDH-B fast type .</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>The alteration can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron which is observed to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>The alteration can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron, which can result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>The alteration can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron, which ended up resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains being observed to finally result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains which is able to finally result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains because it is able to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains because it is able to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains being observed to finally result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which has proven to result finally in super-repetitor .</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which is able to finally result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which is observed to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which is shown to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which is shown to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains, which ended up resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the coupling of intron 12 which is able to finally result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the coupling of intron 12 which is shown to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 ear because it is able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 ear which is shown to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras because it is able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras being observed to finally result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras which is able to finally result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras, which can result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains because it is able to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains being observed to finally result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains being observed to finally result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains being observed to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains being observed to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which is able to finally result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which is observed to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit after having resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit that may have resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which has proven to result finally in an electrophoretic subunit variant of the fast type LDH-B .</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is shown to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit, which can result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit, which can result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>The alteration can cause thermal instability and affect the net charge of the varying subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>The alteration can cause thermal instability and affect the net charge of the varying subunit which is able to finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>The alteration can cause thermal instability and affect the net charge of the varying subunit which is shown to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit after having resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit being observed to finally result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit being observed to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit which has proven to result finally in a variant electrophoretic subunit LDH-B fast type .</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit which is shown to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit which is shown to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit, which ended up resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>The alteration can result thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is capable of giving rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>The alteration can result thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>The alteration can result thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which has finally been shown to be a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>The alteration can result thermal instability and affect a new mutation in codon 210 which is capable of giving rise to substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>The alteration can result thermal instability and affect a new mutation to codon 210 which has finally been shown to be replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>The alteration can result thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which has finally been shown to be mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>The alteration can result thermal instability and affect alternative spacer of a single transcription which has finally been shown to be difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>The alteration can result thermal instability and affect differential slicing which is capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>The alteration can result thermal instability and affect differential spasms which has finally been shown to be existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>The alteration can result thermal instability and affect differentiated xis which is capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>The alteration can result thermal instability and affect exon 13 juar in s1031 animals which has finally been shown to be a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>The alteration can result thermal instability and affect exon 13 jump in s1031 animals which has finally been shown to be a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>The alteration can result thermal instability and affect exon 13 jump in s1031 animals which is capable of giving rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>The alteration can result thermal instability and affect expression of cADNA DNA isoform II in COS7 cells which is capable of giving rise to a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>The alteration can result thermal instability and affect expression of cDNA ISOform II DNA in COS7 which has finally been shown to be a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>The alteration can result thermal instability and affect expression of cDNA ISOform II DNA in COS7 which is capable of giving rise to a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>The alteration can result thermal instability and affect float in ras-dependent signaling which is capable of giving rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which has finally been shown to be a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which has finally been shown to be a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which has finally been shown to be a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which is capable of giving rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which is capable of giving rise to a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>The alteration can result thermal instability and affect fluctuation in signaling depending on the ras which has finally been shown to be a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>The alteration can result thermal instability and affect glow in signalling depending on the ras which has finally been shown to be a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>The alteration can result thermal instability and affect liquid charge of varying subunits which is capable of giving rise to an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>The alteration can result thermal instability and affect liquid load of the variable subunit which has finally been shown to be fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>The alteration can result thermal instability and affect multiple alternative subdomains which is capable of giving rise to super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>The alteration can result thermal instability and affect not to use the normal donor site of the coupling of intron 12 which has finally been shown to be a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>The alteration can result thermal instability and affect reduction of signaling as a function of ras which has finally been shown to be a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>The alteration can result thermal instability and affect some alternative subdomains which has finally been shown to be superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which has finally been shown to be an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which is capable of giving rise to an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which is capable of giving rise to an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which is capable of giving rise to an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>The alteration may cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells which has been demonstrated to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>The alteration may cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells, which may ultimately resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>The alteration may cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 which may result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>The alteration may cause thermal instability and affect Exon 13 jumping in s1031 animals which is observed to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>The alteration may cause thermal instability and affect Exon 13 jumping in s1031 animals which may result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>The alteration may cause thermal instability and affect Exon 13 jumping in s1031 animals, which may eventually result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>The alteration may cause thermal instability and affect Exon 13 jumping in s1031 animals, which may ultimately resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells being demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells which finally resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells which has been demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 which may result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 which resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7, which may ultimately resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>The alteration may cause thermal instability and affect Expression of isoform II cDNA in COS7 cells which is observed to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>The alteration may cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>The alteration may cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>The alteration may cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells, which may ultimately resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>The alteration may cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 being demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>The alteration may cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7, which may eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 being demonstrated to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which has been demonstrated to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which has been demonstrated to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which is observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which is observed to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which is observed to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which may result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210, which may eventually result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210, which may eventually result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210, which may ultimately resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>The alteration may cause thermal instability and affect a new mutation to codon 210 which finally resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>The alteration may cause thermal instability and affect a new mutation to codon 210 which resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>The alteration may cause thermal instability and affect a new mutation to codon 210, which may eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, which may eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which has been demonstrated to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which is observed to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which may result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which finally resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is observed to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains which has been demonstrated to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains which may result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains which resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>The alteration may cause thermal instability and affect alternative spacer of a single transcription which has been demonstrated to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>The alteration may cause thermal instability and affect alternative spacer of a single transcription which is observed to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>The alteration may cause thermal instability and affect differential slicing which has been demonstrated to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>The alteration may cause thermal instability and affect differential spacing, which may eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>The alteration may cause thermal instability and affect differential spasms which finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>The alteration may cause thermal instability and affect differential spasms which resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>The alteration may cause thermal instability and affect differential spasms, which may ultimately resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>The alteration may cause thermal instability and affect differentiated xis which finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>The alteration may cause thermal instability and affect differentiated xis which has been demonstrated to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>The alteration may cause thermal instability and affect differentiated xis which may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>The alteration may cause thermal instability and affect exon 13 juar in s1031 animals being demonstrated to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>The alteration may cause thermal instability and affect exon 13 jump in s1031 animals being demonstrated to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>The alteration may cause thermal instability and affect exon 13 jump in s1031 animals which finally resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>The alteration may cause thermal instability and affect exon 13 jump in s1031 animals which may result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>The alteration may cause thermal instability and affect exon 13 jump in s1031 animals which resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>The alteration may cause thermal instability and affect exon 13 jumping in animals s1031 which may result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>The alteration may cause thermal instability and affect expression of cADNA DNA isoform II in COS7 cells which is observed to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which has been demonstrated to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which has been demonstrated to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which may result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which may eventually result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which may ultimately resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which may ultimately resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>The alteration may cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which finally resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>The alteration may cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which has been demonstrated to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>The alteration may cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which is observed to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>The alteration may cause thermal instability and affect float in ras-dependent signaling which is observed to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>The alteration may cause thermal instability and affect float in ras-dependent signaling which resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>The alteration may cause thermal instability and affect float in ras-dependent signaling, which may ultimately resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which is observed to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may eventually result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may eventually result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may ultimately resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may ultimately resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras which finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras, which may ultimately resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras being demonstrated to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras which is observed to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras, which may eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>The alteration may cause thermal instability and affect glow-dependent signaling fluctuation which has been demonstrated to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>The alteration may cause thermal instability and affect glow-dependent signaling fluctuation, which may ultimately resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>The alteration may cause thermal instability and affect grid-dependent fluctuation in signaling which has been demonstrated to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>The alteration may cause thermal instability and affect grid-dependent fluctuation in signaling, which may eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which may result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits, which may eventually result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>The alteration may cause thermal instability and affect liquid load of the variable subunit being demonstrated to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>The alteration may cause thermal instability and affect liquid load of the variable subunit, which may eventually result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>The alteration may cause thermal instability and affect liquid load of the variable subunit, which may ultimately resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>The alteration may cause thermal instability and affect liquid load of the variant subunit which has been demonstrated to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>The alteration may cause thermal instability and affect liquid load of the variant subunit which may result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>The alteration may cause thermal instability and affect liquid load of the variant subunit which resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>The alteration may cause thermal instability and affect liquid load of variant subunit, which may eventually result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>The alteration may cause thermal instability and affect missing to use the normal donor site of the ear 12 intron being demonstrated to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>The alteration may cause thermal instability and affect missing to use the normal donor site of the ear 12 intron which is observed to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>The alteration may cause thermal instability and affect missing to use the normal donor site of the ear 12 intron which may result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which finally resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which may result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>The alteration may cause thermal instability and affect not to use the normal donor site of the intron 12 ear being demonstrated to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras being demonstrated to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras which is observed to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras which resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras, which may eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras, which may ultimately resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>The alteration may cause thermal instability and affect some alternative subdomains which may result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>The alteration may cause thermal instability and affect some alternative subdomains, which may ultimately resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which has been demonstrated to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which has been demonstrated to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which may result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>The alteration may cause thermal instability and affect the net charge of the varying subunit being demonstrated to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>The alteration may cause thermal instability and affect the net charge of the varying subunit, which may eventually result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>The alteration may cause thermal instability and affect the net load of the variant subunit which has been demonstrated to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>The alteration may cause thermal instability and affect the net load of the variant subunit which is observed to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>The alteration may cause thermal instability and affect the net load of the variant subunit, which may eventually result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional initiation resulted in the mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, as predicted, has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start has the ability to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulted in the mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>The alternative exon coupling 139 nt is capable of result rise to mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>The alternative exon coupling 139 nt may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>The alternative exon coupling 139 nt resulted in the mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>The alternative exon coupling 139 nt will result in the mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>The alternative exon coupling 139 nt, as predicted, has resulted in the mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>The alternative exon coupling 139 nt, as predicted, has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>The alternative mixed subdomains has resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>The alternative mixed subdomains is capable of result rise to superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>The alternative mixed subdomains, as predicted, has the ability to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>The alternative spacer of a single transcription and alternative transcriptional initiation, as result in our study, are capable of giving rise to difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>The alternative spacer of a single transcription resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>The change can cause heat instability and affect CdNA II DNA expression of isoform II in COS7 cells which resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 by finally being able to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which has resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which will eventually result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals after it has resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals which eventually resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals which has been shown to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals which has resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals which will eventually result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 by being able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 cells which has finally resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which has resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which will eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells after it has resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells by being able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells that may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells that may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which has been shown to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which has finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which may eventually have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which will eventually result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells by being able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which can eventually result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which can result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which may eventually have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells by being able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells by finally being able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells which can result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells which may eventually have resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>The change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 which has been shown to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>The change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 which may eventually have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 after it has resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 after it has resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 by finally being able to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 by finally being able to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 that may have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 that may have resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which can eventually result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which can eventually result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which can eventually result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which eventually resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which eventually resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has been shown to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has been shown to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has been shown to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has finally resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which may eventually have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which may eventually have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which may eventually have resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which will eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which will eventually result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 by being able to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 that may have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which can eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which has resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which will eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation after it has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation by being able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which has finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which may eventually have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which can result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which will eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start by being able to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that may have resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which can eventually result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt after it has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt by being able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt which can eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt which resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>The change can cause heat instability and affect alternative mixed subdomains by being able to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>The change can cause heat instability and affect alternative mixed subdomains that may have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>The change can cause heat instability and affect alternative mixed subdomains that may have resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which has been shown to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which has resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which has resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which may eventually have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>The change can cause heat instability and affect alternative spacer of a single transcription which may eventually have resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>The change can cause heat instability and affect differential slicing that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>The change can cause heat instability and affect differential slicing which can eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>The change can cause heat instability and affect differential spacing by being able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>The change can cause heat instability and affect differential spacing that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>The change can cause heat instability and affect differential spacing which resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>The change can cause heat instability and affect differential spacing which will eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>The change can cause heat instability and affect differential spasms by finally being able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>The change can cause heat instability and affect differential spasms which can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>The change can cause heat instability and affect differential spasms which has finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>The change can cause heat instability and affect differentiated xis that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>The change can cause heat instability and affect differentiated xis which has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals which can result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals which eventually resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals which has been shown to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals which has finally resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals by being able to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which can eventually result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which can eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which eventually resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which will eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells which can result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells which has finally resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells which has resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells which resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 by being able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 by finally being able to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 by finally being able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which can eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which can result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which eventually resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which has finally resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which has resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells by being able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells which resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II in COS7 cells by finally being able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II in COS7 cells which has finally resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>The change can cause heat instability and affect failure to use the normal donor site of the intron 12 ear which eventually resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling which can eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling which can result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling which eventually resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling which has resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling which resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling after it has resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling after it has resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling after it has resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling by being able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling by being able to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling by finally being able to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which eventually resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which eventually resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has been shown to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has been shown to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has finally resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which will eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras by being able to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which eventually resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which eventually resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which will eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which will eventually result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras by being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which can eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which may eventually have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras after it has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras by being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras by finally being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras which eventually resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>The change can cause heat instability and affect glow in signalling depending on the ras after it has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>The change can cause heat instability and affect glow in signalling depending on the ras which has been shown to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>The change can cause heat instability and affect glow in signalling depending on the ras which has finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>The change can cause heat instability and affect glow in signalling depending on the ras which may eventually have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which eventually resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which has been shown to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which may eventually have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>The change can cause heat instability and affect grid-dependent fluctuation in signaling which has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>The change can cause heat instability and affect grid-dependent fluctuation in signaling which resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits after it has resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits by being able to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which can eventually result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which has finally resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which may eventually have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which will eventually result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>The change can cause heat instability and affect liquid load of the variable subunit which can eventually result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>The change can cause heat instability and affect liquid load of the variable subunit which may eventually have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>The change can cause heat instability and affect liquid load of the variable subunit which resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>The change can cause heat instability and affect liquid load of the variant subunit by finally being able to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>The change can cause heat instability and affect liquid load of variant subunit by being able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>The change can cause heat instability and affect liquid load of variant subunit that may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>The change can cause heat instability and affect liquid load of variant subunit which can result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>The change can cause heat instability and affect missing to use the normal donor site of the ear 12 intron that may have resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>The change can cause heat instability and affect missing to use the normal donor site of the ear 12 intron which can result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>The change can cause heat instability and affect missing to use the normal donor site of the ear 12 intron which has finally resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>The change can cause heat instability and affect multiple alternate subdomains which has been shown to result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>The change can cause heat instability and affect multiple alternate subdomains which will eventually result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>The change can cause heat instability and affect multiple alternative subdomains by being able to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which has finally resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which may eventually have resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which may eventually have resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which will eventually result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 which can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 which eventually resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 which resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 ear after it has resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras which can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras which has been shown to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras which has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras which has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>The change can cause heat instability and affect some alternative subdomains which has been shown to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>The change can cause heat instability and affect some alternative subdomains which has resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>The change can cause heat instability and affect some alternative subdomains which will eventually result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit by finally being able to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit that may have resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which can result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which can result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which eventually resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which has been shown to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which has been shown to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which may eventually have resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which will eventually result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit by finally being able to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit which has finally resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit which has resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit which may eventually have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>The change can cause heat instability and affect the net load of the variant subunit by finally being able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>The change can cause heat instability and affect the net load of the variant subunit which can result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>The change can cause heat instability and affect the net load of the variant subunit which will eventually result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>The change can cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells that is observed to finally result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>The change can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 that is observed to finally result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>The change can cause thermal instability and affect Exon 13 jumping in s1031 animals and is shown to ultimately result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>The change can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 and is shown to ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>The change can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells and is shown to finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>The change can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 that is observed to finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>The change can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells and is shown to ultimately result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>The change can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells that is observed to finally result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>The change can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells that is observed to finally result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>The change can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 and is shown to ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>The change can cause thermal instability and affect a new mutation in codon 210 and is shown to ultimately result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>The change can cause thermal instability and affect a new mutation in codon 210 that is observed to finally result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>The change can cause thermal instability and affect a new mutation in codon 210 that is observed to finally result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>The change can cause thermal instability and affect a new mutation to codon 210 and is shown to finally result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>The change can cause thermal instability and affect a new mutation to codon 210 and is shown to ultimately result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>The change can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation and is shown to finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>The change can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation and is shown to ultimately result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>The change can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start and is shown to ultimately result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>The change can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start that is observed to finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>The change can cause thermal instability and affect alternative exon coupling 139 nt and is shown to finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>The change can cause thermal instability and affect alternative mixed subdomains and is shown to ultimately result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>The change can cause thermal instability and affect alternative spacer of a single transcription and is shown to ultimately result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>The change can cause thermal instability and affect differential slicing that is observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>The change can cause thermal instability and affect differential spacing and is shown to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>The change can cause thermal instability and affect differentiated xis and is shown to ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>The change can cause thermal instability and affect differentiated xis that is observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>The change can cause thermal instability and affect exon 13 jump in s1031 animals and is shown to finally result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>The change can cause thermal instability and affect exon 13 jump in s1031 animals and is shown to finally result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>The change can cause thermal instability and affect expression of cADNA DNA isoform II in COS7 cells that is observed to finally result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 and is shown to ultimately result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 and is shown to ultimately result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to finally result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to finally result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to ultimately result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling that is observed to finally result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on ras and is shown to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on ras and is shown to ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on ras that is observed to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on the ras and is shown to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on the ras and is shown to finally result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on the ras and is shown to ultimately result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on the ras that is observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>The change can cause thermal instability and affect glow-dependent signaling fluctuation that is observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>The change can cause thermal instability and affect grid-dependent fluctuation in signaling and is shown to ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>The change can cause thermal instability and affect liquid charge of varying subunits and is shown to finally result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>The change can cause thermal instability and affect liquid charge of varying subunits that is observed to finally result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>The change can cause thermal instability and affect liquid charge of varying subunits that is observed to finally result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>The change can cause thermal instability and affect liquid load of the variable subunit that is observed to finally result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>The change can cause thermal instability and affect liquid load of the variant subunit and is shown to ultimately result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>The change can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron and is shown to ultimately result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>The change can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron that is observed to finally result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>The change can cause thermal instability and affect multiple alternative subdomains and is shown to finally result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>The change can cause thermal instability and affect multiple alternative subdomains that is observed to finally result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>The change can cause thermal instability and affect not to use the normal donor site of the intron 12 ear and is shown to ultimately result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>The change can cause thermal instability and affect reduction of signaling as a function of ras and is shown to ultimately result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>The change can cause thermal instability and affect some alternative subdomains that is observed to finally result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to finally result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to ultimately result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>The change can cause thermal instability and affect the net charge of the varying subunit and is shown to finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>The change can cause thermal instability and affect the net charge of the varying subunit that is observed to finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>The change can cause thermal instability and affect the net load of the variant subunit and is shown to ultimately result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>The change can cause thermal instability and affect the net load of the variant subunit and is shown to ultimately result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that has the ability to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed differential slicing that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed differential spacing that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that has the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jumping in animals s1031 that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells that has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that has the ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that has the ability to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that has the ability to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that has the ability to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that has the ability to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>The differential spasms and alternative transcriptional initiation, as result in our study, are capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>The differentiated xis and alternative transcriptional initiation, as result in our study, are capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>The exon 13 juar in s1031 animals and alternative transcriptional initiation, as result in our study, are capable of giving rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>The exon 13 juar in s1031 animals has resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>The exon 13 juar in s1031 animals has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>The exon 13 juar in s1031 animals, as predicted, has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>The exon 13 jump in s1031 animals has resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>The exon 13 jump in s1031 animals has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>The exon 13 jump in s1031 animals is capable of result rise to a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>The exon 13 jump in s1031 animals resulted in the a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>The exon 13 jumping in animals s1031 and alternative transcriptional initiation, as result in our study, are capable of giving rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>The exon 13 jumping in animals s1031 resulted in the a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>The exon 13 jumping in animals s1031, as predicted, has resulted in the a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>The expression of cADNA DNA isoform II in COS7 cells has the ability to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>The expression of cADNA DNA isoform II in COS7 cells resulted in the a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>The expression of cADNA DNA isoform II in COS7 cells will result in the a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>The expression of cADNA DNA isoform II in COS7 cells, as predicted, has resulted in the a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>The expression of cADNA DNA isoform II in COS7 cells, as predicted, has the ability to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>The expression of cDNA ISOform II DNA in COS7 has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>The expression of cDNA ISOform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>The expression of cDNA ISOform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>The expression of cDNA ISOform II DNA in COS7 may have resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>The expression of cDNA ISOform II DNA in COS7, as predicted, has resulted in the a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>The expression of cDNA ISOform II DNA in COS7, as predicted, has resulted in the a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>The expression of cDNA ISOform II DNA in COS7, as predicted, has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>The expression of the DNA-cDNA ISOform II in COS7 cells, as predicted, has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>The failure to use the normal donor site of the intron 12 ear, as predicted, has resulted in the a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>The float in ras-dependent signaling has resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>The float in ras-dependent signaling will result in the a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>The float in ras-dependent signaling, as predicted, has resulted in the a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>The fluctuation in ras-dependent signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>The fluctuation in ras-dependent signaling may have resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>The fluctuation in ras-dependent signaling will result in the a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>The fluctuation in ras-dependent signaling will result in the a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has resulted in the a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>The fluctuation in signaling depending on ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>The fluctuation in signaling depending on ras has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>The fluctuation in signaling depending on ras resulted in the a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>The fluctuation in signaling depending on ras, as predicted, has resulted in the a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>The fluctuation in signaling depending on the ras has the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>The fluctuation in signaling depending on the ras is capable of result rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>The fluctuation in signaling depending on the ras may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>The fluctuation in signaling depending on the ras resulted in the a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>The fluctuation in signaling depending on the ras will result in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>The fluctuation in signaling depending on the ras, as predicted, has resulted in the a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>The fluctuation in signaling depending on the ras, as predicted, has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed CdNA II DNA expression of isoform II in COS7 cells that was observed to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 that may have resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Exon 13 jumping in s1031 animals that will result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 and was able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 cells and was able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 cells that is able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 resulting in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that was observed to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that was observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells and was able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that was observed to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of isoform II cDNA in COS7 cells that has the ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of isoform II cDNA in COS7 cells that is able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of isoform II cDNA in COS7 cells that will result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells that may result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells that resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 and was able to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 resulting in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that has the ability to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that is able to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that was observed to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that was observed to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that will result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 and was able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 resulting in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that is able to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that is able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that may have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that is able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that may result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that is able to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that is able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that has the ability to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that has the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that may have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that may have resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spacing that is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spacing that was observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spacing that will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms and was able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms that is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms that was observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms that will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis and was able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals and was able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals that is able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that was observed to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jumping in animals s1031 that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells that may result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 and was able to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 and was able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that is able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that may result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that was observed to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that will result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells and was able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells that has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells that will result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II in COS7 cells and was able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II in COS7 cells that is able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal donor site of the intron 12 ear and was able to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal donor site of the intron 12 ear that has the ability to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed float in ras-dependent signaling resulting in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed float in ras-dependent signaling that resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed float in ras-dependent signaling that will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling and was able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that is able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that is able to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that was observed to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras and was able to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras and was able to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras and was able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signalling depending on the ras resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signalling depending on the ras that is able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signalling depending on the ras that was observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow-dependent signaling fluctuation that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow-dependent signaling fluctuation that was observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed grid-dependent fluctuation in signaling and was able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed grid-dependent fluctuation in signaling that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of varying subunits that was observed to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of varying subunits that will result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of the variable subunit that resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of variant subunit that may result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of variant subunit that resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron that was observed to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains and was able to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that is able to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the coupling of intron 12 that has the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the coupling of intron 12 that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the coupling of intron 12 that will result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that has the ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that is able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that may result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that was observed to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that is able to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that was observed to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit and was able to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit and was able to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit and was able to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that has the ability to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that has the ability to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may have resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the varying subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the varying subunit that will result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that has the ability to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that has the ability to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that may have resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that may result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that may result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 results in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 that may result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 cells that could resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that may result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 which resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells results in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells which resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells which resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of the cdNA II DNA from isoform II in COS7 results in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of the cdNA II DNA from isoform II in COS7 that may result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 resulting in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 resulting in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 results in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 results in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 that may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 that may result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that could resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start results in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that may result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon coupling 139 nt which resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative mixed subdomains which resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential spacing which resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differentiated xis that could resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 juar in s1031 animals resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jump in s1031 animals results in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jump in s1031 animals which resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jump in s1031 animals which resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jumping in animals s1031 resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jumping in animals s1031 which resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells results in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells which resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of the DNA-cDNA ISOform II in COS7 cells which resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras that could resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras that may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on the ras resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on the ras which resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed glow-dependent signaling fluctuation resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed glow-dependent signaling fluctuation results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed grid-dependent fluctuation in signaling resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed grid-dependent fluctuation in signaling that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits results in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits that could resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits that could resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variable subunit results in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variable subunit that may result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variable subunit which resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variant subunit results in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variant subunit that could resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of variant subunit that may result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of variant subunit which resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed multiple alternate subdomains that may result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed multiple alternative subdomains that could resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed multiple alternative subdomains that may result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed not to use the normal donor site of the intron 12 ear which resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras that could resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras that could resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras that may result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras which resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that CdNA II DNA expression of isoform II in COS7 cells could result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 cells could result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 cells resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 could result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of isoform II cDNA in COS7 cells could result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of the cD DNA of isoform II in COS7 cells resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of the cdNA II DNA from isoform II in COS7 could result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of the cdNA II DNA from isoform II in COS7 had the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of the cdNA II DNA from isoform II in COS7 resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a new mutation in codon 210 could result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a new mutation in codon 210 had the ability to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a new mutation in codon 210 resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a new mutation to codon 210 could result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 cutting (139 nt) and alternative transcriptional initiation could result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 cutting (139 nt) and alternative transcriptional start could result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 exhaustion (139 nt) and alternative transcriptional start had the ability to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative mixed subdomains had the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative mixed subdomains resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative mixed subdomains resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative spacer of a single transcription resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that exon 13 jump in s1031 animals resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that exon 13 jumping in animals s1031 could result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cADNA DNA isoform II in COS7 cells had the ability to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA ISOform II DNA in COS7 had the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of the DNA-cDNA ISOform II DNA in COS7 cells resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that failure to use the normal donor site of the intron 12 ear could result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that float in ras-dependent signaling could result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that float in ras-dependent signaling had the ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling could result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling could result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling had the ability to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on ras could result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on ras had the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on the ras could result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on the ras resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow in signaling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow-dependent signaling fluctuation had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid charge of varying subunits could result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid charge of varying subunits had the ability to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid load of the variant subunit could result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid load of the variant subunit resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternate subdomains resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternative subdomains could result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternative subdomains had the ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that not to use the normal donor site of the coupling of intron 12 could result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that not to use the normal donor site of the intron 12 ear had the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduction of signaling as a function of ras resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net charge of the variant subunit had the ability to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net charge of the variant subunit resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net charge of the varying subunit could result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net load of the variant subunit could result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit results in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit results in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net load of the variant subunit resulting in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net load of the variant subunit results in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net load of the variant subunit which resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>The glow in signalling depending on the ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>The glow-dependent signaling fluctuation and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>The glow-dependent signaling fluctuation has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>The glow-dependent signaling fluctuation has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>The glow-dependent signaling fluctuation may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes DNA II expression of Isoform II DNA in COS7 and may result rise to a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals after having resulted a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals that results in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals with ability to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 after having resulted a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 after having resulted a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 and may result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 cells after having resulted a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 cells resulted in the complete a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1237">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 cells that are result as entirely a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1238">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 with ability to entirely result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1239">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 with ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1240">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 with ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1241">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells and may result rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1242">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells resulted in the complete a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1243">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells that resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1244">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of the cD DNA of isoform II in COS7 cells that results in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1245">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of the cD DNA of isoform II in COS7 cells with ability to entirely result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1246">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of the cdNA II DNA from isoform II in COS7 and may result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1247">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 after having resulted replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1248">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 after having resulted replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1249">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 and may result rise to replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1250">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 and may result rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1251">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 and may result rise to replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1252">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1253">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1254">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1255">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1256">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that results in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1257">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation to codon 210 and may result rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1258">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation to codon 210 that results in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1259">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that are result as entirely mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1260">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start with ability to entirely result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1261">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains after having resulted super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1262">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains and may result rise to superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1263">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains with ability to entirely result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1264">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential slicing resulted in the complete existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1265">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential slicing that results in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1266">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential slicing with ability to entirely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1267">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential spacing that results in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1268">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential spacing with ability to entirely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1269">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential spasms and may result rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1270">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 juar in s1031 animals resulted in the complete a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1271">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 juar in s1031 animals that are result as entirely a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1272">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 juar in s1031 animals that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1273">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 juar in s1031 animals that results in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1274">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals after having resulted a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1275">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals and may result rise to a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1276">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals resulted in the complete a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1277">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals with ability to entirely result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1278">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jumping in animals s1031 with ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1279">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cADNA DNA isoform II in COS7 cells that resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1280">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cADNA DNA isoform II in COS7 cells with ability to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1281">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 and may result rise to a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1282">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 and may result rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1283">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 that resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1284">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 with ability to entirely result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1285">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 with ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1286">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells and may result rise to a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1287">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that are result as entirely a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1288">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that results in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1289">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes failure to use the normal donor site of the intron 12 ear and may result rise to a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1290">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes float in ras-dependent signaling and may result rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1291">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes float in ras-dependent signaling resulted in the complete a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1292">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes float in ras-dependent signaling with ability to entirely result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1293">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes float in ras-dependent signaling with ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1294">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling and may result rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1295">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling resulted in the complete a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1296">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling resulted in the complete a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1297">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling resulted in the complete a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1298">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that are result as entirely a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1299">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that are result as entirely a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1300">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1301">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that results in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1302">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to entirely result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1303">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to entirely result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1304">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to entirely result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1305">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1306">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1307">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on ras after having resulted a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1308">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on ras and may result rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1309">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras resulted in the complete a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1310">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras that are result as entirely a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1311">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1312">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signaling depending on the ras that are result as entirely a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1313">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signaling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1314">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signaling depending on the ras with ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1315">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signalling depending on the ras that are result as entirely a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1316">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow-dependent signaling fluctuation resulted in the complete a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1317">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow-dependent signaling fluctuation that are result as entirely a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1318">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow-dependent signaling fluctuation with ability to entirely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1319">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits resulted in the complete a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1320">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits that are result as entirely a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1321">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits with ability to entirely result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1322">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits with ability to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1323">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of the variable subunit that are result as entirely fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1324">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of the variable subunit with ability to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1325">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of the variant subunit after having resulted fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1326">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of the variant subunit resulted in the complete fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1327">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of the variant subunit that are result as entirely fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1328">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of variant subunit after having resulted a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1329">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of variant subunit that are result as entirely a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1330">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of variant subunit with ability to entirely result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1331">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron resulted in the complete a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1332">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron that are result as entirely a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1333">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron that resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1334">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains after having resulted superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1335">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains and may result rise to superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1336">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains that are result as entirely superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1337">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains with ability to entirely result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1338">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains with ability to result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1339">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains and may result rise to superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1340">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains that are result as entirely superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1341">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains with ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1342">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras after having resulted a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1343">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras resulted in the complete a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1344">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras that resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1345">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras with ability to entirely result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1346">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains and may result rise to superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1347">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains that results in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1348">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit after having resulted an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1349">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit that are result as entirely an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1350">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit that results in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1351">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit with ability to entirely result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1352">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit with ability to entirely result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1353">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit with ability to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1354">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the varying subunit after having resulted a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1355">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the varying subunit resulted in the complete a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1356">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the varying subunit that are result as entirely a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1357">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the varying subunit that resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1358">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the varying subunit that results in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1359">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net load of the variant subunit and may result rise to a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1360">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net load of the variant subunit that results in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1361">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Expression of cDNA isoform II DNA in COS7 that are able to completely result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1362">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a new mutation in codon 210 that are able to completely result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1363">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that are able to completely result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1364">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes differential spacing that are able to completely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1365">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes differentiated xis that are able to completely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1366">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes fluctuation in ras-dependent signaling that are able to completely result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1367">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes glow-dependent signaling fluctuation that are able to completely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1368">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes liquid load of variant subunit that are able to completely result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1369">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes missing to use the normal donor site of the ear 12 intron that are able to completely result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1370">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes not to use the normal donor site of the intron 12 ear that are able to completely result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1371">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes reduction of signaling as a function of ras that are able to completely result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1372">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the net charge of the variant subunit that are able to completely result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1373">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes Expression of the cD DNA of isoform II in COS7 cells that has the ability to completely result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1374">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a new mutation in codon 210 that has the ability to completely result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1375">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a new mutation to codon 210 that has the ability to completely result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1376">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that has the ability to completely result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1377">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes alternative exon coupling 139 nt that has the ability to completely result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1378">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes alternative mixed subdomains that has the ability to completely result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1379">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes differentiated xis that has the ability to completely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1380">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes failure to use the normal donor site of the intron 12 ear that has the ability to completely result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1381">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes fluctuation in signaling depending on ras that has the ability to completely result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1382">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes liquid charge of varying subunits that has the ability to completely result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1383">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes liquid load of the variable subunit that has the ability to completely result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1384">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes liquid load of the variant subunit that has the ability to completely result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1385">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes multiple alternative subdomains that has the ability to completely result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1386">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes not to use the normal donor site of the coupling of intron 12 that has the ability to completely result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1387">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes the net charge of the varying subunit that has the ability to completely result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1388">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes the net load of the variant subunit that has the ability to completely result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1389">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes CdNA II DNA expression of isoform II in COS7 cells that can result entirely in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1390">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes DNA II expression of Isoform II DNA in COS7 and is observed to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1391">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes DNA II expression of Isoform II DNA in COS7 that can result entirely in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1392">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes DNA II expression of Isoform II DNA in COS7 that resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1393">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals that will result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1394">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 that will result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1395">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 and is observed to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1396">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 and is observed to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1397">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that can result entirely in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1398">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that can result entirely in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1399">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1400">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1401">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that will result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1402">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that can result entirely in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1403">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that will result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1404">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative exon coupling 139 nt that will result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1405">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains and is observed to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1406">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains and is observed to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1407">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1408">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1409">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative spacer of a single transcription that will result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1410">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differential spacing and is observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1411">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differentiated xis and is observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1412">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differentiated xis that will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1413">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes exon 13 jump in s1031 animals that will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1414">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes exon 13 jumping in animals s1031 that can result entirely in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1415">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cADNA DNA isoform II in COS7 cells that can result entirely in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1416">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cADNA DNA isoform II in COS7 cells that resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1417">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cADNA DNA isoform II in COS7 cells that will result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1418">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 and is observed to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1419">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 that can result entirely in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1420">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 that will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1421">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II DNA in COS7 cells that resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1422">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that will result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1423">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes float in ras-dependent signaling that will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1424">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling and is observed to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1425">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that can result entirely in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1426">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that can result entirely in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1427">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1428">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1429">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1430">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1431">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes glow in signaling depending on the ras and is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1432">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid charge of varying subunits that resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1433">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of the variable subunit and is observed to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1434">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of the variable subunit that will result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1435">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of the variant subunit that can result entirely in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1436">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of the variant subunit that will result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1437">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron and is observed to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1438">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternative subdomains that resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1439">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternative subdomains that will result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1440">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the coupling of intron 12 and is observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1441">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 ear and is observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1442">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 ear that resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1443">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of signaling as a function of ras that will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1444">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net charge of the variant subunit and is observed to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1445">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net load of the variant subunit and is observed to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1446">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes DNA II expression of Isoform II DNA in COS7 that resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1447">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes Expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1448">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes Expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1449">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a new mutation in codon 210 that has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1450">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a new mutation in codon 210 that resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1451">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a new mutation to codon 210 that has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1452">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1453">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1454">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative spacer of a single transcription that has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1455">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes differential spasms that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1456">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes exon 13 jump in s1031 animals that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1457">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes exon 13 jumping in animals s1031 that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1458">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes expression of cDNA ISOform II DNA in COS7 that resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1459">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes expression of cDNA ISOform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1460">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in ras-dependent signaling that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1461">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in ras-dependent signaling that has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1462">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1463">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1464">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1465">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1466">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes liquid charge of varying subunits that resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1467">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes some alternative subdomains that has the ability to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1468">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes some alternative subdomains that resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1469">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the net charge of the variant subunit that resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1470">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the net charge of the varying subunit that resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1471">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the net load of the variant subunit that has the ability to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1472">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the net load of the variant subunit that has the ability to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1473">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes CdNA II DNA expression of isoform II in COS7 cells which may have resulted entirely in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1474">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes DNA II expression of Isoform II DNA in COS7 that may have resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1475">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes DNA II expression of Isoform II DNA in COS7 which may have resulted entirely in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1476">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Exon 13 jumping in s1031 animals that result able to give rise to a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1477">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Exon 13 jumping in s1031 animals which may have resulted entirely in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1478">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 cells that may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1479">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 cells which may have resulted entirely in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1480">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 that result able to give rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1481">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1482">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cdNA II DNA of isoform II in COS7 cells that resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1483">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of isoform II cDNA in COS7 cells that resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1484">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of the cdNA II DNA from isoform II in COS7 that resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1485">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that may have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1486">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1487">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that result able to give rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1488">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1489">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1490">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1491">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation to codon 210 that result able to give rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1492">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation to codon 210 which may have resulted entirely in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1493">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that result able to give rise to mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1494">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which may have resulted entirely in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1495">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 cutting (139 nt) and alternative transcriptional start which may have resulted entirely in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1496">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that result able to give rise to mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1497">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon coupling 139 nt that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1498">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative mixed subdomains that may have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1499">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential slicing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1500">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential slicing which may have resulted entirely in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1501">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential spacing which may have resulted entirely in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1502">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 juar in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1503">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 juar in s1031 animals that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1504">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 jump in s1031 animals that may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1505">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 jumping in animals s1031 that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1506">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 that result able to give rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1507">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1508">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 which may have resulted entirely in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1509">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of the DNA-cDNA ISOform II DNA in COS7 cells which may have resulted entirely in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1510">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes failure to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1511">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes failure to use the normal donor site of the intron 12 ear that resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1512">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1513">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in ras-dependent signaling that result able to give rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1514">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in ras-dependent signaling that result able to give rise to a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1515">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in ras-dependent signaling that result able to give rise to a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1516">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1517">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on ras that may have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1518">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1519">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on ras which may have resulted entirely in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1520">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1521">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1522">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras that result able to give rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1523">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1524">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes glow in signalling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1525">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes glow in signalling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1526">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes glow-dependent signaling fluctuation that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1527">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits that may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1528">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits that result able to give rise to a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1529">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits that resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1530">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits which may have resulted entirely in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1531">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid load of the variant subunit which may have resulted entirely in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1532">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid load of variant subunit that resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1533">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes missing to use the normal donor site of the ear 12 intron that may have resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1534">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes missing to use the normal donor site of the ear 12 intron that result able to give rise to a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1535">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes missing to use the normal donor site of the ear 12 intron that resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1536">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes missing to use the normal donor site of the ear 12 intron which may have resulted entirely in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1537">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternative subdomains that result able to give rise to super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1538">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes not to use the normal donor site of the coupling of intron 12 which may have resulted entirely in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1539">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes not to use the normal donor site of the intron 12 ear that resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1540">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of signaling as a function of ras that result able to give rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1541">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of signaling as a function of ras that result able to give rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1542">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of signaling as a function of ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1543">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that may have resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1544">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1545">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a new mutation in codon 210 that will result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1546">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a new mutation in codon 210 that will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1547">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes differential spacing that will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1548">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 that will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1549">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes expression of the DNA-cDNA ISOform II in COS7 cells that will result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1550">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes fluctuation in ras-dependent signaling that will result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1551">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes fluctuation in ras-dependent signaling that will result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1552">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes fluctuation in signaling depending on the ras that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1553">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes glow in signalling depending on the ras that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1554">
                    <text>The liquid charge of varying subunits is capable of result rise to a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1555">
                    <text>The liquid charge of varying subunits is capable of result rise to an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1556">
                    <text>The liquid charge of varying subunits, as predicted, has the ability to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1557">
                    <text>The liquid charge of varying subunits, as predicted, has the ability to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1558">
                    <text>The liquid load of the variable subunit and alternative transcriptional initiation, as result in our study, are capable of giving rise to fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1559">
                    <text>The liquid load of the variable subunit is capable of result rise to fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1560">
                    <text>The liquid load of the variant subunit will result in the fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1561">
                    <text>The liquid load of variant subunit has resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1562">
                    <text>The liquid load of variant subunit is capable of result rise to a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1563">
                    <text>The missing to use the normal donor site of the ear 12 intron may have resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1564">
                    <text>The multiple alternative subdomains has resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1565">
                    <text>The multiple alternative subdomains has the ability to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1566">
                    <text>The not to use the normal donor site of the coupling of intron 12 has resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1567">
                    <text>The not to use the normal donor site of the intron 12 ear may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1568">
                    <text>The not to use the normal donor site of the intron 12 ear resulted in the a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1569">
                    <text>The reduction of signaling as a function of ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1570">
                    <text>The reduction of signaling as a function of ras has resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1571">
                    <text>The reduction of signaling as a function of ras may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1572">
                    <text>The research shows a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity resulting from float in ras-dependent signaling.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1573">
                    <text>The research shows a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity resulting from glow-dependent signaling fluctuation.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1574">
                    <text>The research shows a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity resulting from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1575">
                    <text>The research shows a fast-type LDH-B electrophoretic subunit resulting from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1576">
                    <text>The research shows a fast-type LDH-B electrophoretic subunit resulting from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1577">
                    <text>The research shows a marked increase in acetylhydratelase PAF activity resulting from expression of cADNA DNA isoform II in COS7 cells.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1578">
                    <text>The research shows a marked increase in acetylhydrolase activity PAF resulting from Expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1579">
                    <text>The research shows existence of NF-YA isoforms resulting from differentiated xis.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1580">
                    <text>The research shows fast-type electrophoretic subunit LDH-B resulting from liquid load of the variant subunit.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1581">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from float in ras-dependent signaling.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1582">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1583">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from glow in signalling depending on the ras.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1584">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1585">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in signaling depending on ras.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1586">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1587">
                    <text>The sequence analysis of the HDIbeta gene indicates that a fast-type LDH-B electrophoretic subunit has the ability to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1588">
                    <text>The sequence analysis of the HDIbeta gene indicates that a fast-type LDH-B electrophoretic subunit has the ability to result from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1589">
                    <text>The sequence analysis of the HDIbeta gene indicates that a marked increase in the activity of PAF acetylhydrolase has the ability to result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1590">
                    <text>The sequence analysis of the HDIbeta gene indicates that a marked increase in the activity of acetylhydralase of PAF has the ability to result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1591">
                    <text>The sequence analysis of the HDIbeta gene indicates that a marked increase in the activity of acetylhydrolase PAF has the ability to result from Expression of the cD DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1592">
                    <text>The sequence analysis of the HDIbeta gene indicates that a rapid type of electrophoretic subunit LDH-B has the ability to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1593">
                    <text>The sequence analysis of the HDIbeta gene indicates that a variant electrophoretic subunit LDH-B fast type has the ability to result from liquid load of variant subunit.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1594">
                    <text>The sequence analysis of the HDIbeta gene indicates that a variant electrophoretic subunit LDH-B has the ability to result from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1595">
                    <text>The sequence analysis of the HDIbeta gene indicates that existence of NF-YA isoforms has the ability to result from differentiated xis.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1596">
                    <text>The sequence analysis of the HDIbeta gene indicates that mRNA species with different 5 UTRs has the ability to result from alternative exon 2 exhaustion (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1597">
                    <text>The sequence analysis of the HDIbeta gene indicates that replacement of isoleucine with valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1598">
                    <text>The sequence analysis of the HDIbeta gene indicates that substitution of isoleucine to valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1599">
                    <text>The some alternative subdomains resulted in the super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1600">
                    <text>The the net charge of the variant subunit resulted in the an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1601">
                    <text>The the net charge of the varying subunit has the ability to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1602">
                    <text>The the net load of the variant subunit and alternative transcriptional initiation, as result in our study, are capable of giving rise to a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1603">
                    <text>The the net load of the variant subunit has resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1604">
                    <text>The the net load of the variant subunit, as predicted, has the ability to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1605">
                    <text>We also report a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from grid-dependent fluctuation in signaling.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1606">
                    <text>We also report a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1607">
                    <text>We also report a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from reduction of signaling as a function of ras.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1608">
                    <text>We also report a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1609">
                    <text>We also report a fast-type LDH-B electrophoretic subunit that may have resulted from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1610">
                    <text>We also report a marked increase in the acetylhydrase activity of PAF that may have resulted from CdNA II DNA expression of isoform II in COS7 cells.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1611">
                    <text>We also report a marked increase in the activity of PAF acetylhydrolase that may have resulted from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1612">
                    <text>We also report a product of 543 bp that may have resulted from exon 13 jumping in animals s1031.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1613">
                    <text>We also report a variant electrophoretic subunit LDH-B fast type that may have resulted from liquid load of variant subunit.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1614">
                    <text>We also report existence of NF-YA isoforms that may have resulted from differentiated xis.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1615">
                    <text>We also report replacement of isoleucine with valine that may have resulted from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1616">
                    <text>We also report superrepetition that may have resulted from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1617">
                    <text>We also report superrepetitor that may have resulted from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1618">
                    <text>We also report the a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity with the capability to result from reduction of signaling as a function of ras.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1619">
                    <text>We also report the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity with the capability to result from glow-dependent signaling fluctuation.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1620">
                    <text>We also report the a marked increase in acetylhydrolase PAF activity with the capability to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1621">
                    <text>We also report the a marked increase in the activity of PAF acetylhydrolase with the capability to result from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1622">
                    <text>We also report the a variant electrophoretic subunit LDH-B fast type with the capability to result from liquid load of variant subunit.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1623">
                    <text>We also report the a variant with the capability to result from not to use the normal donor site of the coupling of intron 12.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1624">
                    <text>We also report the existence of NF-YA isoforms with the capability to result from differential slicing.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1625">
                    <text>We also report the substitution of isoleucine to valine with the capability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1626">
                    <text>We also report the superrepetitor with the capability to result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1627">
                    <text>We also reported that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity is able to result from glow in signaling depending on the ras.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1628">
                    <text>We also reported that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity is able to result from grid-dependent fluctuation in signaling.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1629">
                    <text>We also reported that a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity is able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1630">
                    <text>We also reported that a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1 is able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1631">
                    <text>We also reported that a fast-type LDH-B electrophoretic subunit is able to result from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1632">
                    <text>We also reported that a marked increase in acetylhydrolase PAF activity is able to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1633">
                    <text>We also reported that a marked increase in the acetylhydrase activity of PAF is able to result from CdNA II DNA expression of isoform II in COS7 cells.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1634">
                    <text>We also reported that a product of 543 bp is able to result from exon 13 jumping in animals s1031.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1635">
                    <text>We also reported that a rapid type of electrophoretic subunit LDH-B is able to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1636">
                    <text>We also reported that a variant is able to result from not to use the normal donor site of the coupling of intron 12.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1637">
                    <text>We also reported that existence of NF-YA isoforms is able to result from differential spasms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1638">
                    <text>a 543 bp product has the ability to result from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1639">
                    <text>a 543 bp product was able to result from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1640">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to probably result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1641">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1642">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from glow in signaling depending on the ras.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1643">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity was able to result from glow-dependent signaling fluctuation.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1644">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to probably result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1645">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1646">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1647">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was able to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1648">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1649">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 has the ability to probably result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1650">
                    <text>a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1 has the ability to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1651">
                    <text>a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1 was able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1652">
                    <text>a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1 was also reported to be able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1653">
                    <text>a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 was also reported to be able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1654">
                    <text>a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1655">
                    <text>a fast-type LDH-B electrophoretic subunit has the ability to probably result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1656">
                    <text>a fast-type LDH-B electrophoretic subunit was able to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1657">
                    <text>a fast-type LDH-B electrophoretic subunit was able to result from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1658">
                    <text>a marked increase in acetylhydrolase PAF activity has the ability to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1659">
                    <text>a marked increase in the acetylhydrase activity of PAF was also reported to be able to result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1660">
                    <text>a marked increase in the activity of PAF acetylhydase has the ability to result from DNA II expression of Isoform II DNA in COS7.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1661">
                    <text>a marked increase in the activity of PAF acetylhydrolase has the ability to probably result from Expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1662">
                    <text>a marked increase in the activity of PAF acetylhydrolase has the ability to result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1663">
                    <text>a marked increase in the activity of PAF acetylhydrolase was able to result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1664">
                    <text>a marked increase in the activity of PAF acetylhydrolase was also reported to be able to result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1665">
                    <text>a marked increase in the activity of acetylhydrolase PAF has the ability to probably result from Expression of the cD DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1666">
                    <text>a marked increase in the activity of acetylhydroxylase PAF has the ability to result from expression of the DNA-cDNA ISOform II in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1667">
                    <text>a marked increase in the activity of acetylhydroxylase PAF was able to result from expression of the DNA-cDNA ISOform II in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1668">
                    <text>a new mutation in codon 210 can eventually result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1669">
                    <text>a new mutation in codon 210 cells has resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1670">
                    <text>a new mutation in codon 210 cells has resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1671">
                    <text>a new mutation in codon 210 cells has resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1672">
                    <text>a new mutation in codon 210 cells is eventually able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1673">
                    <text>a new mutation in codon 210 finally resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1674">
                    <text>a new mutation in codon 210 has finally resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1675">
                    <text>a new mutation in codon 210 has resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1676">
                    <text>a new mutation in codon 210 is able to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1677">
                    <text>a new mutation in codon 210 is capable of result rise to replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1678">
                    <text>a new mutation in codon 210 is capable of result rise to replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1679">
                    <text>a new mutation in codon 210 is capable of result rise to substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1680">
                    <text>a new mutation in codon 210 is likely to resulting in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1681">
                    <text>a new mutation in codon 210 is likely to resulting in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1682">
                    <text>a new mutation in codon 210 is shown to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1683">
                    <text>a new mutation in codon 210 is shown to ultimately result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1684">
                    <text>a new mutation in codon 210 may eventually result in replace isoleucine with valine</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1685">
                    <text>a new mutation in codon 210 may result in replace isoleucine with valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1686">
                    <text>a new mutation in codon 210 may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1687">
                    <text>a new mutation in codon 210 may ultimately result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1688">
                    <text>a new mutation in codon 210 may ultimately result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1689">
                    <text>a new mutation in codon 210 resulted in replacement of isoleucine to valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1690">
                    <text>a new mutation in codon 210 resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1691">
                    <text>a new mutation in codon 210 resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1692">
                    <text>a new mutation in codon 210 will finally result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1693">
                    <text>a new mutation in codon 210 will result in replacement of isoleucine to valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1694">
                    <text>a new mutation in codon 210 will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1695">
                    <text>a new mutation in codon 210 will result in replacing isoleucine in valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1696">
                    <text>a new mutation in codon 210, as predicted, can result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1697">
                    <text>a new mutation in codon 210, as predicted, may have resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1698">
                    <text>a new mutation in codon 210, as predicted, may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1699">
                    <text>a new mutation in codon 210, as predicted, will result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1700">
                    <text>a new mutation in codon 210, as predicted, will result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1701">
                    <text>a new mutation in codon 210, as we have predicted, has the ability to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1702">
                    <text>a new mutation in codon 210, as we have predicted, has the ability to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1703">
                    <text>a new mutation in codon 210, as we have predicted, is able to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1704">
                    <text>a new mutation in codon 210, as we have predicted, may have resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1705">
                    <text>a new mutation in codon 210, as we have predicted, may result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1706">
                    <text>a new mutation in codon 210, as we have predicted, may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1707">
                    <text>a new mutation in codon 210, as we have predicted, may resulting in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1708">
                    <text>a new mutation in codon 210, as we have predicted, may resulting in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1709">
                    <text>a new mutation in codon 210, as we have predicted, may resulting in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1710">
                    <text>a new mutation in codon 210, as we have predicted, resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1711">
                    <text>a new mutation to codon 210 can eventually result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1712">
                    <text>a new mutation to codon 210 has resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1713">
                    <text>a new mutation to codon 210 has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1714">
                    <text>a new mutation to codon 210 is capable of result rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1715">
                    <text>a new mutation to codon 210 may eventually result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1716">
                    <text>a new mutation to codon 210 may eventually result in replacement of isoleucine with valine</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1717">
                    <text>a new mutation to codon 210 may ultimately result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1718">
                    <text>a new mutation to codon 210, as predicted, resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1719">
                    <text>a new mutation to codon 210, as predicted, will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1720">
                    <text>a new mutation to codon 210, as we have predicted, is able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1721">
                    <text>a product of 543 bp has the ability to result from exon 13 jumping in animals s1031.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1722">
                    <text>a product of 543 bp was also reported to be able to result from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1723">
                    <text>a rapid type of electrophoretic subunit LDH-B was able to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1724">
                    <text>a variant electrophoretic subunit LDH-B fast type was able to result from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1725">
                    <text>a variant was able to result from missing to use the normal donor site of the ear 12 intron.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1726">
                    <text>a variant was able to result from not to use the normal donor site of the intron 12 ear.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1727">
                    <text>a variant was also reported to be able to result from not to use the normal donor site of the coupling of intron 12.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1728">
                    <text>a variant was also reported to be able to result from not to use the normal donor site of the intron 12 ear.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1729">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation can ultimately resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1730">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation cells is eventually able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1731">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1732">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1733">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation may result in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1734">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation may ultimately resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1735">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation will finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1736">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, as we have predicted, may result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1737">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start cells may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1738">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1739">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start will finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1740">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start will result in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1741">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start, as predicted, may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1742">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start, as predicted, will result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1743">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start, as we have predicted, may resulting in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1744">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start, as we have predicted, resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1745">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1746">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can ultimately resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1747">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start cells can result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1748">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may result in mRNA species with different 5 UTRs .</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1749">
                    <text>alternative exon coupling 139 nt finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1750">
                    <text>alternative exon coupling 139 nt has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1751">
                    <text>alternative exon coupling 139 nt may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1752">
                    <text>alternative exon coupling 139 nt will result in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1753">
                    <text>alternative exon coupling 139 nt, as we have predicted, may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1754">
                    <text>alternative exon coupling 139 nt, as we have predicted, resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1755">
                    <text>alternative mixed subdomains cells has resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1756">
                    <text>alternative mixed subdomains cells has resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1757">
                    <text>alternative mixed subdomains cells has the ability to ultimately result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1758">
                    <text>alternative mixed subdomains may result in super-repetitor .</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1759">
                    <text>alternative mixed subdomains will finally result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1760">
                    <text>alternative mixed subdomains will result in superrepetition .</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1761">
                    <text>alternative mixed subdomains will result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1762">
                    <text>alternative mixed subdomains, as predicted, can result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1763">
                    <text>alternative mixed subdomains, as we have predicted, is likely to resulting in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1764">
                    <text>alternative mixed subdomains, as we have predicted, is likely to resulting in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1765">
                    <text>alternative mixed subdomains, as we have predicted, may resulting in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1766">
                    <text>alternative spacer of a single transcription cells has the ability to ultimately result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1767">
                    <text>alternative spacer of a single transcription cells may have resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1768">
                    <text>alternative spacer of a single transcription has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1769">
                    <text>alternative spacer of a single transcription is likely to resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1770">
                    <text>alternative spacer of a single transcription may have finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1771">
                    <text>alternative spacer of a single transcription may result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1772">
                    <text>alternative spacer of a single transcription will result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) .</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1773">
                    <text>an electrophoretic subunit LDH-B has the ability to probably result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1774">
                    <text>an electrophoretic subunit variant of the fast type LDH-B has the ability to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1775">
                    <text>an electrophoretic subunit variant of the fast type LDH-B was also reported to be able to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1776">
                    <text>difference in the 28 C-terminal amino acids between beta(1) and beta(2) was able to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1777">
                    <text>differential slicing is shown to ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1778">
                    <text>differential slicing may eventually result in existence of NF-YA isoforms</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1779">
                    <text>differential slicing, as predicted, can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1780">
                    <text>differential slicing, as we have predicted, is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1781">
                    <text>differential spacing can ultimately resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1782">
                    <text>differential spacing cells has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1783">
                    <text>differential spacing cells may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1784">
                    <text>differential spacing has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1785">
                    <text>differential spacing may eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1786">
                    <text>differential spacing may ultimately resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1787">
                    <text>differential spacing resulted in existence of NF-YA isoforms .</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1788">
                    <text>differential spacing, as predicted, may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1789">
                    <text>differential spasms eventually resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1790">
                    <text>differential spasms has the ability to eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1791">
                    <text>differential spasms is shown to ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1792">
                    <text>differential spasms resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1793">
                    <text>differential spasms, as we have predicted, is likely to resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1794">
                    <text>differential spasms, as we have predicted, may resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1795">
                    <text>differentiated xis can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1796">
                    <text>differentiated xis cells has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1797">
                    <text>differentiated xis eventually resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1798">
                    <text>differentiated xis has finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1799">
                    <text>differentiated xis will finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1800">
                    <text>differentiated xis, as we have predicted, is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1801">
                    <text>existence of NF-YA isoforms has the ability to probably result from differential spacing.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1802">
                    <text>existence of NF-YA isoforms has the ability to probably result from differential spasms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1803">
                    <text>existence of NF-YA isoforms was able to result from differential spacing.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1804">
                    <text>exon 13 juar in s1031 animals, as we have predicted, may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1805">
                    <text>exon 13 juar in s1031 animals, as we have result, is able to give rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1806">
                    <text>exon 13 jump in s1031 animals can ultimately resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1807">
                    <text>exon 13 jump in s1031 animals cells can result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1808">
                    <text>exon 13 jump in s1031 animals cells can result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1809">
                    <text>exon 13 jump in s1031 animals eventually resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1810">
                    <text>exon 13 jump in s1031 animals has finally resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1811">
                    <text>exon 13 jump in s1031 animals has the ability to eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1812">
                    <text>exon 13 jump in s1031 animals is shown to ultimately result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1813">
                    <text>exon 13 jump in s1031 animals may eventually result in a 543 bp product</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1814">
                    <text>exon 13 jump in s1031 animals may ultimately resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1815">
                    <text>exon 13 jump in s1031 animals may ultimately resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1816">
                    <text>exon 13 jump in s1031 animals, as we have predicted, may resulting in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1817">
                    <text>exon 13 jumping in animals s1031 cells has resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1818">
                    <text>exon 13 jumping in animals s1031 cells has the ability to ultimately result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1819">
                    <text>exon 13 jumping in animals s1031 will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1820">
                    <text>exon 13 jumping in animals s1031, as we have predicted, resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1821">
                    <text>expression of cADNA DNA isoform II in COS7 cells cells eventually resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1822">
                    <text>expression of cADNA DNA isoform II in COS7 cells cells may have resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1823">
                    <text>expression of cADNA DNA isoform II in COS7 cells may result in a marked increase in acetylhydratelase PAF activity .</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1824">
                    <text>expression of cADNA DNA isoform II in COS7 cells may ultimately result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1825">
                    <text>expression of cADNA DNA isoform II in COS7 cells, as we have predicted, may have resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1826">
                    <text>expression of cADNA DNA isoform II in COS7 cells, as we have predicted, may result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1827">
                    <text>expression of cDNA ISOform II DNA in COS7 can ultimately resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1828">
                    <text>expression of cDNA ISOform II DNA in COS7 cells has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1829">
                    <text>expression of cDNA ISOform II DNA in COS7 eventually resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1830">
                    <text>expression of cDNA ISOform II DNA in COS7 eventually resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1831">
                    <text>expression of cDNA ISOform II DNA in COS7 finally resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1832">
                    <text>expression of cDNA ISOform II DNA in COS7 has finally resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1833">
                    <text>expression of cDNA ISOform II DNA in COS7 is able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1834">
                    <text>expression of cDNA ISOform II DNA in COS7 is shown to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1835">
                    <text>expression of cDNA ISOform II DNA in COS7 is shown to ultimately result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1836">
                    <text>expression of cDNA ISOform II DNA in COS7 may eventually result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1837">
                    <text>expression of cDNA ISOform II DNA in COS7 may have finally resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1838">
                    <text>expression of cDNA ISOform II DNA in COS7 resulted in a marked increase in acetylhydrolase PAF activity .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1839">
                    <text>expression of cDNA ISOform II DNA in COS7 will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1840">
                    <text>expression of cDNA ISOform II DNA in COS7, as predicted, resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1841">
                    <text>expression of cDNA ISOform II DNA in COS7, as predicted, will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1842">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1843">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, is able to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1844">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, is able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1845">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, may resulting in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1846">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1847">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1848">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, will result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1849">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells cells can result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1850">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells cells is eventually able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1851">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells has resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1852">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1853">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells may eventually result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1854">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1855">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells will result in a marked increase in the activity of acetylhydroxylase PAF .</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1856">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells will result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1857">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells, as predicted, can result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1858">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells, as we have predicted, is able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1859">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells, as we have predicted, will result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1860">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells cells eventually resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1861">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells eventually resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1862">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells is likely to resulting in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1863">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells is shown to ultimately result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1864">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1865">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells resulted in a marked increase in the activity of acetylhydroxylase PAF .</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1866">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells will eventually result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1867">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells, as predicted, may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1868">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells, as we have predicted, is likely to resulting in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1869">
                    <text>failure to use the normal donor site of the intron 12 ear eventually resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1870">
                    <text>failure to use the normal donor site of the intron 12 ear has resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1871">
                    <text>failure to use the normal donor site of the intron 12 ear may eventually result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1872">
                    <text>failure to use the normal donor site of the intron 12 ear may have finally resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1873">
                    <text>failure to use the normal donor site of the intron 12 ear, as predicted, will result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1874">
                    <text>failure to use the normal donor site of the intron 12 ear, as we have predicted, has the ability to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1875">
                    <text>failure to use the normal donor site of the intron 12 ear, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1876">
                    <text>fast-type electrophoretic subunit LDH-B has the ability to probably result from liquid load of the variable subunit.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1877">
                    <text>float in ras-dependent signaling cells can result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1878">
                    <text>float in ras-dependent signaling cells has the ability to ultimately result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1879">
                    <text>float in ras-dependent signaling cells is eventually able to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1880">
                    <text>float in ras-dependent signaling eventually resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1881">
                    <text>float in ras-dependent signaling is capable of result rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1882">
                    <text>float in ras-dependent signaling is likely to resulting in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1883">
                    <text>float in ras-dependent signaling may eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1884">
                    <text>float in ras-dependent signaling will finally result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1885">
                    <text>float in ras-dependent signaling, as predicted, resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1886">
                    <text>fluctuation in ras-dependent signaling can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1887">
                    <text>fluctuation in ras-dependent signaling can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1888">
                    <text>fluctuation in ras-dependent signaling cells can result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1889">
                    <text>fluctuation in ras-dependent signaling cells can result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1890">
                    <text>fluctuation in ras-dependent signaling cells eventually resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1891">
                    <text>fluctuation in ras-dependent signaling cells has resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1892">
                    <text>fluctuation in ras-dependent signaling cells has the ability to ultimately result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1893">
                    <text>fluctuation in ras-dependent signaling is shown to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1894">
                    <text>fluctuation in ras-dependent signaling is shown to ultimately result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1895">
                    <text>fluctuation in ras-dependent signaling may eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1896">
                    <text>fluctuation in ras-dependent signaling may eventually result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1897">
                    <text>fluctuation in ras-dependent signaling may have finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1898">
                    <text>fluctuation in ras-dependent signaling may have finally resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1899">
                    <text>fluctuation in ras-dependent signaling may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1900">
                    <text>fluctuation in ras-dependent signaling may ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1901">
                    <text>fluctuation in ras-dependent signaling may ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1902">
                    <text>fluctuation in ras-dependent signaling may ultimately resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1903">
                    <text>fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1904">
                    <text>fluctuation in ras-dependent signaling resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1905">
                    <text>fluctuation in ras-dependent signaling will eventually result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1906">
                    <text>fluctuation in ras-dependent signaling, as predicted, can result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1907">
                    <text>fluctuation in ras-dependent signaling, as predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1908">
                    <text>fluctuation in ras-dependent signaling, as predicted, resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1909">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, is able to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1910">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, is able to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1911">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1912">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1913">
                    <text>fluctuation in signaling depending on ras cells eventually resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1914">
                    <text>fluctuation in signaling depending on ras eventually resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1915">
                    <text>fluctuation in signaling depending on ras has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1916">
                    <text>fluctuation in signaling depending on ras has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1917">
                    <text>fluctuation in signaling depending on ras may have finally resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1918">
                    <text>fluctuation in signaling depending on ras may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1919">
                    <text>fluctuation in signaling depending on ras may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1920">
                    <text>fluctuation in signaling depending on ras resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1921">
                    <text>fluctuation in signaling depending on ras, as predicted, may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1922">
                    <text>fluctuation in signaling depending on ras, as we have predicted, may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1923">
                    <text>fluctuation in signaling depending on ras, as we have predicted, may have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1924">
                    <text>fluctuation in signaling depending on ras, as we have predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1925">
                    <text>fluctuation in signaling depending on the ras can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1926">
                    <text>fluctuation in signaling depending on the ras cells eventually resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1927">
                    <text>fluctuation in signaling depending on the ras cells has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1928">
                    <text>fluctuation in signaling depending on the ras cells has the ability to ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1929">
                    <text>fluctuation in signaling depending on the ras cells is eventually able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1930">
                    <text>fluctuation in signaling depending on the ras eventually resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1931">
                    <text>fluctuation in signaling depending on the ras eventually resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1932">
                    <text>fluctuation in signaling depending on the ras has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1933">
                    <text>fluctuation in signaling depending on the ras may eventually result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1934">
                    <text>fluctuation in signaling depending on the ras may have finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1935">
                    <text>fluctuation in signaling depending on the ras may ultimately resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1936">
                    <text>fluctuation in signaling depending on the ras resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1937">
                    <text>fluctuation in signaling depending on the ras, as predicted, can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1938">
                    <text>fluctuation in signaling depending on the ras, as predicted, will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1939">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1940">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1941">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1942">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1943">
                    <text>glow in signaling depending on the ras cells has the ability to ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1944">
                    <text>glow in signaling depending on the ras cells is eventually able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1945">
                    <text>glow in signaling depending on the ras finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1946">
                    <text>glow in signaling depending on the ras has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1947">
                    <text>glow in signaling depending on the ras is likely to resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1948">
                    <text>glow in signaling depending on the ras will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1949">
                    <text>glow in signaling depending on the ras, as predicted, may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1950">
                    <text>glow in signaling depending on the ras, as we have predicted, may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1951">
                    <text>glow in signalling depending on the ras can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1952">
                    <text>glow in signalling depending on the ras may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1953">
                    <text>glow in signalling depending on the ras will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1954">
                    <text>glow in signalling depending on the ras, as predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1955">
                    <text>glow in signalling depending on the ras, as we have predicted, may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1956">
                    <text>glow in signalling depending on the ras, as we have predicted, may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1957">
                    <text>glow in signalling depending on the ras, as we have predicted, will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1958">
                    <text>glow-dependent signaling fluctuation can eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1959">
                    <text>glow-dependent signaling fluctuation may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1960">
                    <text>glow-dependent signaling fluctuation may ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1961">
                    <text>glow-dependent signaling fluctuation will finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1962">
                    <text>glow-dependent signaling fluctuation will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1963">
                    <text>glow-dependent signaling fluctuation, as predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1964">
                    <text>grid-dependent fluctuation in signaling can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1965">
                    <text>grid-dependent fluctuation in signaling cells is eventually able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1966">
                    <text>grid-dependent fluctuation in signaling resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1967">
                    <text>grid-dependent fluctuation in signaling, as predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1968">
                    <text>liquid charge of varying subunits cells is eventually able to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1969">
                    <text>liquid charge of varying subunits is capable of result rise to a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1970">
                    <text>liquid charge of varying subunits may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1971">
                    <text>liquid charge of varying subunits may ultimately result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1972">
                    <text>liquid charge of varying subunits, as predicted, resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1973">
                    <text>liquid charge of varying subunits, as we have predicted, may have resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1974">
                    <text>liquid charge of varying subunits, as we have predicted, may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1975">
                    <text>liquid charge of varying subunits, as we have predicted, may resulting in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1976">
                    <text>liquid charge of varying subunits, as we have predicted, may resulting in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1977">
                    <text>liquid load of the variable subunit cells has the ability to ultimately result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1978">
                    <text>liquid load of the variable subunit will eventually result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1979">
                    <text>liquid load of the variable subunit, as we have predicted, is able to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1980">
                    <text>liquid load of the variant subunit eventually resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1981">
                    <text>liquid load of the variant subunit is capable of result rise to fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1982">
                    <text>liquid load of the variant subunit may eventually result in fast-type electrophoretic subunit LDH-B</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1983">
                    <text>liquid load of the variant subunit may result in fast-type electrophoretic subunit LDH-B .</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1984">
                    <text>liquid load of the variant subunit, as predicted, can result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1985">
                    <text>liquid load of the variant subunit, as we have predicted, may result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1986">
                    <text>liquid load of variant subunit can eventually result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1987">
                    <text>liquid load of variant subunit may eventually result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1988">
                    <text>liquid load of variant subunit will finally result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1989">
                    <text>liquid load of variant subunit will result in a variant electrophoretic subunit LDH-B fast type .</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1990">
                    <text>liquid load of variant subunit, as predicted, may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1991">
                    <text>liquid load of variant subunit, as we have predicted, has the ability to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1992">
                    <text>liquid load of variant subunit, as we have predicted, is able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1993">
                    <text>mRNA species with 5 different UTRs was able to result from alternative exon 2 cutting (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1994">
                    <text>mRNA species with 5 different UTRs was able to result from alternative exon 2 cutting (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1995">
                    <text>missing to use the normal donor site of the ear 12 intron can ultimately resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1996">
                    <text>missing to use the normal donor site of the ear 12 intron finally resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1997">
                    <text>missing to use the normal donor site of the ear 12 intron is capable of result rise to a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1998">
                    <text>missing to use the normal donor site of the ear 12 intron may eventually result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1999">
                    <text>missing to use the normal donor site of the ear 12 intron may ultimately result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2000">
                    <text>missing to use the normal donor site of the ear 12 intron, as predicted, resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2001">
                    <text>missing to use the normal donor site of the ear 12 intron, as we have predicted, is likely to resulting in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2002">
                    <text>missing to use the normal donor site of the ear 12 intron, as we have predicted, resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2003">
                    <text>multiple alternate subdomains cells has the ability to ultimately result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2004">
                    <text>multiple alternate subdomains has finally resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2005">
                    <text>multiple alternate subdomains is shown to ultimately result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2006">
                    <text>multiple alternate subdomains may eventually result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2007">
                    <text>multiple alternative subdomains can eventually result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2008">
                    <text>multiple alternative subdomains cells eventually resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2009">
                    <text>multiple alternative subdomains cells may have resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2010">
                    <text>multiple alternative subdomains has finally resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2011">
                    <text>multiple alternative subdomains has the ability to eventually result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2012">
                    <text>multiple alternative subdomains is shown to ultimately result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2013">
                    <text>multiple alternative subdomains may ultimately resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2014">
                    <text>multiple alternative subdomains, as we have predicted, has the ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2015">
                    <text>not to use the normal donor site of the coupling of intron 12 can ultimately resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2016">
                    <text>not to use the normal donor site of the coupling of intron 12 is shown to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2017">
                    <text>not to use the normal donor site of the coupling of intron 12 resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2018">
                    <text>not to use the normal donor site of the coupling of intron 12, as predicted, can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2019">
                    <text>not to use the normal donor site of the coupling of intron 12, as we have predicted, is able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2020">
                    <text>not to use the normal donor site of the intron 12 ear may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2021">
                    <text>not to use the normal donor site of the intron 12 ear, as we have predicted, resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2022">
                    <text>not to use the normal donor site of the intron 12 ear, as we have result, is able to give rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2023">
                    <text>reduction of signaling as a function of ras can ultimately resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2024">
                    <text>reduction of signaling as a function of ras cells can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2025">
                    <text>reduction of signaling as a function of ras cells has the ability to ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2026">
                    <text>reduction of signaling as a function of ras cells is eventually able to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2027">
                    <text>reduction of signaling as a function of ras finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2028">
                    <text>reduction of signaling as a function of ras has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2029">
                    <text>reduction of signaling as a function of ras has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2030">
                    <text>reduction of signaling as a function of ras has the ability to eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2031">
                    <text>reduction of signaling as a function of ras is shown to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2032">
                    <text>reduction of signaling as a function of ras is shown to ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2033">
                    <text>reduction of signaling as a function of ras may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2034">
                    <text>reduction of signaling as a function of ras may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2035">
                    <text>reduction of signaling as a function of ras will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2036">
                    <text>reduction of signaling as a function of ras, as we have result, is able to give rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2037">
                    <text>replacement of isoleucine to valine has the ability to probably result from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="2038">
                    <text>replacement of isoleucine to valine was also reported to be able to result from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="2039">
                    <text>replacement of isoleucine with valine has the ability to result from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="2040">
                    <text>some alternative subdomains can ultimately resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2041">
                    <text>some alternative subdomains cells is eventually able to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2042">
                    <text>some alternative subdomains cells is eventually able to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2043">
                    <text>some alternative subdomains is able to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2044">
                    <text>some alternative subdomains is able to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2045">
                    <text>some alternative subdomains is capable of result rise to super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2046">
                    <text>some alternative subdomains may eventually result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2047">
                    <text>some alternative subdomains may have finally resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2048">
                    <text>some alternative subdomains resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2049">
                    <text>some alternative subdomains resulted in superrepetitor .</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2050">
                    <text>some alternative subdomains will eventually result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2051">
                    <text>some alternative subdomains, as predicted, resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2052">
                    <text>some alternative subdomains, as we have predicted, is able to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2053">
                    <text>some alternative subdomains, as we have predicted, is likely to resulting in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2054">
                    <text>some alternative subdomains, as we have predicted, may result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2055">
                    <text>some alternative subdomains, as we have predicted, may resulting in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2056">
                    <text>some alternative subdomains, as we have predicted, will result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2057">
                    <text>substitution of isoleucine to valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="2058">
                    <text>super-repetitor has the ability to result from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2059">
                    <text>superrepetition has the ability to probably result from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2060">
                    <text>superrepetition has the ability to probably result from multiple alternate subdomains.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2061">
                    <text>superrepetitor has the ability to probably result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2062">
                    <text>the net charge of the variant subunit can eventually result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2063">
                    <text>the net charge of the variant subunit can eventually result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2064">
                    <text>the net charge of the variant subunit can result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2065">
                    <text>the net charge of the variant subunit cells is eventually able to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2066">
                    <text>the net charge of the variant subunit cells may have resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2067">
                    <text>the net charge of the variant subunit has the ability to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2068">
                    <text>the net charge of the variant subunit has the ability to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2069">
                    <text>the net charge of the variant subunit is capable of result rise to an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2070">
                    <text>the net charge of the variant subunit is likely to resulting in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2071">
                    <text>the net charge of the variant subunit is likely to resulting in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2072">
                    <text>the net charge of the variant subunit is shown to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2073">
                    <text>the net charge of the variant subunit is shown to ultimately result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2074">
                    <text>the net charge of the variant subunit may have finally resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2075">
                    <text>the net charge of the variant subunit may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2076">
                    <text>the net charge of the variant subunit may have resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2077">
                    <text>the net charge of the variant subunit may result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2078">
                    <text>the net charge of the variant subunit may result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2079">
                    <text>the net charge of the variant subunit may ultimately result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2080">
                    <text>the net charge of the variant subunit will finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2081">
                    <text>the net charge of the variant subunit will finally result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2082">
                    <text>the net charge of the variant subunit will result in an electrophoretic subunit LDH-B .</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2083">
                    <text>the net charge of the variant subunit, as predicted, resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2084">
                    <text>the net charge of the variant subunit, as we have predicted, has the ability to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2085">
                    <text>the net charge of the variant subunit, as we have predicted, has the ability to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2086">
                    <text>the net charge of the variant subunit, as we have predicted, is able to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2087">
                    <text>the net charge of the variant subunit, as we have predicted, resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2088">
                    <text>the net charge of the variant subunit, as we have predicted, will result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2089">
                    <text>the net charge of the varying subunit can result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2090">
                    <text>the net charge of the varying subunit may have finally resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2091">
                    <text>the net charge of the varying subunit may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2092">
                    <text>the net charge of the varying subunit may result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2093">
                    <text>the net charge of the varying subunit may ultimately result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2094">
                    <text>the net load of the variant subunit cells has resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2095">
                    <text>the net load of the variant subunit cells is eventually able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2096">
                    <text>the net load of the variant subunit may eventually result in a variant electrophoretic subunit LDH-B fast type</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2097">
                    <text>the net load of the variant subunit resulted in a variant electrophoretic subunit LDH-B .</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2098">
                    <text>the net load of the variant subunit will eventually result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2099">
                    <text>the net load of the variant subunit will result in a variant electrophoretic subunit LDH-B .</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2100">
                    <text>the net load of the variant subunit, as predicted, may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2101">
                    <text>the net load of the variant subunit, as we have predicted, may resulting in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2102">
                    <text>the net load of the variant subunit, as we have predicted, will result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling has resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling has the ability to eventually result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling is likely to resulting in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling is shown to result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may have resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may ultimately result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Change can cause heat instability and affect Diminutive EGL-15 signal resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Change can cause heat instability and affect Loading Signor of the EGL-15 results in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Change can cause heat instability and affect a decrease in csgA gene transcription from csglin coding results in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Change can cause heat instability and affect a decrease in transcription of the csgA gene from csglin encoding results in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF results in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Change can cause heat instability and affect alternative deflection of a single transcription resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start results in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Change can cause heat instability and affect alternative spacer of a single transcription resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation results in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Change can cause heat instability and affect both 5 and 3 splice mutations resulting in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Change can cause heat instability and affect both the mutations at the site of 5 and 3 splices results in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Change can cause heat instability and affect cooperative binding of the repressor to its two sites resulting in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Change can cause heat instability and affect cooperative bonding of the repressor to its two sites results in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Change can cause heat instability and affect decreases the EGL-15 signaling results in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Change can cause heat instability and affect exon 13 skipping in animals s1031 results in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Change can cause heat instability and affect failure to use the normal donor site of splice of intron 12 resulting in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Change can cause heat instability and affect multiple alternative subdomains resulting in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Change can cause heat instability and affect reduced signaling by EGL-15 resulting in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Change can cause heat instability and affect reduction of EGL-15 signaling results in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Change can cause heat instability and affect the donor place of normal helix of intron 12 could not be used results in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used resulting in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Decrease Signor of the EGL-15 cells is eventually able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Decrease Signor of the EGL-15 resulted in a phenotype of scrubbing body morphology .</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Decrease Signor of the EGL-15, as predicted, will result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Decrease Signor of the EGL-15, as we have predicted, is able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Decrease Signor of the EGL-15, as we have predicted, may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Decrease Signor of the EGL-15, as we have predicted, may resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Diminutive EGL-15 signal cells can result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Diminutive EGL-15 signal cells has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Diminutive EGL-15 signal cells has the ability to ultimately result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Diminutive EGL-15 signal has resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Diminutive EGL-15 signal is capable of result rise to a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Diminutive EGL-15 signal may eventually result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Diminutive EGL-15 signal may eventually result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Diminutive EGL-15 signal may result in a phenotype of scrawny morphology .</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Diminutive EGL-15 signal resulted in a phenotype of scrawny morphology .</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>Diminutive EGL-15 signal resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>Diminutive EGL-15 signal resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>Diminutive EGL-15 signal, as predicted, can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>Diminutive EGL-15 signal, as predicted, resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>Diminutive EGL-15 signal, as we have predicted, may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>Diminutive EGL-15 signal, as we have predicted, may resulting in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>Diminutive EGL-15 signal, as we have predicted, may resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>Diminutive EGL-15 signal, as we have result, is able to give rise to a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that alternative of a single transcription cut had the ability to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that alternative splicing of a single transcription had the ability to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that both 5 and 3 splice local mutations had the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that both 5 and 3 splice mutations had the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that both the mutations of 5 and 3 splices had the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that cooperative bonding of the repressor to its two sites had the ability to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that differential splicing had the ability to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that multiple alternative subdomains had the ability to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that not to use the normal donor site of the intron 12 splice had the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that reduced EGL-15 signal had the ability to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that reduction of the EGL-15 signaling had the ability to result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that some alternative subdomains had the ability to result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the normal donor site of intron 12 donation could not be used had the ability to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the normal site of the intron 12 splice donor could not be used had the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>GL-15 Decrease Flag cells has the ability to ultimately result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>GL-15 Decrease Flag eventually resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>GL-15 Decrease Flag has finally resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>GL-15 Decrease Flag may have finally resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>GL-15 Decrease Flag may ultimately result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>GL-15 Decrease Flag resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>GL-15 Decrease Flag, as predicted, resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>GL-15 Decrease Flag, as we have predicted, may result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>It has also been reported that a 543 bp product resulted from exon 13 skipping in animals s1031.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>It has also been reported that a Clr phenotype resulted from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>It has also been reported that a Clr phenotype resulted from a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>It has also been reported that a Clr phenotype resulted from a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>It has also been reported that a marked increase in acetylhydrolase activity PAF resulted from expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>It has also been reported that a variant resulted from failure to use the normal donor site of splice of intron 12.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>It has also been reported that a variant resulted from the normal donor site of intron 12 donation could not be used.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>It has also been reported that of high proportion of mature mRNA containing introns resulted from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>It has also been reported that the existence of isoforms of NF-YA resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>It has also been reported that the negative effect of the mutation cpxA resulted from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>Loading Signor of the EGL-15 cells eventually resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>Loading Signor of the EGL-15 may have finally resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>Loading Signor of the EGL-15, as predicted, may have resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>Mutations that are able to result in Diminutive EGL-15 signal may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>Mutations that are able to result in a decrease in the transcription of csgA coding gene csgA csgA may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>Mutations that are able to result in a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>Mutations that are able to result in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>Mutations that are able to result in alternative splicing of a single transcription may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>Mutations that are able to result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>Mutations that are able to result in differential spacing may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">differential spacing</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>Mutations that are able to result in expression of cDNA isoform II DNA in COS7 may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>Mutations that are able to result in liquid charge of the variant subunit may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>Mutations that are able to result in losing the transcriptional repression of the lacZ gene may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">losing the transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>Mutations that are able to result in loss due to transcriptional repression of the lacZ gene may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>Mutations that are able to result in reduced signaling by EGL-15 may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>Mutations that are able to result in the donor place of normal helix of intron 12 could not be used may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>Mutations that are able to result in the loss of transcriptional repression of the lacZ gene may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>Mutations that are able to result in the normal splice donor site of the 12th intron could not be used may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>Mutations that can result in a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>Mutations that can result in a decrease in the transcription of the csgA gene encoding csgA can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>Mutations that can result in a new mutation in codon 210 can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>Mutations that can result in a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>Mutations that can result in a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>Mutations that can result in a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>Mutations that can result in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>Mutations that can result in a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>Mutations that can result in alternative of a single transcription cut can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>Mutations that can result in both 5 and 3 splice mutations can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>Mutations that can result in both the mutations at the site of 5 and 3 splices can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>Mutations that can result in differential encryption can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">differential encryption</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>Mutations that can result in expression of cDNA isoform II DNA in COS7 can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>Mutations that can result in failure to use the normal donor site of splice of intron 12 can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>Mutations that can result in fluctuation in ras-dependent signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>Mutations that can result in liquid charge of the variant subunit can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>Mutations that can result in loss of transcriptional repression of the lacZ gene can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>Mutations that can result in reduced transcription of the csgA gene encoding for the clinic can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>Mutations that can result in the loss of transcriptional repression of the lacZ gene can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>Mutations that can result in the normal site of the intron 12 splice donor could not be used can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>Mutations that can result in the normal splice donor site of intron 12 could not be used can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>Mutations that can result in the place of normal splice donor of intron 12 could not be used can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>Mutations that can resulted in Loading Signor of the EGL-15 can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>Mutations that can resulted in a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>Mutations that can resulted in a decrease in transcription of the csgA gene from csglin encoding can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>Mutations that can resulted in a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>Mutations that can resulted in alternative deflection of a single transcription can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>Mutations that can resulted in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>Mutations that can resulted in failure to use the normal site of the intron 12 splice donor can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>Mutations that can resulted in liquid load of variant subunit can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>Mutations that can resulted in the expression of isoforms of Nrf1 can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>Mutations that can resulted in the normal splice donor site of intron 12 could not be used can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>Mutations that have the ability to result in Diminutive EGL-15 signal can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>Mutations that have the ability to result in a decrease in csgA gene transcription from csglin coding may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>Mutations that have the ability to result in a decrease in transcription of the csgA gene from csglin encoding can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>Mutations that have the ability to result in a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>Mutations that have the ability to result in a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>Mutations that have the ability to result in a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Mutations that have the ability to result in a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Mutations that have the ability to result in a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Mutations that have the ability to result in a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Mutations that have the ability to result in alternative deflection of a single transcription may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Mutations that have the ability to result in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>Mutations that have the ability to result in alternative spacer of a single transcription can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>Mutations that have the ability to result in alternative splicing of a single transcription may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>Mutations that have the ability to result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>Mutations that have the ability to result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>Mutations that have the ability to result in both the mutations of 5 and 3 splices may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>Mutations that have the ability to result in failure to use the normal donor site of splice of intron 12 can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>Mutations that have the ability to result in reduction of csgA gene transcription csgA coding can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>Mutations that have the ability to result in reduction of csgA gene transcription csgA coding may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>Mutations that have the ability to result in the normal site of the intron 12 fitting donor could not be used may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Mutations that have the ability to result in the normal splice donor site of the 12th intron could not be used may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Mutations that have the ability to result in the other three mutations can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the other three mutations</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Mutations that may result in a decrease in csgA gene transcription from csglin coding may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Mutations that may result in a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Mutations that may result in alternative deflection of a single transcription may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Mutations that may result in both 5 and 3 splice local mutations may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Mutations that may result in cooperative binding of the repressor to its two sites may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Mutations that may result in differential encryption may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">differential encryption</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Mutations that may result in failure to use the normal site of the intron 12 splice donor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Mutations that may result in losing the transcriptional repression of the lacZ gene may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">losing the transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Mutations that may result in some alternative subdomains may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">some alternative subdomains</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Mutations that may result in the loss of transcriptional repression of the lacZ gene may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Mutations that may result in the normal site of the intron 12 fitting donor could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Mutations that may result in the normal site of the intron 12 splice donor could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Mutations that may result in the normal splice donor site of the 12th intron could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Mutations that may resulted in A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Mutations that may resulted in a new mutation in codon 210 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Mutations that may resulted in a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Mutations that may resulted in a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Mutations that may resulted in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Mutations that may resulted in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Mutations that may resulted in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Mutations that may resulted in failure to use the normal site of the intron 12 splice donor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Mutations that may resulted in not to use the normal donor site of the intron 12 splice may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Mutations that may resulted in reduced EGL-15 signal may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Mutations that may resulted in reduced transcription of the csgA gene encoding for the clinic may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Mutations that may resulted in reduction of csgA gene transcription csgA coding may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Mutations that may resulted in reduction of the EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Mutations that result in Diminutive EGL-15 signal can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Mutations that result in Diminutive EGL-15 signal may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Mutations that result in GL-15 Decrease Flag can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Mutations that result in a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>Mutations that result in a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>Mutations that result in alternative spacer of a single transcription may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>Mutations that result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>Mutations that result in both 5 and 3 splice local mutations can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>Mutations that result in decreases the EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>Mutations that result in differential encryption may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">differential encryption</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>Mutations that result in differential spasms can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">differential spasms</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>Mutations that result in expression of cDNA isoform II DNA in COS7 can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>Mutations that result in failure to use the normal donor site of splice of intron 12 can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>Mutations that result in growth in ras-dependent signaling can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>Mutations that result in liquid charge of the variant subunit can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>Mutations that result in reduced transcription of the csgA curlin encoder gene may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>Mutations that result in reduced transcription of the csgA gene encoding for the clinic may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>Mutations that result in reduction of EGL-15 signaling can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>Mutations that result in reduction of EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>Mutations that result in the donor place of normal helix of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>Mutations that result in the donor site of the normal helix of intron 12 could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>Mutations that result in the net charge of the variant subunit may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>Mutations that resulted in Decrease Signor of the EGL-15 can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>Mutations that resulted in a decrease in the transcription of the csgA gene encoding csgA can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>Mutations that resulted in a decrease in the transcription of the csgA gene from csglin encoding may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>Mutations that resulted in a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>Mutations that resulted in a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>Mutations that resulted in a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>Mutations that resulted in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>Mutations that resulted in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>Mutations that resulted in a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>Mutations that resulted in a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>Mutations that resulted in alternative exon splicing 139 nt can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>Mutations that resulted in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>Mutations that resulted in cooperative binding of the repressor to its two sites may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>Mutations that resulted in decreasing EGL-15 signal can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>Mutations that resulted in decreasing EGL-15 signal may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>Mutations that resulted in differential spacing can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">differential spacing</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>Mutations that resulted in exon 13 skipping in animals s1031 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>Mutations that resulted in failure to use the normal donor site of splice of intron 12 may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>Mutations that resulted in fluctuation in ras-dependent signaling may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>Mutations that resulted in growth in ras-dependent signaling can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>Mutations that resulted in liquid charge of the variant subunit may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>Mutations that resulted in loss of transcriptional repression of the lacZ gene may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>Mutations that resulted in reduced EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>Mutations that resulted in reduced transcription of the csgA curlin encoder gene can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>Mutations that resulted in reduced transcription of the csgA gene encoding for the clinic may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>Mutations that resulted in the loss of transcriptional repression of the lacZ gene may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>Mutations that resulted in the normal docking donor site of intron 12 could not be used may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>Mutations that resulted in the normal splice donor site of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>Mutations that resulted in the place of normal splice donor of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>Mutations that resulting in GL-15 Decrease Flag can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>Mutations that resulting in a decrease in csgA gene transcription from csglin coding can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>Mutations that resulting in a decrease in csgA gene transcription from csglin coding may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>Mutations that resulting in a decrease in the transcription of the csgA gene encoding csgA may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>Mutations that resulting in a decrease in transcription of the csgA gene encoding csgA can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>Mutations that resulting in a decrease in transcription of the csgA gene encoding csgA may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>Mutations that resulting in a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>Mutations that resulting in a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>Mutations that resulting in a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>Mutations that resulting in a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>Mutations that resulting in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>Mutations that resulting in a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>Mutations that resulting in a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>Mutations that resulting in exon 13 skipping in animals s1031 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>Mutations that resulting in expression of Nrf1 isoforms may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>Mutations that resulting in fluctuation in ras-dependent signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>Mutations that resulting in multiple alternative subdomains can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>Mutations that resulting in reduced transcription of the csgA gene encoding for curline can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>Mutations that resulting in reduced transcription of the csgA gene encoding for the clinic can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>Mutations that resulting in the donor place of normal helix of intron 12 could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>Mutations that resulting in the donor place of normal helix of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>Mutations that resulting in the normal site of the intron 12 fitting donor could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>Mutations that resulting in the normal splice donor site of the 12th intron could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>Mutations that resulting in the normal splice donor site of the 12th intron could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>The Decrease Signor of the EGL-15 and alternative transcriptional initiation, as result in our study, are capable of giving rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>The Decrease Signor of the EGL-15 resulted in the a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>The Diminutive EGL-15 signal will result in the a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>The Diminutive EGL-15 signal, as predicted, has the ability to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>The Diminutive EGL-15 signal, as predicted, has the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>The GL-15 Decrease Flag may have resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>The a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors has resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>The a decrease in the transcription of csgA coding gene csgA csgA will result in the the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>The a decrease in the transcription of csgA coding gene csgA csgA, as predicted, has the ability to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>The a decrease in the transcription of the csgA gene encoding csgA has the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>The a decrease in the transcription of the csgA gene encoding csgA will result in the the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>The a decrease in the transcription of the csgA gene from csglin encoding and alternative transcriptional initiation, as result in our study, are capable of giving rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>The a decrease in transcription of the csgA gene from csglin encoding has resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>The a decrease in transcription of the csgA gene from csglin encoding is capable of result rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as predicted, has resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor, as predicted, has resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors will result in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, as predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF will result in the a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, as predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, as predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>The alteration can cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>The alteration can cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling being observed to result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>The alteration can cause thermal instability and affect Decrease Signor of the EGL-15, which can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal after having resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal because it is able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal being observed to finally result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal which is able to finally result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal, which ended up resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>The alteration can cause thermal instability and affect Loading Signor of the EGL-15 because it is able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>The alteration can cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors after having resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>The alteration can cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors, which can result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>The alteration can cause thermal instability and affect a decrease in csgA gene transcription from csglin coding which has proven to result finally in the negative effect of cpxA mutation .</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>The alteration can cause thermal instability and affect a decrease in csgA gene transcription from csglin coding which is able to finally result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>The alteration can cause thermal instability and affect a decrease in the transcription of csgA coding gene csgA csgA being observed to finally result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>The alteration can cause thermal instability and affect a decrease in the transcription of the csgA gene from csglin encoding, which can result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>The alteration can cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA being observed to finally result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>The alteration can cause thermal instability and affect a decrease in transcription of the csgA gene from csglin encoding which is shown to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development which has proven to result finally in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development, which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development, which ended up resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF being observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor after having resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor, which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which has proven to result finally in a Clr phenotype .</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF being observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF after having resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling after having resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling because it is able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling, which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF which is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF, which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>The alteration can cause thermal instability and affect alternative deflection of a single transcription because it is able to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>The alteration can cause thermal instability and affect alternative deflection of a single transcription that may have resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which has proven to result finally in mRNA species with different 5UTRs .</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is able to finally result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>The alteration can cause thermal instability and affect alternative exon splicing 139 nt that may have resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>The alteration can cause thermal instability and affect alternative of a single transcription cut after having resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>The alteration can cause thermal instability and affect alternative of a single transcription cut because it is able to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>The alteration can cause thermal instability and affect alternative of a single transcription cut, which can result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>The alteration can cause thermal instability and affect alternative splicing of a single transcription after having resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>The alteration can cause thermal instability and affect alternative splicing of a single transcription being observed to finally result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>The alteration can cause thermal instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is shown to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>The alteration can cause thermal instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, which ended up resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>The alteration can cause thermal instability and affect both 5 and 3 splice mutations which is observed to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices because it is able to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices being observed to finally result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices being observed to finally result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices being observed to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which ended up resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which ended up resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>The alteration can cause thermal instability and affect both the mutations of 5 and 3 splices after having resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>The alteration can cause thermal instability and affect cooperative bonding of the repressor to its two sites after having resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>The alteration can cause thermal instability and affect cooperative bonding of the repressor to its two sites that may have resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>The alteration can cause thermal instability and affect declining EGL-15 which is shown to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>The alteration can cause thermal instability and affect declining EGL-15, which ended up resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>The alteration can cause thermal instability and affect decreases the EGL-15 signaling because it is able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>The alteration can cause thermal instability and affect decreases the EGL-15 signaling being observed to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>The alteration can cause thermal instability and affect decreasing EGL-15 sign, which can result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>The alteration can cause thermal instability and affect decreasing EGL-15 signal which has proven to result finally in scratched body morphology phenotype .</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>The alteration can cause thermal instability and affect decreasing EGL-15 signal which is able to finally result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>The alteration can cause thermal instability and affect differential encryption, which ended up resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>The alteration can cause thermal instability and affect differential splicing being observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>The alteration can cause thermal instability and affect differential splicing being observed to finally result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>The alteration can cause thermal instability and affect differential splicing being observed to finally result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>The alteration can cause thermal instability and affect differential splicing which has proven to result finally in the existence of isoforms of NF-YA .</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>The alteration can cause thermal instability and affect differential splicing which is able to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>The alteration can cause thermal instability and affect differential splicing which is shown to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>The alteration can cause thermal instability and affect expression of cDNA isoform II DNA in COS7 which has proven to result finally in a marked increase in acetylhydrolase activity PAF .</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>The alteration can cause thermal instability and affect expression of cDNA isoform II DNA in COS7, which ended up resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>The alteration can cause thermal instability and affect failure to use the normal site of the intron 12 splice donor being observed to finally result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>The alteration can cause thermal instability and affect failure to use the normal site of the intron 12 splice donor, which ended up resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>The alteration can cause thermal instability and affect liquid charge of the variant subunit after having resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>The alteration can cause thermal instability and affect liquid charge of the variant subunit that may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is able to finally result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is observed to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>The alteration can cause thermal instability and affect mixed alternative subdomains being observed to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>The alteration can cause thermal instability and affect mixed alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains being observed to finally result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 splice, which can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>The alteration can cause thermal instability and affect reduced EGL-15 signal being observed to finally result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>The alteration can cause thermal instability and affect reduced EGL-15 signaling which has proven to result finally in a phenotype of dirty body morphology .</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>The alteration can cause thermal instability and affect reduced EGL-15 signaling which is able to finally result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>The alteration can cause thermal instability and affect reduced signaling by EGL-15 after having resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>The alteration can cause thermal instability and affect reduced signaling by EGL-15 because it is able to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>The alteration can cause thermal instability and affect reduced signaling by EGL-15 being observed to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>The alteration can cause thermal instability and affect reduced signaling by EGL-15 that may have resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA curlin encoder gene because it is able to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA curlin encoder gene which is able to finally result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA curlin encoder gene which is observed to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for curline which is observed to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic because it is able to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which is shown to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic, which can result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic, which ended up resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling after having resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling because it is able to result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling because it is able to result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling being observed to finally result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling that may have resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling which has proven to result finally in dirty body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling, which ended up resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>The alteration can cause thermal instability and affect reduction of csgA gene transcription csgA coding after having resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>The alteration can cause thermal instability and affect reduction of csgA gene transcription csgA coding that may have resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>The alteration can cause thermal instability and affect reduction of the EGL-15 signaling after having resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>The alteration can cause thermal instability and affect the donor site of the normal helix of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>The alteration can cause thermal instability and affect the expression of isoforms of Nrf1 that may have resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>The alteration can cause thermal instability and affect the normal docking donor site of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>The alteration can cause thermal instability and affect the normal donor site of intron 12 donation could not be used because it is able to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>The alteration can cause thermal instability and affect the normal donor site of intron 12 donation could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>The alteration can cause thermal instability and affect the normal donor site of intron 12 donation could not be used which is shown to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>The alteration can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used, which can result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>The alteration can cause thermal instability and affect the normal splice donor site of intron 12 could not be used being observed to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>The alteration can cause thermal instability and affect the normal splice donor site of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>The alteration can cause thermal instability and affect the normal splice donor site of the 12th intron could not be used which has proven to result finally in a variant .</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>The alteration can cause thermal instability and affect the other three changes because it is able to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>The alteration can cause thermal instability and affect the other three mutations that may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>The alteration can cause thermal instability and affect the place of normal splice donor of intron 12 could not be used being observed to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>The alteration can result thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors which has finally been shown to be a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>The alteration can result thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development which is capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>The alteration can result thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which is capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>The alteration can result thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is capable of giving rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>The alteration can result thermal instability and affect alternative of a single transcription cut which is capable of giving rise to difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>The alteration can result thermal instability and affect alternative splicing of a single transcription which has finally been shown to be the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>The alteration can result thermal instability and affect alternative splicing of a single transcription which has finally been shown to be the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>The alteration can result thermal instability and affect alternative splicing of a single transcription which is capable of giving rise to the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>The alteration can result thermal instability and affect both 5 and 3 splice mutations which has finally been shown to be high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>The alteration can result thermal instability and affect both the mutations at the site of 5 and 3 splices which is capable of giving rise to of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>The alteration can result thermal instability and affect cooperative bonding of the repressor to its two sites which is capable of giving rise to repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>The alteration can result thermal instability and affect decreasing EGL-15 signal which is capable of giving rise to scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>The alteration can result thermal instability and affect expression of cDNA isoform II DNA in COS7 which has finally been shown to be a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>The alteration can result thermal instability and affect failure to use the normal site of the intron 12 splice donor which has finally been shown to be a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>The alteration can result thermal instability and affect growth in ras-dependent signaling which has finally been shown to be a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>The alteration can result thermal instability and affect liquid charge of the variant subunit which is capable of giving rise to an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>The alteration can result thermal instability and affect mixed alternative subdomains which is capable of giving rise to a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>The alteration can result thermal instability and affect multiple alternative subdomains which is capable of giving rise to a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>The alteration can result thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which has finally been shown to be negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>The alteration can result thermal instability and affect reduction of EGL-15 signaling which has finally been shown to be a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>The alteration can result thermal instability and affect reduction of csgA gene transcription csgA coding which is capable of giving rise to negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>The alteration can result thermal instability and affect some alternative subdomains which has finally been shown to be a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>The alteration can result thermal instability and affect the donor site of the normal helix of intron 12 could not be used which has finally been shown to be a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>The alteration can result thermal instability and affect the donor site of the normal helix of intron 12 could not be used which is capable of giving rise to a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>The alteration can result thermal instability and affect the normal donor site of intron 12 donation could not be used which has finally been shown to be a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>The alteration may cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>The alteration may cause thermal instability and affect Decrease Signor of the EGL-15 which is observed to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal which finally resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal which may result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal which resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>The alteration may cause thermal instability and affect GL-15 Decrease Flag which resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>The alteration may cause thermal instability and affect Loading Signor of the EGL-15 which has been demonstrated to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>The alteration may cause thermal instability and affect Loading Signor of the EGL-15 which is observed to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>The alteration may cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>The alteration may cause thermal instability and affect a decrease in the transcription of csgA coding gene csgA csgA which has been demonstrated to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>The alteration may cause thermal instability and affect a decrease in the transcription of the csgA gene encoding csgA which resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>The alteration may cause thermal instability and affect a decrease in the transcription of the csgA gene from csglin encoding which is observed to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>The alteration may cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA which is observed to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>The alteration may cause thermal instability and affect a decrease in transcription of the csgA gene from csglin encoding which has been demonstrated to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF which may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, which may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive which has been demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive which may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, which may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF, which may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor, which may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which has been demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, which may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, which may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF, which may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>The alteration may cause thermal instability and affect alternative deflection of a single transcription which has been demonstrated to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>The alteration may cause thermal instability and affect alternative exon splicing 139 nt which may result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>The alteration may cause thermal instability and affect alternative spacer of a single transcription, which may eventually result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>The alteration may cause thermal instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, which may ultimately resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>The alteration may cause thermal instability and affect both 5 and 3 splice mutations being demonstrated to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>The alteration may cause thermal instability and affect both 5 and 3 splice mutations which finally resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>The alteration may cause thermal instability and affect both 5 and 3 splice mutations which is observed to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>The alteration may cause thermal instability and affect both the mutations at the site of 5 and 3 splices which finally resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>The alteration may cause thermal instability and affect both the mutations at the site of 5 and 3 splices which may result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>The alteration may cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which may eventually result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>The alteration may cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which may ultimately resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>The alteration may cause thermal instability and affect both the mutations of 5 and 3 splices which has been demonstrated to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>The alteration may cause thermal instability and affect both the mutations of 5 and 3 splices which is observed to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>The alteration may cause thermal instability and affect both the mutations of 5 and 3 splices which may result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>The alteration may cause thermal instability and affect declining EGL-15 which resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>The alteration may cause thermal instability and affect decreases the EGL-15 signaling which finally resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>The alteration may cause thermal instability and affect decreasing EGL-15 sign which resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>The alteration may cause thermal instability and affect differential encryption which has been demonstrated to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>The alteration may cause thermal instability and affect differential encryption, which may eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>The alteration may cause thermal instability and affect differential splicing which finally resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>The alteration may cause thermal instability and affect differential splicing which has been demonstrated to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>The alteration may cause thermal instability and affect differential splicing which may result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>The alteration may cause thermal instability and affect differential splicing, which may ultimately resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>The alteration may cause thermal instability and affect expression of Nrf1 isoforms being demonstrated to result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>The alteration may cause thermal instability and affect expression of cDNA isoform II DNA in COS7 which is observed to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>The alteration may cause thermal instability and affect expression of cDNA isoform II DNA in COS7, which may ultimately resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>The alteration may cause thermal instability and affect growth in ras-dependent signaling being demonstrated to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>The alteration may cause thermal instability and affect growth in ras-dependent signaling which finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>The alteration may cause thermal instability and affect growth in ras-dependent signaling which is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>The alteration may cause thermal instability and affect growth in ras-dependent signaling, which may eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>The alteration may cause thermal instability and affect liquid charge of the variant subunit being demonstrated to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>The alteration may cause thermal instability and affect liquid charge of the variant subunit which finally resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>The alteration may cause thermal instability and affect liquid charge of the variant subunit which has been demonstrated to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits being demonstrated to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which has been demonstrated to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits, which may ultimately resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which is observed to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which may result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains, which may ultimately resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>The alteration may cause thermal instability and affect reduced EGL-15 signaling being demonstrated to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>The alteration may cause thermal instability and affect reduced signaling by EGL-15 being demonstrated to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>The alteration may cause thermal instability and affect reduced signaling by EGL-15 which may result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>The alteration may cause thermal instability and affect reduced signaling by EGL-15, which may ultimately resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>The alteration may cause thermal instability and affect reduced transcription of the csgA gene encoding for curline which finally resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>The alteration may cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic being demonstrated to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>The alteration may cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which finally resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling which is observed to result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling which may result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling which resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>The alteration may cause thermal instability and affect reduction of csgA gene transcription csgA coding being demonstrated to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>The alteration may cause thermal instability and affect reduction of csgA gene transcription csgA coding which has been demonstrated to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>The alteration may cause thermal instability and affect some alternative subdomains which resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>The alteration may cause thermal instability and affect the donor place of normal helix of intron 12 could not be used which has been demonstrated to result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>The alteration may cause thermal instability and affect the donor site of the normal helix of intron 12 could not be used, which may eventually result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>The alteration may cause thermal instability and affect the expression of isoforms of Nrf1, which may eventually result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which finally resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="558">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit, which may ultimately resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="559">
                    <text>The alteration may cause thermal instability and affect the normal docking donor site of intron 12 could not be used, which may ultimately resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="560">
                    <text>The alteration may cause thermal instability and affect the normal donor site of intron 12 donation could not be used being demonstrated to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="561">
                    <text>The alteration may cause thermal instability and affect the normal donor site of intron 12 donation could not be used which may result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="562">
                    <text>The alteration may cause thermal instability and affect the normal donor site of intron 12 donation could not be used, which may ultimately resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="563">
                    <text>The alteration may cause thermal instability and affect the normal splice donor site of intron 12 could not be used which has been demonstrated to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="564">
                    <text>The alteration may cause thermal instability and affect the normal splice donor site of the 12th intron could not be used, which may eventually result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="565">
                    <text>The alteration may cause thermal instability and affect the normal splice donor site of the 12th intron could not be used, which may ultimately resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="566">
                    <text>The alteration may cause thermal instability and affect the other three alterations being demonstrated to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="567">
                    <text>The alteration may cause thermal instability and affect the other three alterations which is observed to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="568">
                    <text>The alteration may cause thermal instability and affect the other three changes which has been demonstrated to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="569">
                    <text>The alteration may cause thermal instability and affect the place of normal splice donor of intron 12 could not be used which finally resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="570">
                    <text>The alternative deflection of a single transcription will result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="571">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start will result in the mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="572">
                    <text>The alternative exon splicing 139 nt will result in the mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="573">
                    <text>The alternative of a single transcription cut will result in the difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="574">
                    <text>The alternative splicing of a single transcription and alternative transcriptional initiation, as result in our study, are capable of giving rise to the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="575">
                    <text>The alternative splicing of a single transcription has resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="576">
                    <text>The alternative splicing of a single transcription has the ability to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="577">
                    <text>The alternative splicing of a single transcription resulted in the the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="578">
                    <text>The alternative splicing of a single transcription will result in the the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="579">
                    <text>The alternative splicing of a single transcription, as predicted, has resulted in the the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="580">
                    <text>The alternative splicing of a single transcription, as predicted, has resulted in the the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="581">
                    <text>The alternative splicing of a single transcription, as predicted, has the ability to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="582">
                    <text>The alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, resulted in the mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="583">
                    <text>The both 5 and 3 splice local mutations is capable of result rise to high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="584">
                    <text>The both 5 and 3 splice local mutations, as predicted, has resulted in the high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="585">
                    <text>The both the mutations at the site of 5 and 3 splices and alternative transcriptional initiation, as result in our study, are capable of giving rise to high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="586">
                    <text>The both the mutations at the site of 5 and 3 splices has the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="587">
                    <text>The both the mutations at the site of 5 and 3 splices, as predicted, has resulted in the of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="588">
                    <text>The both the mutations of 5 and 3 splices resulted in the of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="589">
                    <text>The change can cause heat instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="590">
                    <text>The change can cause heat instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which has finally resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="591">
                    <text>The change can cause heat instability and affect Decrease Signor of the EGL-15 which can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="592">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal after it has resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="593">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which can eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="594">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="595">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which has resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="596">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="597">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which has resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="598">
                    <text>The change can cause heat instability and affect GL-15 Decrease Flag that may have resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="599">
                    <text>The change can cause heat instability and affect GL-15 Decrease Flag which has resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="600">
                    <text>The change can cause heat instability and affect Loading Signor of the EGL-15 by being able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="601">
                    <text>The change can cause heat instability and affect Loading Signor of the EGL-15 which eventually resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="602">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors after it has resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="603">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors by being able to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="604">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors which can result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="605">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="606">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="607">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which can eventually result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="608">
                    <text>The change can cause heat instability and affect a decrease in csgA gene transcription from csglin coding that may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="609">
                    <text>The change can cause heat instability and affect a decrease in csgA gene transcription from csglin coding which may eventually have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="610">
                    <text>The change can cause heat instability and affect a decrease in the transcription of csgA coding gene csgA csgA which has finally resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="611">
                    <text>The change can cause heat instability and affect a decrease in the transcription of the csgA gene encoding csgA by finally being able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="612">
                    <text>The change can cause heat instability and affect a decrease in the transcription of the csgA gene encoding csgA which can result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="613">
                    <text>The change can cause heat instability and affect a decrease in the transcription of the csgA gene from csglin encoding that may have resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="614">
                    <text>The change can cause heat instability and affect a decrease in the transcription of the csgA gene from csglin encoding which can result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="615">
                    <text>The change can cause heat instability and affect a decrease in the transcription of the csgA gene from csglin encoding which has finally resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="616">
                    <text>The change can cause heat instability and affect a decrease in transcription of the csgA gene from csglin encoding which resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="617">
                    <text>The change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="618">
                    <text>The change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="619">
                    <text>The change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="620">
                    <text>The change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="621">
                    <text>The change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF which may eventually have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="622">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="623">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="624">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor which has been shown to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="625">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="626">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="627">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="628">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="629">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="630">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which has been shown to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="631">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="632">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="633">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which may eventually have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="634">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="635">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="636">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="637">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="638">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling by finally being able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="639">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="640">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="641">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="642">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF by finally being able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="643">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling by finally being able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="644">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="645">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF after it has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="646">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="647">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="648">
                    <text>The change can cause heat instability and affect alternative deflection of a single transcription which has finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="649">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which has finally resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="650">
                    <text>The change can cause heat instability and affect alternative exon splicing 139 nt after it has resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="651">
                    <text>The change can cause heat instability and affect alternative exon splicing 139 nt by being able to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="652">
                    <text>The change can cause heat instability and affect alternative exon splicing 139 nt that may have resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="653">
                    <text>The change can cause heat instability and affect alternative exon splicing 139 nt which has been shown to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="654">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut which eventually resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="655">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut which may eventually have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="656">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut which may eventually have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="657">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut which resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="658">
                    <text>The change can cause heat instability and affect alternative spacer of a single transcription which has resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="659">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription after it has resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="660">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription by finally being able to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="661">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which eventually resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="662">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, after it has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="663">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, which has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="664">
                    <text>The change can cause heat instability and affect both 5 and 3 splice local mutations which has been shown to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="665">
                    <text>The change can cause heat instability and affect both 5 and 3 splice local mutations which has finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="666">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations after it has resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="667">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations by finally being able to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="668">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations that may have resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="669">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which eventually resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="670">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which has been shown to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="671">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which has finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="672">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices after it has resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="673">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices by being able to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="674">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices by finally being able to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="675">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices which has been shown to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="676">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices which may eventually have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="677">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices which resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="678">
                    <text>The change can cause heat instability and affect both the mutations of 5 and 3 splices which can result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="679">
                    <text>The change can cause heat instability and affect both the mutations of 5 and 3 splices which may eventually have resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="680">
                    <text>The change can cause heat instability and affect both the mutations of 5 and 3 splices which resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="681">
                    <text>The change can cause heat instability and affect cooperative binding of the repressor to its two sites by being able to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="682">
                    <text>The change can cause heat instability and affect cooperative binding of the repressor to its two sites by finally being able to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="683">
                    <text>The change can cause heat instability and affect cooperative bonding of the repressor to its two sites which can result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="684">
                    <text>The change can cause heat instability and affect cooperative bonding of the repressor to its two sites which will eventually result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="685">
                    <text>The change can cause heat instability and affect declining EGL-15 after it has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="686">
                    <text>The change can cause heat instability and affect declining EGL-15 which resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="687">
                    <text>The change can cause heat instability and affect decreases the EGL-15 signaling after it has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="688">
                    <text>The change can cause heat instability and affect decreases the EGL-15 signaling which has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="689">
                    <text>The change can cause heat instability and affect decreases the EGL-15 signaling which resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="690">
                    <text>The change can cause heat instability and affect decreases the EGL-15 signaling which will eventually result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="691">
                    <text>The change can cause heat instability and affect decreasing EGL-15 sign which can result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="692">
                    <text>The change can cause heat instability and affect decreasing EGL-15 sign which will eventually result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="693">
                    <text>The change can cause heat instability and affect differential splicing by finally being able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="694">
                    <text>The change can cause heat instability and affect differential splicing that may have resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="695">
                    <text>The change can cause heat instability and affect differential splicing which may eventually have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="696">
                    <text>The change can cause heat instability and affect differential splicing which will eventually result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="697">
                    <text>The change can cause heat instability and affect expression of cDNA isoform II DNA in COS7 by being able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="698">
                    <text>The change can cause heat instability and affect failure to use the normal site of the intron 12 splice donor which eventually resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="699">
                    <text>The change can cause heat instability and affect failure to use the normal site of the intron 12 splice donor which has resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="700">
                    <text>The change can cause heat instability and affect failure to use the normal site of the intron 12 splice donor which may eventually have resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="701">
                    <text>The change can cause heat instability and affect growth in ras-dependent signaling which can eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="702">
                    <text>The change can cause heat instability and affect growth in ras-dependent signaling which may eventually have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="703">
                    <text>The change can cause heat instability and affect liquid charge of the variant subunit which can result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="704">
                    <text>The change can cause heat instability and affect mixed alternative subdomains after it has resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="705">
                    <text>The change can cause heat instability and affect mixed alternative subdomains by finally being able to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="706">
                    <text>The change can cause heat instability and affect mixed alternative subdomains which can result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="707">
                    <text>The change can cause heat instability and affect mixed alternative subdomains which eventually resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="708">
                    <text>The change can cause heat instability and affect mixed alternative subdomains which has been shown to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="709">
                    <text>The change can cause heat instability and affect mixed alternative subdomains which resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="710">
                    <text>The change can cause heat instability and affect multiple alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="711">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which has been shown to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="712">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which will eventually result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="713">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 splice which eventually resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="714">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 splice which has finally resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="715">
                    <text>The change can cause heat instability and affect reduced EGL-15 signal by being able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="716">
                    <text>The change can cause heat instability and affect reduced EGL-15 signaling which has finally resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="717">
                    <text>The change can cause heat instability and affect reduced EGL-15 signaling which will eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="718">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 that may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="719">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 which can result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="720">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 which eventually resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="721">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 which will eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="722">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA curlin encoder gene that may have resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="723">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA curlin encoder gene which has been shown to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="724">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA curlin encoder gene which has resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="725">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA gene encoding for the clinic by being able to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="726">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA gene encoding for the clinic which resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="727">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling after it has resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="728">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling by finally being able to result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="729">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which can eventually result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="730">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which has resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="731">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which will eventually result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="732">
                    <text>The change can cause heat instability and affect reduction of csgA gene transcription csgA coding by finally being able to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="733">
                    <text>The change can cause heat instability and affect reduction of the EGL-15 signaling after it has resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="734">
                    <text>The change can cause heat instability and affect reduction of the EGL-15 signaling which has been shown to result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="735">
                    <text>The change can cause heat instability and affect some alternative subdomains after it has resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="736">
                    <text>The change can cause heat instability and affect the donor place of normal helix of intron 12 could not be used which has finally resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="737">
                    <text>The change can cause heat instability and affect the donor site of the normal helix of intron 12 could not be used after it has resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="738">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit by being able to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="739">
                    <text>The change can cause heat instability and affect the normal donor site of intron 12 donation could not be used by finally being able to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="740">
                    <text>The change can cause heat instability and affect the normal site of the intron 12 fitting donor could not be used by being able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="741">
                    <text>The change can cause heat instability and affect the normal site of the intron 12 fitting donor could not be used which will eventually result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="742">
                    <text>The change can cause heat instability and affect the normal site of the intron 12 splice donor could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="743">
                    <text>The change can cause heat instability and affect the normal splice donor site of the 12th intron could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="744">
                    <text>The change can cause heat instability and affect the normal splice donor site of the 12th intron could not be used which has finally resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="745">
                    <text>The change can cause heat instability and affect the other three changes by finally being able to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="746">
                    <text>The change can cause heat instability and affect the other three changes which may eventually have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="747">
                    <text>The change can cause heat instability and affect the other three changes which resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="748">
                    <text>The change can cause heat instability and affect the other three mutations which has been shown to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="749">
                    <text>The change can cause heat instability and affect the other three mutations which may eventually have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="750">
                    <text>The change can cause heat instability and affect the other three mutations which will eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="751">
                    <text>The change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used by being able to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="752">
                    <text>The change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used which can result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="753">
                    <text>The change can cause thermal instability and affect Loading Signor of the EGL-15 and is shown to finally result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="754">
                    <text>The change can cause thermal instability and affect Loading Signor of the EGL-15 that is observed to finally result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="755">
                    <text>The change can cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="756">
                    <text>The change can cause thermal instability and affect a decrease in the transcription of csgA coding gene csgA csgA that is observed to finally result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="757">
                    <text>The change can cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA that is observed to finally result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="758">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="759">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="760">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="761">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="762">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="763">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="764">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="765">
                    <text>The change can cause thermal instability and affect alternative deflection of a single transcription and is shown to finally result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="766">
                    <text>The change can cause thermal instability and affect alternative of a single transcription cut and is shown to finally result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="767">
                    <text>The change can cause thermal instability and affect alternative of a single transcription cut and is shown to ultimately result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="768">
                    <text>The change can cause thermal instability and affect alternative of a single transcription cut and is shown to ultimately result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="769">
                    <text>The change can cause thermal instability and affect alternative of a single transcription cut that is observed to finally result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="770">
                    <text>The change can cause thermal instability and affect both 5 and 3 splice local mutations and is shown to finally result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="771">
                    <text>The change can cause thermal instability and affect both 5 and 3 splice mutations and is shown to finally result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="772">
                    <text>The change can cause thermal instability and affect both 5 and 3 splice mutations that is observed to finally result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="773">
                    <text>The change can cause thermal instability and affect both 5 and 3 splice mutations that is observed to finally result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="774">
                    <text>The change can cause thermal instability and affect both the mutations at the site of 5 and 3 splices and is shown to ultimately result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="775">
                    <text>The change can cause thermal instability and affect both the mutations at the site of 5 and 3 splices that is observed to finally result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="776">
                    <text>The change can cause thermal instability and affect declining EGL-15 and is shown to ultimately result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="777">
                    <text>The change can cause thermal instability and affect decreasing EGL-15 signal and is shown to ultimately result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="778">
                    <text>The change can cause thermal instability and affect differential encryption and is shown to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="779">
                    <text>The change can cause thermal instability and affect exon 13 skipping in animals s1031 that is observed to finally result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="780">
                    <text>The change can cause thermal instability and affect expression of cDNA isoform II DNA in COS7 that is observed to finally result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="781">
                    <text>The change can cause thermal instability and affect growth in ras-dependent signaling that is observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="782">
                    <text>The change can cause thermal instability and affect liquid charge of the variant subunit and is shown to finally result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="783">
                    <text>The change can cause thermal instability and affect liquid charge of varying subunits that is observed to finally result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="784">
                    <text>The change can cause thermal instability and affect reduced EGL-15 signal and is shown to ultimately result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="785">
                    <text>The change can cause thermal instability and affect reduced transcription of the csgA curlin encoder gene and is shown to finally result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="786">
                    <text>The change can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic and is shown to finally result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="787">
                    <text>The change can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic that is observed to finally result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="788">
                    <text>The change can cause thermal instability and affect reduction of EGL-15 signaling that is observed to finally result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="789">
                    <text>The change can cause thermal instability and affect reduction of the EGL-15 signaling and is shown to finally result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="790">
                    <text>The change can cause thermal instability and affect reduction of the EGL-15 signaling that is observed to finally result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="791">
                    <text>The change can cause thermal instability and affect the donor site of the normal helix of intron 12 could not be used and is shown to ultimately result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="792">
                    <text>The change can cause thermal instability and affect the normal donor site of intron 12 donation could not be used and is shown to ultimately result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="793">
                    <text>The change can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used and is shown to finally result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="794">
                    <text>The change can cause thermal instability and affect the other three changes and is shown to ultimately result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="795">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="796">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="797">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="798">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice local mutations that has the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="799">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations that has the ability to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="800">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices that has the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="801">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed cooperative bonding of the repressor to its two sites that has the ability to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="802">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 signal that has the ability to result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="803">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for curline that has the ability to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="804">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for the clinic that has the ability to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="805">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling that has the ability to result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="806">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed the normal donor site of intron 12 donation could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="807">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed the other three alterations that has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="808">
                    <text>The cooperative binding of the repressor to its two sites has the ability to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="809">
                    <text>The cooperative binding of the repressor to its two sites is capable of result rise to repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="810">
                    <text>The cooperative binding of the repressor to its two sites, as predicted, has resulted in the repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="811">
                    <text>The cooperative bonding of the repressor to its two sites and alternative transcriptional initiation, as result in our study, are capable of giving rise to repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="812">
                    <text>The cooperative bonding of the repressor to its two sites will result in the repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="813">
                    <text>The declining EGL-15 has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="814">
                    <text>The declining EGL-15, as predicted, has resulted in the a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="815">
                    <text>The decreases the EGL-15 signaling will result in the a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="816">
                    <text>The decreases the EGL-15 signaling, as predicted, has the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="817">
                    <text>The decreasing EGL-15 sign has resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="818">
                    <text>The decreasing EGL-15 signal has the ability to result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="819">
                    <text>The decreasing EGL-15 signal will result in the scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="820">
                    <text>The differential splicing may have resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="821">
                    <text>The differential splicing resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="822">
                    <text>The differential splicing will result in the the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="823">
                    <text>The exon 13 skipping in animals s1031 has resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="824">
                    <text>The exon 13 skipping in animals s1031, as predicted, has resulted in the a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="825">
                    <text>The expression of Nrf1 isoforms has resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="826">
                    <text>The expression of Nrf1 isoforms will result in the this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="827">
                    <text>The expression of cDNA isoform II DNA in COS7 is capable of result rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="828">
                    <text>The failure to use the normal donor site of splice of intron 12 has resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="829">
                    <text>The failure to use the normal donor site of splice of intron 12, as predicted, has resulted in the a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="830">
                    <text>The failure to use the normal donor site of splice of intron 12, as predicted, has the ability to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="831">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling and was able to result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="832">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Decrease Signor of the EGL-15 and was able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="833">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Decrease Signor of the EGL-15 resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="834">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Decrease Signor of the EGL-15 that may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="835">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal resulting in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="836">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that was observed to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="837">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed GL-15 Decrease Flag that is able to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="838">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors that will result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="839">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that may result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="840">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="841">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in csgA gene transcription from csglin coding that was observed to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="842">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in csgA gene transcription from csglin coding that will result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="843">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in the transcription of the csgA gene encoding csgA and was able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="844">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in the transcription of the csgA gene from csglin encoding that is able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="845">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene encoding csgA that has the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="846">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene from csglin encoding and was able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="847">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene from csglin encoding resulting in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="848">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="849">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF and was able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="850">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF that was observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="851">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor and was able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="852">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="853">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="854">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="855">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="856">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="857">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="858">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="859">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="860">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="861">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="862">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that was observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="863">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="864">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and was able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="865">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="866">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="867">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="868">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="869">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF that is able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="870">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="871">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="872">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative deflection of a single transcription that may result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="873">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulting in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="874">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="875">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon splicing 139 nt and was able to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="876">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon splicing 139 nt that will result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="877">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative of a single transcription cut that may result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="878">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative of a single transcription cut that was observed to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="879">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative of a single transcription cut that will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="880">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that may have resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="881">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that may result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="882">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of a single transcription that was observed to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="883">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of a single transcription that will result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="884">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, and was able to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="885">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, that may result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="886">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice local mutations that is able to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="887">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice local mutations that resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="888">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice local mutations that was observed to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="889">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations resulting in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="890">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations resulting in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="891">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations that is able to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="892">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations that resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="893">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations that will result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="894">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices that was observed to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="895">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices that will result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="896">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations of 5 and 3 splices resulting in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="897">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations of 5 and 3 splices that may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="898">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed cooperative binding of the repressor to its two sites that may result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="899">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed cooperative bonding of the repressor to its two sites that resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="900">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreases the EGL-15 signaling and was able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="901">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreases the EGL-15 signaling that has the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="902">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreases the EGL-15 signaling that resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="903">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 sign that may result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="904">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing and was able to result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="905">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that may result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="906">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="907">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that was observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="908">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of Nrf1 isoforms resulting in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="909">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="910">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal donor site of splice of intron 12 that was observed to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="911">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of varying subunits resulting in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="912">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed mixed alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="913">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that has the ability to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="914">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="915">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that will result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="916">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 splice that is able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="917">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced EGL-15 signal that will result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="918">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced EGL-15 signaling that has the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="919">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced signaling by EGL-15 resulting in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="920">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced signaling by EGL-15 that may have resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="921">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced signaling by EGL-15 that resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="922">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA curlin encoder gene and was able to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="923">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA curlin encoder gene that was observed to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="924">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for curline resulting in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="925">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for curline that may result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="926">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for the clinic that may result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="927">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for the clinic that resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="928">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling resulting in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="929">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling that was observed to result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="930">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of csgA gene transcription csgA coding that resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="931">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of the EGL-15 signaling that may result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="932">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of the EGL-15 signaling that was observed to result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="933">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="934">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the donor place of normal helix of intron 12 could not be used that is able to result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="935">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the donor site of the normal helix of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="936">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the donor site of the normal helix of intron 12 could not be used that may have resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="937">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the expression of isoforms of Nrf1 resulting in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="938">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the expression of isoforms of Nrf1 that is able to result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="939">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the expression of isoforms of Nrf1 that may have resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="940">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit resulting in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="941">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that has the ability to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="942">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal docking donor site of intron 12 could not be used resulting in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="943">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal donor site of intron 12 donation could not be used that may result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="944">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 fitting donor could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="945">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 splice donor could not be used resulting in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="946">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 splice donor could not be used that may result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="947">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 splice donor could not be used that resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="948">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 splice donor could not be used that will result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="949">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="950">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of the 12th intron could not be used that resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="951">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the other three alterations that has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="952">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the other three alterations that may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="953">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the other three mutations that may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="954">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the place of normal splice donor of intron 12 could not be used resulting in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="955">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that could resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="956">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Decrease Signor of the EGL-15 that may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="957">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Diminutive EGL-15 signal results in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="958">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Loading Signor of the EGL-15 that may result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="959">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors results in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="960">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="961">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in csgA gene transcription from csglin coding results in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="962">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in csgA gene transcription from csglin coding that could resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="963">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in the transcription of csgA coding gene csgA csgA resulting in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="964">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in the transcription of csgA coding gene csgA csgA which resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="965">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="966">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that could resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="967">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive results in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="968">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor that may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="969">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor results in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="970">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that could resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="971">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="972">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="973">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="974">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that could resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="975">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF results in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="976">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="977">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="978">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start results in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="979">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon splicing 139 nt results in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="980">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription resulting in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="981">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription results in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="982">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription that could resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="983">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription that may result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="984">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription that may result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="985">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both 5 and 3 splice mutations that may result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="986">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices which resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="987">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations of 5 and 3 splices results in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="988">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations of 5 and 3 splices that could resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="989">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed cooperative bonding of the repressor to its two sites that could resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="990">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed declining EGL-15 results in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="991">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed declining EGL-15 that may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="992">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed decreases the EGL-15 signaling resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="993">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed decreasing EGL-15 sign results in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="994">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed decreasing EGL-15 signal resulting in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="995">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="996">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing resulting in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="997">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing that could resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="998">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing which resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="999">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 skipping in animals s1031 resulting in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1000">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed growth in ras-dependent signaling that could resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1001">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits that could resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1002">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced EGL-15 signaling results in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1003">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced transcription of the csgA gene encoding for curline resulting in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1004">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced transcription of the csgA gene encoding for the clinic that could resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1005">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of EGL-15 signaling that could resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1006">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of EGL-15 signaling that may result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1007">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of EGL-15 signaling which resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1008">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of csgA gene transcription csgA coding that could resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1009">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed some alternative subdomains results in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1010">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a decrease in the transcription of csgA coding gene csgA csgA could result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1011">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a decrease in the transcription of the csgA gene from csglin encoding had the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1012">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a decrease in transcription of the csgA gene encoding csgA could result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1013">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a decrease in transcription of the csgA gene from csglin encoding had the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1014">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1015">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1016">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF could result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1017">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1018">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1019">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1020">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor could result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1021">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling could result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1022">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1023">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1024">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative deflection of a single transcription resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1025">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1026">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative of a single transcription cut could result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1027">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative splicing of a single transcription had the ability to result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1028">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both 5 and 3 splice local mutations had the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1029">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both 5 and 3 splice mutations could result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1030">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both 5 and 3 splice mutations had the ability to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1031">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both the mutations of 5 and 3 splices could result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1032">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both the mutations of 5 and 3 splices had the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1033">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that cooperative bonding of the repressor to its two sites could result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1034">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that differential encryption could result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1035">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA isoform II DNA in COS7 had the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1036">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that growth in ras-dependent signaling resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1037">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternative subdomains could result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1038">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternative subdomains had the ability to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1039">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the donor site of the normal helix of intron 12 could not be used had the ability to result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1040">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net charge of the variant subunit could result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1041">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the normal splice donor site of intron 12 could not be used could result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1042">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the normal splice donor site of intron 12 could not be used had the ability to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1043">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the other three alterations had the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1044">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the other three mutations could result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1045">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the donor place of normal helix of intron 12 could not be used that may result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1046">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the expression of isoforms of Nrf1 results in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1047">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the expression of isoforms of Nrf1 that could resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1048">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit which resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1049">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal docking donor site of intron 12 could not be used which resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1050">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal splice donor site of the 12th intron could not be used which resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1051">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the other three changes resulting in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1052">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the other three mutations that may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1053">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the place of normal splice donor of intron 12 could not be used resulting in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1054">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the place of normal splice donor of intron 12 could not be used that may result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1055">
                    <text>The growth in ras-dependent signaling may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1056">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling after having resulted a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1057">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Decrease Signor of the EGL-15 that resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1058">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Decrease Signor of the EGL-15 that results in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1059">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Diminutive EGL-15 signal after having resulted a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1060">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Diminutive EGL-15 signal and may result rise to a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1061">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes GL-15 Decrease Flag with ability to entirely result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1062">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors after having resulted a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1063">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors and may result rise to a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1064">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors resulted in the complete a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1065">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors that are result as entirely a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1066">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in transcription of the csgA gene from csglin encoding that resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1067">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1068">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1069">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF and may result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1070">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor resulted in the complete a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1071">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1072">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor resulted in the complete a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1073">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1074">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor with ability to entirely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1075">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that are result as entirely a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1076">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that results in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1077">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1078">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF with ability to entirely result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1079">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative deflection of a single transcription with ability to entirely result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1080">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that are result as entirely mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1081">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start with ability to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1082">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative of a single transcription cut after having resulted difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1083">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative of a single transcription cut resulted in the complete difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1084">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative of a single transcription cut that results in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1085">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative of a single transcription cut with ability to entirely result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1086">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative of a single transcription cut with ability to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1087">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative splicing of a single transcription resulted in the complete the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1088">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation after having resulted mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1089">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both 5 and 3 splice local mutations resulted in the complete high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1090">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both 5 and 3 splice local mutations with ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1091">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices and may result rise to high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1092">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices that are result as entirely of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1093">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations of 5 and 3 splices and may result rise to of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1094">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations of 5 and 3 splices with ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1095">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes cooperative binding of the repressor to its two sites with ability to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1096">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes declining EGL-15 with ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1097">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential splicing after having resulted existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1098">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential splicing after having resulted the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1099">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential splicing and may result rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1100">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential splicing and may result rise to the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1101">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of Nrf1 isoforms and may result rise to this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1102">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of Nrf1 isoforms with ability to entirely result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1103">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes failure to use the normal donor site of splice of intron 12 resulted in the complete a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1104">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes failure to use the normal donor site of splice of intron 12 with ability to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1105">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes failure to use the normal site of the intron 12 splice donor and may result rise to a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1106">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of the variant subunit resulted in the complete an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1107">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits resulted in the complete an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1108">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes mixed alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1109">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains after having resulted superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1110">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1111">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains with ability to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1112">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced EGL-15 signal with ability to entirely result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1113">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced EGL-15 signaling that resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1114">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for curline resulted in the complete negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1115">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for curline with ability to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1116">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic resulted in the complete negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1117">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic that resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1118">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic that results in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1119">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of EGL-15 signaling and may result rise to scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1120">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of EGL-15 signaling that results in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1121">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of csgA gene transcription csgA coding after having resulted negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1122">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of the EGL-15 signaling that results in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1123">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains that are result as entirely a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1124">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the expression of isoforms of Nrf1 and may result rise to this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1125">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the expression of isoforms of Nrf1 with ability to entirely result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1126">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit after having resulted a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1127">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal docking donor site of intron 12 could not be used with ability to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1128">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal donor site of intron 12 donation could not be used that resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1129">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 fitting donor could not be used that are result as entirely a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1130">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 fitting donor could not be used that results in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1131">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 splice donor could not be used and may result rise to a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1132">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal splice donor site of intron 12 could not be used that results in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1133">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the other three alterations and may result rise to non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1134">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the other three alterations with ability to entirely result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1135">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that are able to completely result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1136">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Diminutive EGL-15 signal that are able to completely result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1137">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Diminutive EGL-15 signal that are able to completely result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1138">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Loading Signor of the EGL-15 that are able to completely result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1139">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that are able to completely result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1140">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, that are able to completely result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1141">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes cooperative bonding of the repressor to its two sites that are able to completely result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1142">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes differential splicing that are able to completely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1143">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes exon 13 skipping in animals s1031 that are able to completely result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1144">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes reduced transcription of the csgA gene encoding for the clinic that are able to completely result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1145">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1146">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a decrease in transcription of the csgA gene encoding csgA that has the ability to completely result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1147">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1148">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1149">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1150">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1151">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes both 5 and 3 splice mutations that has the ability to completely result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1152">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes failure to use the normal site of the intron 12 splice donor that has the ability to completely result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1153">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Decrease Signor of the EGL-15 that can result entirely in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1154">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Diminutive EGL-15 signal and is observed to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1155">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Diminutive EGL-15 signal that resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1156">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes GL-15 Decrease Flag that can result entirely in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1157">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that will result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1158">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a decrease in the transcription of csgA coding gene csgA csgA and is observed to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1159">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a decrease in the transcription of csgA coding gene csgA csgA that can result entirely in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1160">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a decrease in the transcription of the csgA gene encoding csgA that resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1161">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1162">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1163">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF that can result entirely in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1164">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1165">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1166">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors and is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1167">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1168">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1169">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative exon splicing 139 nt that will result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1170">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative of a single transcription cut that resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1171">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that can result entirely in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1172">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, that will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1173">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices and is observed to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1174">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices that resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1175">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes both the mutations of 5 and 3 splices that will result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1176">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes cooperative binding of the repressor to its two sites that will result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1177">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes cooperative bonding of the repressor to its two sites that can result entirely in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1178">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes declining EGL-15 and is observed to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1179">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes decreases the EGL-15 signaling and is observed to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1180">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes decreasing EGL-15 sign that resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1181">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differential splicing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1182">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of Nrf1 isoforms that can result entirely in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1183">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes failure to use the normal donor site of splice of intron 12 that will result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1184">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes growth in ras-dependent signaling and is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1185">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes growth in ras-dependent signaling that can result entirely in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1186">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes growth in ras-dependent signaling that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1187">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid charge of the variant subunit that resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1188">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1189">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 splice and is observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1190">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 splice that will result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1191">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced signaling by EGL-15 that can result entirely in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1192">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic and is observed to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1193">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of EGL-15 signaling that will result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1194">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of EGL-15 signaling that will result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1195">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of csgA gene transcription csgA coding that can result entirely in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1196">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the normal docking donor site of intron 12 could not be used that can result entirely in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1197">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the normal splice donor site of the 12th intron could not be used that will result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1198">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the other three changes that will result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1199">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1200">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1201">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1202">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1203">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1204">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1205">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative exon splicing 139 nt that has the ability to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1206">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative of a single transcription cut that resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1207">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, that has the ability to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1208">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes both the mutations at the site of 5 and 3 splices that has the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1209">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes both the mutations at the site of 5 and 3 splices that resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1210">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes both the mutations of 5 and 3 splices that resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1211">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes decreases the EGL-15 signaling that has the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1212">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes differential encryption that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1213">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes exon 13 skipping in animals s1031 that has the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1214">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes multiple alternative subdomains that has the ability to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1215">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes reduction of EGL-15 signaling that has the ability to result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1216">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes reduction of EGL-15 signaling that resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1217">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the normal site of the intron 12 fitting donor could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1218">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the other three mutations that has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1219">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the place of normal splice donor of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1220">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that may have resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1221">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which may have resulted entirely in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1222">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Diminutive EGL-15 signal that resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1223">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Diminutive EGL-15 signal which may have resulted entirely in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1224">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Diminutive EGL-15 signal which may have resulted entirely in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1225">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a decrease in transcription of the csgA gene encoding csgA that result able to give rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1226">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a decrease in transcription of the csgA gene from csglin encoding that result able to give rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1227">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1228">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that result able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1229">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF that result able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1230">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which may have resulted entirely in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1231">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1232">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative of a single transcription cut that may have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1233">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of a single transcription that resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1234">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of a single transcription which may have resulted entirely in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1235">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1236">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, that result able to give rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1237">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both 5 and 3 splice mutations which may have resulted entirely in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1238">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both the mutations at the site of 5 and 3 splices that may have resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1239">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both the mutations at the site of 5 and 3 splices that result able to give rise to of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1240">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both the mutations at the site of 5 and 3 splices that resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1241">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both the mutations of 5 and 3 splices that may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1242">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes cooperative bonding of the repressor to its two sites that may have resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1243">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes decreases the EGL-15 signaling that resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1244">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes decreasing EGL-15 sign that resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1245">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential splicing that result able to give rise to the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1246">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential splicing that resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1247">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 skipping in animals s1031 that may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1248">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes failure to use the normal donor site of splice of intron 12 that result able to give rise to a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1249">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes growth in ras-dependent signaling that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1250">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of the variant subunit which may have resulted entirely in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1251">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes not to use the normal donor site of the intron 12 splice that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1252">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced EGL-15 signal that may have resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1253">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced EGL-15 signaling that result able to give rise to a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1254">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced transcription of the csgA curlin encoder gene that resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1255">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced transcription of the csgA gene encoding for curline which may have resulted entirely in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1256">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced transcription of the csgA gene encoding for the clinic which may have resulted entirely in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1257">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of EGL-15 signaling that result able to give rise to dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1258">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of EGL-15 signaling that resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1259">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of csgA gene transcription csgA coding which may have resulted entirely in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1260">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes some alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1261">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the donor site of the normal helix of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1262">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the expression of isoforms of Nrf1 that may have resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1263">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal docking donor site of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1264">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal donor site of intron 12 donation could not be used that resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1265">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal donor site of intron 12 donation could not be used which may have resulted entirely in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1266">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal splice donor site of intron 12 could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1267">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal splice donor site of the 12th intron could not be used that result able to give rise to a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1268">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the other three changes that resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1269">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a decrease in csgA gene transcription from csglin coding that will result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1270">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1271">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1272">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1273">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1274">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes alternative of a single transcription cut that will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1275">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes both 5 and 3 splice mutations that will result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1276">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes both the mutations of 5 and 3 splices that will result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1277">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes exon 13 skipping in animals s1031 that will result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1278">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes growth in ras-dependent signaling that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1279">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes reduced signaling by EGL-15 that will result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1280">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes reduced transcription of the csgA gene encoding for the clinic that will result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1281">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes reduction of EGL-15 signaling that will result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1282">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes the normal donor site of intron 12 donation could not be used that will result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1283">
                    <text>The mixed alternative subdomains has the ability to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1284">
                    <text>The multiple alternative subdomains and alternative transcriptional initiation, as result in our study, are capable of giving rise to a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1285">
                    <text>The multiple alternative subdomains has resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1286">
                    <text>The multiple alternative subdomains is capable of result rise to a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1287">
                    <text>The multiple alternative subdomains resulted in the a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1288">
                    <text>The multiple alternative subdomains, as predicted, has resulted in the a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1289">
                    <text>The multiple alternative subdomains, as predicted, has the ability to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1290">
                    <text>The reduced EGL-15 signal, as predicted, has resulted in the a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1291">
                    <text>The reduced EGL-15 signaling has the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1292">
                    <text>The reduced EGL-15 signaling will result in the a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1293">
                    <text>The reduced signaling by EGL-15 is capable of result rise to pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1294">
                    <text>The reduced signaling by EGL-15 may have resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1295">
                    <text>The reduced signaling by EGL-15 will result in the pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1296">
                    <text>The reduced signaling by EGL-15, as predicted, has resulted in the pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1297">
                    <text>The reduced signaling by EGL-15, as predicted, has the ability to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1298">
                    <text>The reduced transcription of the csgA curlin encoder gene resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1299">
                    <text>The reduced transcription of the csgA gene encoding for the clinic is capable of result rise to negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1300">
                    <text>The reduced transcription of the csgA gene encoding for the clinic may have resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1301">
                    <text>The reduced transcription of the csgA gene encoding for the clinic may have resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1302">
                    <text>The reduced transcription of the csgA gene encoding for the clinic resulted in the negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1303">
                    <text>The reduced transcription of the csgA gene encoding for the clinic, as predicted, has resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1304">
                    <text>The reduced transcription of the csgA gene encoding for the clinic, as predicted, has the ability to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1305">
                    <text>The reduction of EGL-15 signaling has resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1306">
                    <text>The reduction of csgA gene transcription csgA coding has the ability to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1307">
                    <text>The research shows a Clr phenotype resulting from A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1308">
                    <text>The research shows a Clr phenotype resulting from a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1309">
                    <text>The research shows a Clr phenotype resulting from a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1310">
                    <text>The research shows a superrepetitor resulting from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1311">
                    <text>The research shows a variant resulting from the normal site of the intron 12 splice donor could not be used.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1312">
                    <text>The research shows bodys dirty morphology phenotype resulting from reduction of the EGL-15 signaling.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1313">
                    <text>The research shows existence of NF-YA isoforms resulting from differential encryption.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1314">
                    <text>The research shows of high proportion of mature mRNAs containing introns resulting from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1315">
                    <text>The research shows scrutinic body morphology phenotype resulting from decreasing EGL-15 sign.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1316">
                    <text>The research shows the negative effect of the mutation cpxA resulting from a decrease in transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1317">
                    <text>The research shows this resulting from the expression of isoforms of Nrf1.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1318">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1319">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1320">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1321">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1322">
                    <text>The sequence analysis of the HDIbeta gene indicates that a phenotype of scrawny morphology has the ability to result from reduced EGL-15 signal.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1323">
                    <text>The sequence analysis of the HDIbeta gene indicates that a phenotype of scruwny body morphology has the ability to result from GL-15 Decrease Flag.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1324">
                    <text>The sequence analysis of the HDIbeta gene indicates that a variant has the ability to result from the normal donor site of intron 12 donation could not be used.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1325">
                    <text>The sequence analysis of the HDIbeta gene indicates that bodys dirty morphology phenotype has the ability to result from reduction of the EGL-15 signaling.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1326">
                    <text>The sequence analysis of the HDIbeta gene indicates that difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) has the ability to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1327">
                    <text>The sequence analysis of the HDIbeta gene indicates that high ratios of mature RNAm containing introns has the ability to result from both 5 and 3 splice local mutations.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1328">
                    <text>The sequence analysis of the HDIbeta gene indicates that negative effect of the mutation cpxA has the ability to result from reduced transcription of the csgA curlin encoder gene.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1329">
                    <text>The sequence analysis of the HDIbeta gene indicates that pulled body morphology phenotype has the ability to result from reduced signaling by EGL-15.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1330">
                    <text>The sequence analysis of the HDIbeta gene indicates that superrepetition has the ability to result from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1331">
                    <text>The sequence analysis of the HDIbeta gene indicates that the existence of isoforms of NF-YA has the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1332">
                    <text>The sequence analysis of the HDIbeta gene indicates that the negative effect of cpxA mutation has the ability to result from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1333">
                    <text>The sequence analysis of the HDIbeta gene indicates that the negative effect of the mutation cpxA has the ability to result from a decrease in the transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1334">
                    <text>The sequence analysis of the HDIbeta gene indicates that the negative effect of the mutation cpxA has the ability to result from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1335">
                    <text>The sequence analysis of the HDIbeta gene indicates that this has the ability to result from expression of Nrf1 isoforms.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1336">
                    <text>The the donor place of normal helix of intron 12 could not be used has resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1337">
                    <text>The the donor place of normal helix of intron 12 could not be used, as predicted, has the ability to result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1338">
                    <text>The the donor site of the normal helix of intron 12 could not be used will result in the a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1339">
                    <text>The the net charge of the variant subunit will result in the a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1340">
                    <text>The the normal donor site of intron 12 donation could not be used and alternative transcriptional initiation, as result in our study, are capable of giving rise to a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1341">
                    <text>The the normal site of the intron 12 fitting donor could not be used is capable of result rise to a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1342">
                    <text>The the normal site of the intron 12 fitting donor could not be used may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1343">
                    <text>The the normal site of the intron 12 fitting donor could not be used resulted in the a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1344">
                    <text>The the normal site of the intron 12 splice donor could not be used has resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1345">
                    <text>The the normal site of the intron 12 splice donor could not be used has the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1346">
                    <text>The the normal site of the intron 12 splice donor could not be used may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1347">
                    <text>The the normal splice donor site of intron 12 could not be used and alternative transcriptional initiation, as result in our study, are capable of giving rise to a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1348">
                    <text>The the normal splice donor site of intron 12 could not be used may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1349">
                    <text>The the other three changes and alternative transcriptional initiation, as result in our study, are capable of giving rise to non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1350">
                    <text>The the other three changes may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1351">
                    <text>The the other three mutations, as predicted, has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1352">
                    <text>The the place of normal splice donor of intron 12 could not be used may have resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1353">
                    <text>The the place of normal splice donor of intron 12 could not be used resulted in the a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1354">
                    <text>The the place of normal splice donor of intron 12 could not be used, as predicted, has the ability to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1355">
                    <text>We also report a Clr phenotype that may have resulted from A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1356">
                    <text>We also report a Clr phenotype that may have resulted from a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1357">
                    <text>We also report difference in the 28 C-terminal amino acids between beta(1) and beta(2) that may have resulted from alternative deflection of a single transcription.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1358">
                    <text>We also report high ratios of mature RNAm containing introns that may have resulted from both 5 and 3 splice local mutations.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1359">
                    <text>We also report non-functional truncated proteins that may have resulted from the other three mutations.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1360">
                    <text>We also report of high proportion of mature mRNAs containing introns that may have resulted from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1361">
                    <text>We also report of high proportion of mature mRNAs containing introns that may have resulted from both the mutations of 5 and 3 splices.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1362">
                    <text>We also report the a 543 bp product with the capability to result from exon 13 skipping in animals s1031.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1363">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1364">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1365">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1366">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1367">
                    <text>We also report the a dirty body morphology phenotype with the capability to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1368">
                    <text>We also report the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity with the capability to result from growth in ras-dependent signaling.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1369">
                    <text>We also report the a phenotype of scrubbing body morphology with the capability to result from Diminutive EGL-15 signal.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1370">
                    <text>We also report the a phenotype of scrubbing body morphology with the capability to result from decreases the EGL-15 signaling.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1371">
                    <text>We also report the a superrepetitor with the capability to result from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1372">
                    <text>We also report the a variant with the capability to result from failure to use the normal donor site of splice of intron 12.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1373">
                    <text>We also report the an electrophoretic subunit of fast LDH-B subunits with the capability to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1374">
                    <text>We also report the an electrophoretic subunit of fast-type LDH-B subunits with the capability to result from liquid charge of the variant subunit.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1375">
                    <text>We also report the bodys dirty morphology phenotype with the capability to result from reduction of the EGL-15 signaling.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1376">
                    <text>We also report the difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) with the capability to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1377">
                    <text>We also report the high ratios of mature RNAm containing introns with the capability to result from both 5 and 3 splice mutations.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1378">
                    <text>We also report the negative effect of the mutation cpxA that may have resulted from a decrease in the transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1379">
                    <text>We also report the negative effect of the mutation cpxA with the capability to result from reduced transcription of the csgA curlin encoder gene.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1380">
                    <text>We also report the pulled body morphology phenotype with the capability to result from reduced signaling by EGL-15.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1381">
                    <text>We also report the scratched body morphology phenotype with the capability to result from decreasing EGL-15 signal.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1382">
                    <text>We also report the the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins with the capability to result from alternative splicing of a single transcription.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1383">
                    <text>We also report this that may have resulted from expression of Nrf1 isoforms.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1384">
                    <text>We also report this that may have resulted from the expression of isoforms of Nrf1.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1385">
                    <text>We also reported that a marked increase in acetylhydrolase activity PAF is able to result from expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1386">
                    <text>We also reported that a phenotype of scrawny morphology is able to result from reduced EGL-15 signal.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1387">
                    <text>We also reported that a variant is able to result from failure to use the normal site of the intron 12 splice donor.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1388">
                    <text>We also reported that a variant is able to result from the donor place of normal helix of intron 12 could not be used.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1389">
                    <text>We also reported that of high proportion of mature mRNAs containing introns is able to result from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1390">
                    <text>We also reported that scratched body morphology phenotype is able to result from decreasing EGL-15 signal.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1391">
                    <text>We also reported that this is able to result from expression of Nrf1 isoforms.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1392">
                    <text>a Clr phenotype has the ability to probably result from a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1393">
                    <text>a Clr phenotype has the ability to probably result from a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1394">
                    <text>a Clr phenotype has the ability to probably result from a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1395">
                    <text>a Clr phenotype has the ability to probably result from a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1396">
                    <text>a Clr phenotype has the ability to result from a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1397">
                    <text>a Clr phenotype was able to result from a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1398">
                    <text>a Clr phenotype was also reported to be able to result from a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1399">
                    <text>a Clr phenotype was also reported to be able to result from a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1400">
                    <text>a Clr phenotype was also reported to be able to result from a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1401">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors can result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1402">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1403">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1404">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors cells can result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1405">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors finally resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1406">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1407">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors, as predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1408">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors, as we have predicted, may resulting in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1409">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors, as we have result, is able to give rise to a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1410">
                    <text>a decrease in csgA gene transcription from csglin coding can eventually result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1411">
                    <text>a decrease in csgA gene transcription from csglin coding is likely to resulting in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1412">
                    <text>a decrease in csgA gene transcription from csglin coding may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1413">
                    <text>a decrease in csgA gene transcription from csglin coding, as we have predicted, has the ability to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1414">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA cells may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1415">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA eventually resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1416">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA, as predicted, can result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1417">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA, as we have predicted, has the ability to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1418">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA, as we have predicted, may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1419">
                    <text>a decrease in the transcription of the csgA gene encoding csgA cells has the ability to ultimately result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1420">
                    <text>a decrease in the transcription of the csgA gene encoding csgA cells is eventually able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1421">
                    <text>a decrease in the transcription of the csgA gene encoding csgA has the ability to eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1422">
                    <text>a decrease in the transcription of the csgA gene encoding csgA will eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1423">
                    <text>a decrease in the transcription of the csgA gene encoding csgA, as we have predicted, will result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1424">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding cells is eventually able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1425">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding may eventually result in the negative effect of the mutation cpxA</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1426">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding will eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1427">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding, as we have predicted, may resulting in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1428">
                    <text>a decrease in transcription of the csgA gene encoding csgA has resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1429">
                    <text>a decrease in transcription of the csgA gene encoding csgA may eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1430">
                    <text>a decrease in transcription of the csgA gene encoding csgA will result in the negative effect of the mutation cpxA .</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1431">
                    <text>a decrease in transcription of the csgA gene encoding csgA, as predicted, resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1432">
                    <text>a decrease in transcription of the csgA gene from csglin encoding is shown to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1433">
                    <text>a decrease in transcription of the csgA gene from csglin encoding is shown to ultimately result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1434">
                    <text>a decrease in transcription of the csgA gene from csglin encoding may result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1435">
                    <text>a decrease in transcription of the csgA gene from csglin encoding, as we have predicted, has the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1436">
                    <text>a decrease in transcription of the csgA gene from csglin encoding, as we have result, is able to give rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1437">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity was able to result from growth in ras-dependent signaling.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1438">
                    <text>a phenotype of scrawny morphology has the ability to probably result from Loading Signor of the EGL-15.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1439">
                    <text>a phenotype of scrawny morphology has the ability to result from Diminutive EGL-15 signal.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1440">
                    <text>a phenotype of scrubbing body morphology has the ability to probably result from Diminutive EGL-15 signal.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1441">
                    <text>a phenotype of scrubbing body morphology was also reported to be able to result from Decrease Signor of the EGL-15.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1442">
                    <text>a phenotype of scrubbing body morphology was also reported to be able to result from declining EGL-15.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1443">
                    <text>a phenotype of scruwny body morphology was able to result from GL-15 Decrease Flag.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1444">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1445">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1446">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1447">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1448">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF will finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1449">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1450">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as we have predicted, is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1451">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1452">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF can ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1453">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1454">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1455">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1456">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF will result in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1457">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1458">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1459">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1460">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1461">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1462">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as predicted, can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1463">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1464">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as we have result, is able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1465">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1466">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1467">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1468">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1469">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1470">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development has the ability to eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1471">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1472">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development resulted in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1473">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development, as predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1474">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1475">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1476">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1477">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1478">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive may ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1479">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1480">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive will result in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1481">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, as predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1482">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1483">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, as we have predicted, may resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1484">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF cells can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1485">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1486">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1487">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1488">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1489">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1490">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1491">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may result in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1492">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1493">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor has the ability to eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1494">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1495">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor may ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1496">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor resulted in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1497">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1498">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1499">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1500">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1501">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1502">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1503">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1504">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors will result in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1505">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1506">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, as we have predicted, is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1507">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, as we have predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1508">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor can ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1509">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor cells can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1510">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1511">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor cells has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1512">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1513">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor is likely to resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1514">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1515">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1516">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1517">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1518">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, as we have predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1519">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1520">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1521">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1522">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors, as predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1523">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1524">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors, as we have predicted, is able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1525">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1526">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1527">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1528">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1529">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1530">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as we have result, is able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1531">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1532">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1533">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1534">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, as we have result, is able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1535">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1536">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1537">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1538">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1539">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1540">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling resulted in a Clr phenotype .</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1541">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1542">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1543">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, as predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1544">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF can ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1545">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1546">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1547">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF may eventually result in a Clr phenotype</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1548">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1549">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1550">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1551">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF, as predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1552">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1553">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1554">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1555">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1556">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1557">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1558">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling resulted in a Clr phenotype .</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1559">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling will finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1560">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling, as predicted, can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1561">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF is likely to resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1562">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1563">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1564">
                    <text>a superrepetitor was also reported to be able to result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1565">
                    <text>a variant has the ability to probably result from failure to use the normal donor site of splice of intron 12.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1566">
                    <text>a variant has the ability to probably result from the normal splice donor site of the 12th intron could not be used.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1567">
                    <text>a variant was also reported to be able to result from failure to use the normal donor site of splice of intron 12.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1568">
                    <text>a variant was also reported to be able to result from failure to use the normal site of the intron 12 splice donor.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1569">
                    <text>alternative deflection of a single transcription can eventually result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1570">
                    <text>alternative deflection of a single transcription can result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1571">
                    <text>alternative deflection of a single transcription cells has the ability to ultimately result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1572">
                    <text>alternative deflection of a single transcription has the ability to eventually result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1573">
                    <text>alternative deflection of a single transcription is able to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1574">
                    <text>alternative deflection of a single transcription is capable of result rise to difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1575">
                    <text>alternative deflection of a single transcription, as we have predicted, is likely to resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1576">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start cells can result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1577">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start is capable of result rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1578">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start is shown to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1579">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may eventually result in mRNA species with different 5UTRs</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1580">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may result in mRNA species with different 5UTRs .</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1581">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may ultimately resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1582">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as we have predicted, may result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1583">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as we have predicted, may resulting in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1584">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as we have predicted, will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1585">
                    <text>alternative exon splicing 139 nt cells has resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1586">
                    <text>alternative exon splicing 139 nt may eventually result in mRNA species with 5 distinct UTRs</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1587">
                    <text>alternative exon splicing 139 nt, as we have predicted, is able to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1588">
                    <text>alternative exon splicing 139 nt, as we have predicted, will result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1589">
                    <text>alternative of a single transcription cut has the ability to eventually result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1590">
                    <text>alternative of a single transcription cut is able to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1591">
                    <text>alternative of a single transcription cut is shown to ultimately result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1592">
                    <text>alternative of a single transcription cut may have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1593">
                    <text>alternative of a single transcription cut may ultimately result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1594">
                    <text>alternative of a single transcription cut may ultimately resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1595">
                    <text>alternative of a single transcription cut will eventually result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1596">
                    <text>alternative of a single transcription cut will eventually result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1597">
                    <text>alternative of a single transcription cut will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) .</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1598">
                    <text>alternative of a single transcription cut, as predicted, resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1599">
                    <text>alternative of a single transcription cut, as predicted, will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1600">
                    <text>alternative of a single transcription cut, as we have predicted, may resulting in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1601">
                    <text>alternative spacer of a single transcription can eventually result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1602">
                    <text>alternative spacer of a single transcription may have finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1603">
                    <text>alternative spacer of a single transcription, as predicted, resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1604">
                    <text>alternative spacer of a single transcription, as we have predicted, may resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1605">
                    <text>alternative splicing of a single transcription can result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1606">
                    <text>alternative splicing of a single transcription cells is eventually able to result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1607">
                    <text>alternative splicing of a single transcription cells may have resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1608">
                    <text>alternative splicing of a single transcription is capable of result rise to the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1609">
                    <text>alternative splicing of a single transcription is shown to result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1610">
                    <text>alternative splicing of a single transcription is shown to ultimately result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1611">
                    <text>alternative splicing of a single transcription may ultimately result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1612">
                    <text>alternative splicing of a single transcription will finally result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1613">
                    <text>alternative splicing of a single transcription, as predicted, may have resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1614">
                    <text>alternative splicing of a single transcription, as predicted, resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1615">
                    <text>alternative splicing of a single transcription, as we have predicted, has the ability to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1616">
                    <text>alternative splicing of a single transcription, as we have predicted, may result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1617">
                    <text>alternative splicing of a single transcription, as we have predicted, may result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1618">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation cells has the ability to ultimately result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1619">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation cells is eventually able to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1620">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation has finally resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1621">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation is shown to ultimately result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1622">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have finally resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1623">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as predicted, may have resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1624">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, cells eventually resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1625">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may have resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1626">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1627">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,, as predicted, will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1628">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,, as we have predicted, may resulting in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1629">
                    <text>an electrophoretic subunit of fast-type LDH-B subunits was also reported to be able to result from liquid charge of the variant subunit.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1630">
                    <text>bodys dirty morphology phenotype was able to result from reduction of the EGL-15 signaling.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1631">
                    <text>both 5 and 3 splice local mutations cells has resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1632">
                    <text>both 5 and 3 splice local mutations has finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1633">
                    <text>both 5 and 3 splice local mutations is able to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1634">
                    <text>both 5 and 3 splice local mutations is likely to resulting in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1635">
                    <text>both 5 and 3 splice local mutations may have finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1636">
                    <text>both 5 and 3 splice local mutations may have resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1637">
                    <text>both 5 and 3 splice local mutations may result in high ratios of mature RNAm containing introns .</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1638">
                    <text>both 5 and 3 splice local mutations may result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1639">
                    <text>both 5 and 3 splice local mutations, as we have predicted, has the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1640">
                    <text>both 5 and 3 splice local mutations, as we have predicted, may have resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1641">
                    <text>both 5 and 3 splice mutations cells eventually resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1642">
                    <text>both 5 and 3 splice mutations cells eventually resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1643">
                    <text>both 5 and 3 splice mutations has resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1644">
                    <text>both 5 and 3 splice mutations is able to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1645">
                    <text>both 5 and 3 splice mutations is able to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1646">
                    <text>both 5 and 3 splice mutations is shown to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1647">
                    <text>both 5 and 3 splice mutations may eventually result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1648">
                    <text>both 5 and 3 splice mutations may eventually result in high ratios of mature RNAm containing introns</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1649">
                    <text>both 5 and 3 splice mutations may ultimately resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1650">
                    <text>both 5 and 3 splice mutations resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1651">
                    <text>both 5 and 3 splice mutations, as predicted, resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1652">
                    <text>both 5 and 3 splice mutations, as we have predicted, is likely to resulting in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1653">
                    <text>both 5 and 3 splice mutations, as we have predicted, will result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1654">
                    <text>both the mutations at the site of 5 and 3 splices can eventually result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1655">
                    <text>both the mutations at the site of 5 and 3 splices can ultimately resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1656">
                    <text>both the mutations at the site of 5 and 3 splices can ultimately resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1657">
                    <text>both the mutations at the site of 5 and 3 splices cells eventually resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1658">
                    <text>both the mutations at the site of 5 and 3 splices cells may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1659">
                    <text>both the mutations at the site of 5 and 3 splices is capable of result rise to high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1660">
                    <text>both the mutations at the site of 5 and 3 splices is shown to ultimately result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1661">
                    <text>both the mutations at the site of 5 and 3 splices may result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1662">
                    <text>both the mutations at the site of 5 and 3 splices may result in of high proportion of mature mRNAs containing introns .</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1663">
                    <text>both the mutations at the site of 5 and 3 splices resulted in of high proportion of mature mRNA containing introns .</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1664">
                    <text>both the mutations at the site of 5 and 3 splices will finally result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1665">
                    <text>both the mutations at the site of 5 and 3 splices will finally result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1666">
                    <text>both the mutations at the site of 5 and 3 splices will result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1667">
                    <text>both the mutations at the site of 5 and 3 splices, as predicted, may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1668">
                    <text>both the mutations at the site of 5 and 3 splices, as predicted, will result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1669">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, has the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1670">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, has the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1671">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, may resulting in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1672">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1673">
                    <text>both the mutations of 5 and 3 splices can eventually result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1674">
                    <text>both the mutations of 5 and 3 splices can result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1675">
                    <text>both the mutations of 5 and 3 splices cells has the ability to ultimately result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1676">
                    <text>both the mutations of 5 and 3 splices cells may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1677">
                    <text>both the mutations of 5 and 3 splices may eventually result in of high proportion of mature mRNA containing introns</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1678">
                    <text>both the mutations of 5 and 3 splices may eventually result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1679">
                    <text>both the mutations of 5 and 3 splices, as we have predicted, may resulting in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1680">
                    <text>cooperative binding of the repressor to its two sites can ultimately resulted in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1681">
                    <text>cooperative binding of the repressor to its two sites is capable of result rise to repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1682">
                    <text>cooperative binding of the repressor to its two sites may have finally resulted in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1683">
                    <text>cooperative binding of the repressor to its two sites may result in repression .</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1684">
                    <text>cooperative binding of the repressor to its two sites, as we have predicted, has the ability to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1685">
                    <text>cooperative binding of the repressor to its two sites, as we have predicted, may resulting in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1686">
                    <text>cooperative bonding of the repressor to its two sites, as predicted, resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1687">
                    <text>cooperative bonding of the repressor to its two sites, as we have predicted, is likely to resulting in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1688">
                    <text>declining EGL-15 can ultimately resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1689">
                    <text>declining EGL-15 cells eventually resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1690">
                    <text>declining EGL-15 has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1691">
                    <text>declining EGL-15 may eventually result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1692">
                    <text>declining EGL-15 may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1693">
                    <text>declining EGL-15 will result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1694">
                    <text>declining EGL-15, as predicted, may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1695">
                    <text>declining EGL-15, as we have predicted, is able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1696">
                    <text>declining EGL-15, as we have predicted, may resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1697">
                    <text>decreases the EGL-15 signaling can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1698">
                    <text>decreases the EGL-15 signaling cells can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1699">
                    <text>decreases the EGL-15 signaling eventually resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1700">
                    <text>decreases the EGL-15 signaling may eventually result in a phenotype of scrubbing body morphology</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1701">
                    <text>decreases the EGL-15 signaling will eventually result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1702">
                    <text>decreases the EGL-15 signaling, as we have predicted, may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1703">
                    <text>decreasing EGL-15 sign can eventually result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1704">
                    <text>decreasing EGL-15 sign cells is eventually able to result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1705">
                    <text>decreasing EGL-15 sign finally resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1706">
                    <text>decreasing EGL-15 sign may eventually result in scrutinic body morphology phenotype</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1707">
                    <text>decreasing EGL-15 sign, as predicted, may have resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1708">
                    <text>decreasing EGL-15 sign, as predicted, resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1709">
                    <text>decreasing EGL-15 sign, as we have predicted, has the ability to result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1710">
                    <text>decreasing EGL-15 sign, as we have predicted, resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1711">
                    <text>decreasing EGL-15 signal has resulted in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1712">
                    <text>decreasing EGL-15 signal is shown to result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1713">
                    <text>decreasing EGL-15 signal will eventually result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1714">
                    <text>decreasing EGL-15 signal, as we have predicted, is able to result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1715">
                    <text>difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) was also reported to be able to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1716">
                    <text>difference in the 28 C-terminal amino acids between beta(1) and beta(2) was able to result from alternative deflection of a single transcription.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1717">
                    <text>differential encryption may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1718">
                    <text>differential encryption may ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1719">
                    <text>differential encryption will result in existence of NF-YA isoforms .</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1720">
                    <text>differential encryption, as predicted, will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1721">
                    <text>differential encryption, as we have predicted, is likely to resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1722">
                    <text>differential encryption, as we have predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1723">
                    <text>differential splicing cells can result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1724">
                    <text>differential splicing cells has resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1725">
                    <text>differential splicing cells has the ability to ultimately result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1726">
                    <text>differential splicing eventually resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1727">
                    <text>differential splicing is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1728">
                    <text>differential splicing is able to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1729">
                    <text>differential splicing is likely to resulting in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1730">
                    <text>differential splicing is shown to ultimately result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1731">
                    <text>differential splicing may have finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1732">
                    <text>differential splicing may have finally resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1733">
                    <text>differential splicing may have resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1734">
                    <text>differential splicing resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1735">
                    <text>differential splicing will result in the existence of isoforms of NF-YA .</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1736">
                    <text>differential splicing, as we have predicted, has the ability to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1737">
                    <text>differential splicing, as we have predicted, is likely to resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1738">
                    <text>differential splicing, as we have predicted, may have resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1739">
                    <text>differential splicing, as we have predicted, may result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1740">
                    <text>dirty body morphology phenotype has the ability to probably result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1741">
                    <text>dirty body morphology phenotype was able to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1742">
                    <text>existence of NF-YA isoforms has the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1743">
                    <text>existence of NF-YA isoforms was also reported to be able to result from differential encryption.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1744">
                    <text>exon 13 skipping in animals s1031 cells has the ability to ultimately result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1745">
                    <text>exon 13 skipping in animals s1031 may result in a 543 bp product .</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1746">
                    <text>expression of Nrf1 isoforms cells can result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1747">
                    <text>expression of Nrf1 isoforms eventually resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1748">
                    <text>expression of Nrf1 isoforms has the ability to eventually result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1749">
                    <text>expression of Nrf1 isoforms has the ability to result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1750">
                    <text>expression of Nrf1 isoforms may result in this .</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1751">
                    <text>expression of Nrf1 isoforms may result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1752">
                    <text>expression of Nrf1 isoforms resulted in this .</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1753">
                    <text>expression of Nrf1 isoforms will eventually result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1754">
                    <text>expression of Nrf1 isoforms, as we have predicted, is able to result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1755">
                    <text>expression of cDNA isoform II DNA in COS7 can eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1756">
                    <text>expression of cDNA isoform II DNA in COS7 eventually resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1757">
                    <text>expression of cDNA isoform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1758">
                    <text>expression of cDNA isoform II DNA in COS7 is shown to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1759">
                    <text>expression of cDNA isoform II DNA in COS7 may result in a marked increase in acetylhydrolase activity PAF .</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1760">
                    <text>expression of cDNA isoform II DNA in COS7, as we have predicted, is likely to resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1761">
                    <text>failure to use the normal donor site of splice of intron 12 cells may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1762">
                    <text>failure to use the normal donor site of splice of intron 12 may eventually result in a variant</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1763">
                    <text>failure to use the normal donor site of splice of intron 12 will result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1764">
                    <text>failure to use the normal donor site of splice of intron 12, as we have predicted, resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1765">
                    <text>failure to use the normal donor site of splice of intron 12, as we have result, is able to give rise to a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1766">
                    <text>failure to use the normal site of the intron 12 splice donor is likely to resulting in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1767">
                    <text>failure to use the normal site of the intron 12 splice donor may result in a variant .</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1768">
                    <text>failure to use the normal site of the intron 12 splice donor, as we have predicted, is able to result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1769">
                    <text>failure to use the normal site of the intron 12 splice donor, as we have predicted, is likely to resulting in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1770">
                    <text>growth in ras-dependent signaling cells is eventually able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1771">
                    <text>growth in ras-dependent signaling has the ability to eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1772">
                    <text>growth in ras-dependent signaling is able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1773">
                    <text>growth in ras-dependent signaling is shown to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1774">
                    <text>growth in ras-dependent signaling resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1775">
                    <text>growth in ras-dependent signaling resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1776">
                    <text>growth in ras-dependent signaling will finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1777">
                    <text>growth in ras-dependent signaling, as we have predicted, may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1778">
                    <text>growth in ras-dependent signaling, as we have result, is able to give rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1779">
                    <text>liquid charge of the variant subunit cells eventually resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1780">
                    <text>liquid charge of the variant subunit has resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1781">
                    <text>liquid charge of the variant subunit may eventually result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1782">
                    <text>liquid charge of the variant subunit, as we have predicted, may resulting in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1783">
                    <text>liquid charge of varying subunits can eventually result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1784">
                    <text>liquid charge of varying subunits cells eventually resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1785">
                    <text>liquid charge of varying subunits cells has resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1786">
                    <text>liquid charge of varying subunits has finally resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1787">
                    <text>liquid charge of varying subunits may have resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1788">
                    <text>liquid charge of varying subunits resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1789">
                    <text>liquid charge of varying subunits will eventually result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1790">
                    <text>liquid charge of varying subunits, as we have result, is able to give rise to an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1791">
                    <text>mRNA species with 5 distinct UTRs was able to result from alternative exon splicing 139 nt.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1792">
                    <text>mRNA species with different 5UTRs has the ability to probably result from alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1793">
                    <text>mRNA species with different 5UTRs has the ability to result from alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1794">
                    <text>mixed alternative subdomains is capable of result rise to a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1795">
                    <text>mixed alternative subdomains may ultimately result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1796">
                    <text>mixed alternative subdomains, as we have predicted, resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1797">
                    <text>multiple alternative subdomains cells can result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1798">
                    <text>multiple alternative subdomains cells has resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1799">
                    <text>multiple alternative subdomains eventually resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1800">
                    <text>multiple alternative subdomains eventually resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1801">
                    <text>multiple alternative subdomains has finally resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1802">
                    <text>multiple alternative subdomains has the ability to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1803">
                    <text>multiple alternative subdomains has the ability to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1804">
                    <text>multiple alternative subdomains is able to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1805">
                    <text>multiple alternative subdomains may result in superrepetition .</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1806">
                    <text>multiple alternative subdomains resulted in superrepetition .</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1807">
                    <text>multiple alternative subdomains resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1808">
                    <text>multiple alternative subdomains, as predicted, resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1809">
                    <text>multiple alternative subdomains, as we have predicted, may have resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1810">
                    <text>multiple alternative subdomains, as we have predicted, may result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1811">
                    <text>negative effect of cpxA mutation was also reported to be able to result from reduction of csgA gene transcription csgA coding.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1812">
                    <text>negative effect of the mutation cpxA has the ability to probably result from reduced transcription of the csgA gene encoding for the clinic.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1813">
                    <text>negative effect of the mutation cpxA was able to result from reduced transcription of the csgA gene encoding for the clinic.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1814">
                    <text>negative mutation effect cpxA was able to result from reduced transcription of the csgA gene encoding for the clinic.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1815">
                    <text>not to use the normal donor site of the intron 12 splice cells can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1816">
                    <text>not to use the normal donor site of the intron 12 splice cells eventually resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1817">
                    <text>not to use the normal donor site of the intron 12 splice cells has the ability to ultimately result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1818">
                    <text>not to use the normal donor site of the intron 12 splice eventually resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1819">
                    <text>not to use the normal donor site of the intron 12 splice finally resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1820">
                    <text>not to use the normal donor site of the intron 12 splice has resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1821">
                    <text>not to use the normal donor site of the intron 12 splice is likely to resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1822">
                    <text>not to use the normal donor site of the intron 12 splice is shown to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1823">
                    <text>not to use the normal donor site of the intron 12 splice may eventually result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1824">
                    <text>not to use the normal donor site of the intron 12 splice may result in a variant .</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1825">
                    <text>not to use the normal donor site of the intron 12 splice will finally result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1826">
                    <text>not to use the normal donor site of the intron 12 splice, as predicted, may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1827">
                    <text>not to use the normal donor site of the intron 12 splice, as we have result, is able to give rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1828">
                    <text>pulled body morphology phenotype was also reported to be able to result from reduced signaling by EGL-15.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1829">
                    <text>reduced EGL-15 signal can result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1830">
                    <text>reduced EGL-15 signal has finally resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1831">
                    <text>reduced EGL-15 signal is likely to resulting in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1832">
                    <text>reduced EGL-15 signal, as we have predicted, resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1833">
                    <text>reduced EGL-15 signaling has the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1834">
                    <text>reduced EGL-15 signaling may have finally resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1835">
                    <text>reduced EGL-15 signaling may result in a phenotype of dirty body morphology .</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1836">
                    <text>reduced EGL-15 signaling resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1837">
                    <text>reduced EGL-15 signaling, as we have predicted, may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1838">
                    <text>reduced signaling by EGL-15 can eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1839">
                    <text>reduced signaling by EGL-15 can result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1840">
                    <text>reduced signaling by EGL-15 cells has resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1841">
                    <text>reduced signaling by EGL-15 eventually resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1842">
                    <text>reduced signaling by EGL-15 is shown to ultimately result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1843">
                    <text>reduced signaling by EGL-15 may eventually result in a phenotype of dirty body morphology</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1844">
                    <text>reduced signaling by EGL-15 may eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1845">
                    <text>reduced signaling by EGL-15 may result in a phenotype of dirty body morphology .</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1846">
                    <text>reduced signaling by EGL-15 will result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1847">
                    <text>reduced signaling by EGL-15, as predicted, can result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1848">
                    <text>reduced signaling by EGL-15, as predicted, resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1849">
                    <text>reduced signaling by EGL-15, as we have predicted, has the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1850">
                    <text>reduced signaling by EGL-15, as we have predicted, is able to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1851">
                    <text>reduced signaling by EGL-15, as we have predicted, may result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1852">
                    <text>reduced signaling by EGL-15, as we have predicted, may resulting in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1853">
                    <text>reduced signaling by EGL-15, as we have predicted, will result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1854">
                    <text>reduced transcription of the csgA curlin encoder gene can result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1855">
                    <text>reduced transcription of the csgA curlin encoder gene can ultimately resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1856">
                    <text>reduced transcription of the csgA curlin encoder gene resulted in negative effect of the mutation cpxA .</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1857">
                    <text>reduced transcription of the csgA curlin encoder gene resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1858">
                    <text>reduced transcription of the csgA curlin encoder gene will finally result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1859">
                    <text>reduced transcription of the csgA curlin encoder gene will result in negative effect of the mutation cpxA .</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1860">
                    <text>reduced transcription of the csgA curlin encoder gene, as we have predicted, will result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1861">
                    <text>reduced transcription of the csgA curlin encoder gene, as we have result, is able to give rise to negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1862">
                    <text>reduced transcription of the csgA gene encoding for curline cells may have resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1863">
                    <text>reduced transcription of the csgA gene encoding for curline finally resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1864">
                    <text>reduced transcription of the csgA gene encoding for curline has resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1865">
                    <text>reduced transcription of the csgA gene encoding for curline has the ability to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1866">
                    <text>reduced transcription of the csgA gene encoding for curline is shown to ultimately result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1867">
                    <text>reduced transcription of the csgA gene encoding for curline will result in negative mutation effect cpxA .</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1868">
                    <text>reduced transcription of the csgA gene encoding for curline, as predicted, resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1869">
                    <text>reduced transcription of the csgA gene encoding for curline, as we have predicted, may result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1870">
                    <text>reduced transcription of the csgA gene encoding for the clinic has the ability to eventually result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1871">
                    <text>reduced transcription of the csgA gene encoding for the clinic has the ability to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1872">
                    <text>reduced transcription of the csgA gene encoding for the clinic may eventually result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1873">
                    <text>reduced transcription of the csgA gene encoding for the clinic may result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1874">
                    <text>reduced transcription of the csgA gene encoding for the clinic may result in negative mutation effect cpxA .</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1875">
                    <text>reduced transcription of the csgA gene encoding for the clinic will result in negative effect of the mutation cpxA .</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1876">
                    <text>reduced transcription of the csgA gene encoding for the clinic, as we have predicted, may resulting in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1877">
                    <text>reduced transcription of the csgA gene encoding for the clinic, as we have predicted, resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1878">
                    <text>reduction of EGL-15 signaling can eventually result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1879">
                    <text>reduction of EGL-15 signaling cells can result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1880">
                    <text>reduction of EGL-15 signaling cells has resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1881">
                    <text>reduction of EGL-15 signaling has finally resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1882">
                    <text>reduction of EGL-15 signaling has the ability to eventually result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1883">
                    <text>reduction of EGL-15 signaling may eventually result in a dirty body morphology phenotype</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1884">
                    <text>reduction of EGL-15 signaling may eventually result in scratched body morphology phenotype</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1885">
                    <text>reduction of EGL-15 signaling may result in scratched body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1886">
                    <text>reduction of EGL-15 signaling resulted in scratched body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1887">
                    <text>reduction of EGL-15 signaling, as predicted, resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1888">
                    <text>reduction of EGL-15 signaling, as predicted, resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1889">
                    <text>reduction of EGL-15 signaling, as predicted, will result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1890">
                    <text>reduction of EGL-15 signaling, as we have predicted, has the ability to result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1891">
                    <text>reduction of EGL-15 signaling, as we have predicted, may have resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1892">
                    <text>reduction of csgA gene transcription csgA coding has the ability to eventually result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1893">
                    <text>reduction of csgA gene transcription csgA coding, as we have predicted, may result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1894">
                    <text>reduction of the EGL-15 signaling cells has the ability to ultimately result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1895">
                    <text>reduction of the EGL-15 signaling is likely to resulting in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1896">
                    <text>scratched body morphology phenotype has the ability to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1897">
                    <text>scrutinic body morphology phenotype has the ability to probably result from decreasing EGL-15 sign.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1898">
                    <text>some alternative subdomains can result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1899">
                    <text>some alternative subdomains can ultimately resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1900">
                    <text>some alternative subdomains cells can result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1901">
                    <text>some alternative subdomains cells may have resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1902">
                    <text>some alternative subdomains has the ability to result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1903">
                    <text>some alternative subdomains is shown to ultimately result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1904">
                    <text>some alternative subdomains, as we have result, is able to give rise to a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1905">
                    <text>superrepetition was able to result from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1906">
                    <text>the difference in the 28 C-terminal amino acids between beta(1) and beta(2) has the ability to probably result from alternative splicing of a single transcription.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1907">
                    <text>the donor place of normal helix of intron 12 could not be used can eventually result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1908">
                    <text>the donor place of normal helix of intron 12 could not be used cells may have resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1909">
                    <text>the donor place of normal helix of intron 12 could not be used has the ability to eventually result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1910">
                    <text>the donor place of normal helix of intron 12 could not be used resulted in a variant .</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1911">
                    <text>the donor place of normal helix of intron 12 could not be used will finally result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1912">
                    <text>the donor place of normal helix of intron 12 could not be used, as we have predicted, will result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1913">
                    <text>the donor site of the normal helix of intron 12 could not be used is shown to ultimately result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1914">
                    <text>the donor site of the normal helix of intron 12 could not be used may have finally resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1915">
                    <text>the existence of isoforms of NF-YA has the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1916">
                    <text>the expression of isoforms of Nrf1 can ultimately resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1917">
                    <text>the expression of isoforms of Nrf1 cells has the ability to ultimately result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1918">
                    <text>the expression of isoforms of Nrf1 cells is eventually able to result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1919">
                    <text>the expression of isoforms of Nrf1 has finally resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1920">
                    <text>the expression of isoforms of Nrf1 has the ability to result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1921">
                    <text>the expression of isoforms of Nrf1 is likely to resulting in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1922">
                    <text>the expression of isoforms of Nrf1 is shown to result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1923">
                    <text>the expression of isoforms of Nrf1 may eventually result in this</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1924">
                    <text>the negative effect of cpxA mutation has the ability to result from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1925">
                    <text>the negative effect of cpxA mutation was able to result from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1926">
                    <text>the negative effect of the mutation cpxA was also reported to be able to result from a decrease in transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1927">
                    <text>the net charge of the variant subunit can ultimately resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1928">
                    <text>the net charge of the variant subunit cells is eventually able to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1929">
                    <text>the net charge of the variant subunit has the ability to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1930">
                    <text>the net charge of the variant subunit is shown to ultimately result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1931">
                    <text>the net charge of the variant subunit resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1932">
                    <text>the net charge of the variant subunit will result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1933">
                    <text>the net charge of the variant subunit, as we have predicted, is likely to resulting in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1934">
                    <text>the normal docking donor site of intron 12 could not be used eventually resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1935">
                    <text>the normal docking donor site of intron 12 could not be used is capable of result rise to a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1936">
                    <text>the normal docking donor site of intron 12 could not be used may eventually result in a variant</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1937">
                    <text>the normal docking donor site of intron 12 could not be used may result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1938">
                    <text>the normal docking donor site of intron 12 could not be used will result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1939">
                    <text>the normal docking donor site of intron 12 could not be used, as predicted, can result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1940">
                    <text>the normal docking donor site of intron 12 could not be used, as we have predicted, is likely to resulting in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1941">
                    <text>the normal donor site of intron 12 donation could not be used may ultimately result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1942">
                    <text>the normal donor site of intron 12 donation could not be used resulted in a variant .</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1943">
                    <text>the normal donor site of intron 12 donation could not be used will finally result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1944">
                    <text>the normal donor site of intron 12 donation could not be used, as we have predicted, has the ability to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1945">
                    <text>the normal site of the intron 12 fitting donor could not be used cells is eventually able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1946">
                    <text>the normal site of the intron 12 fitting donor could not be used, as predicted, may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1947">
                    <text>the normal site of the intron 12 fitting donor could not be used, as we have predicted, may result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1948">
                    <text>the normal site of the intron 12 splice donor could not be used eventually resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1949">
                    <text>the normal site of the intron 12 splice donor could not be used has the ability to eventually result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1950">
                    <text>the normal site of the intron 12 splice donor could not be used may have finally resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1951">
                    <text>the normal site of the intron 12 splice donor could not be used may ultimately result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1952">
                    <text>the normal site of the intron 12 splice donor could not be used may ultimately resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1953">
                    <text>the normal site of the intron 12 splice donor could not be used resulted in a variant .</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1954">
                    <text>the normal site of the intron 12 splice donor could not be used resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1955">
                    <text>the normal site of the intron 12 splice donor could not be used, as predicted, may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1956">
                    <text>the normal site of the intron 12 splice donor could not be used, as we have predicted, is able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1957">
                    <text>the normal site of the intron 12 splice donor could not be used, as we have result, is able to give rise to a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1958">
                    <text>the normal splice donor site of intron 12 could not be used can ultimately resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1959">
                    <text>the normal splice donor site of intron 12 could not be used cells has resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1960">
                    <text>the normal splice donor site of intron 12 could not be used cells may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1961">
                    <text>the normal splice donor site of intron 12 could not be used has resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1962">
                    <text>the normal splice donor site of intron 12 could not be used may result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1963">
                    <text>the normal splice donor site of intron 12 could not be used resulted in a variant .</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1964">
                    <text>the normal splice donor site of the 12th intron could not be used can ultimately resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1965">
                    <text>the normal splice donor site of the 12th intron could not be used eventually resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1966">
                    <text>the normal splice donor site of the 12th intron could not be used has the ability to result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1967">
                    <text>the normal splice donor site of the 12th intron could not be used is shown to ultimately result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1968">
                    <text>the normal splice donor site of the 12th intron could not be used, as we have predicted, is able to result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1969">
                    <text>the normal splice donor site of the 12th intron could not be used, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1970">
                    <text>the other three alterations cells eventually resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1971">
                    <text>the other three alterations may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1972">
                    <text>the other three alterations, as predicted, will result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1973">
                    <text>the other three alterations, as we have predicted, may resulting in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1974">
                    <text>the other three changes cells has the ability to ultimately result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1975">
                    <text>the other three changes has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1976">
                    <text>the other three changes may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1977">
                    <text>the other three changes will eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1978">
                    <text>the other three changes, as we have predicted, is likely to resulting in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1979">
                    <text>the other three mutations cells has resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1980">
                    <text>the other three mutations has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1981">
                    <text>the other three mutations is shown to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1982">
                    <text>the other three mutations will eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1983">
                    <text>the place of normal splice donor of intron 12 could not be used cells eventually resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1984">
                    <text>the place of normal splice donor of intron 12 could not be used cells is eventually able to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1985">
                    <text>this has the ability to result from expression of Nrf1 isoforms.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1986">
                    <text>this was also reported to be able to result from the expression of isoforms of Nrf1.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
